{"add": {"doc": {"field": [{"@name": "docid", "#text": "BR-TU.09821"}, {"@name": "filename", "#text": "14820_000628671.pdf"}, {"@name": "filetype", "#text": "PDF"}, {"@name": "text", "#text": "UNIVERSIDADE FEDERAL DO RIO GRANDE DO SUL \n\nFACULDADE DE FARM\u00c1CIA \n\nPROGRAMA DE P\u00d3S-GRADUA\u00c7\u00c3O EM CI\u00caNCIAS FARMAC\u00caUTICAS \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\nCOMPOSI\u00c7\u00c3O QU\u00cdMICA E AN\u00c1LISE BIOL\u00d3GICA DE ESP\u00c9CIES DO \nG\u00caNERO Baccharis \n\n \n\n \n\n \n\n \n\n \n\n \n\nSimone Quintana de Oliveira \n\n \n\n \n\n \n\n \n\n \n\n \n\nPorto Alegre, 2008 \n\n\n\n \n2\n\nUNIVERSIDADE FEDERAL DO RIO GRANDE DO SUL \n\nFACULDADE DE FARM\u00c1CIA \n\nPROGRAMA DE P\u00d3S-GRADUA\u00c7\u00c3O EM CI\u00caNCIAS FARMAC\u00caUTICAS \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\nCOMPOSI\u00c7\u00c3O QU\u00cdMICA E AN\u00c1LISE BIOL\u00d3GICA DE ESP\u00c9CIES DO \nG\u00caNERO Baccharis \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\nOrientadora: Profa. Dr. Grace Gosmann \n\nCo-orientador: Prof. Dr. Jos\u00e9 Cl\u00e1udio Fonseca Moreira \n\nTese apresentada por Simone Quintana de \nOliveira para obten\u00e7\u00e3o do T\u00cdTULO DE DOUTOR \nem Ci\u00eancias Farmac\u00eauticas \n\n\n\n \n3\n\nTese apresentada ao Programa de P\u00f3s-gradua\u00e7\u00e3o em Ci\u00eancias Farmac\u00eauticas, em \n\nn\u00edvel de doutorado da Faculdade de Farm\u00e1cia da Universidade Federal do Rio \n\nGrande do Sul e aprovada em 17.01.2008, pela Banca Examinadora constitu\u00edda por \n\n \n\nProfa. Dr. Gilsane Lino Von-Poser \n\nUniversidade Federal do Rio Grande do Sul \n\n \n\nProf. Dr. Jarbas Alves Montanha \n\nUniversidade Federal do Rio Grande do Sul \n\n \n\nProfa. Dr. Kellen Christinia Borges de Souza \n\nUniversidade de Caxias do Sul \n\n \n\n  \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\nBibliotec\u00e1ria respons\u00e1vel: \n\nCl\u00e1udia da Silva Gon\u00e7alves de Leon - CRB 10/1012 \n\n \n\n048c  Oliveira, Simone Quintana de \n \nComposi\u00e7\u00e3o qu\u00edmica e an\u00e1lise biol\u00f3gica de esp\u00e9cies do g\u00eanero \n\nBaccharis/Simone Quintana de Oliveira \u2013 Porto Alegre: UFRGS, 2008. iv, \n127 p.:il., tab. \n\n \nTese (doutorado). UFRGS. Faculdade de Farm\u00e1cia. Programa de P\u00f3s-\n\nGradua\u00e7\u00e3o em Ci\u00eancias Farmac\u00eauticas. \n \n1. Farmacologia. 2. Baccharis. 3. Asteraceae. I. Gosmann, Grace. II. \n\nMoreira, Jos\u00e9 Cl\u00e1udio Fonseca. III. T\u00edtulo. \n \n \n \n\n      CDU: 547.9:582.998.2 \n\n\n\n \n4\n\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n\nAgradecimentos ao CNPq, \u00f3rg\u00e3o que financiou a bolsa para o desenvolvimento \n\ndeste trabalho, ao Laborat\u00f3rio de Fitoqu\u00edmica deste programa de P\u00f3s-Gradua\u00e7\u00e3o \n\nem Ci\u00eancias Farmac\u00eauticas, no qual foi desenvolvida a maior parte do presente \n\ntrabalho, ao Laborat\u00f3rio de Microbiologia do Curso de Farm\u00e1cia da UPF, onde foram \n\nrealizados os ensaios de atividade antibacteriana e ao Laborat\u00f3rio 32 do \n\nDepartamento de Bioqu\u00edmica do Instituto de Ci\u00eancias B\u00e1sicas da Sa\u00fade/UFRGS \n\nonde foram desenvolvidos os experimentos de avalia\u00e7\u00e3o da atividade antioxidante.   \n\n  \n \n  \n\n\n\n \n5\n\nAgradecimentos \n \n\u00c0 Profa. Dra. Grace Gosmann pela orienta\u00e7\u00e3o, amizade, carinho, est\u00edmulo e \n\nconfian\u00e7a no decorrer deste trabalho. \n\nAo Prof. Dr. Jos\u00e9 Cl\u00e1udio Fonseca Moreira pela co-orienta\u00e7\u00e3o nos experimentos \n\nrelativos \u00e0 atividade antioxidante. \n\nAos queridos amigos Simone Gnoatto, Juliane Fleck, Gustavo Provensi e Claiton \n\nLencina pela amizade, cumplicidade e muito trabalho em todos estes anos. \n\nAos queridos amigos Fernanda de Costa, Gisele Barbon, Everton Morais, Anna \n\nCarolina Yendo, Luciana Dala Vechia, Cristiane de Oliveira, Caroline e Alexandre \n\nFerraz pelo apoio, carinho e amizade.   \n\n\u00c0s amigas V\u00e2nia Trentin e Virginia Kappel pela ajuda e parceria inestim\u00e1veis neste \n\ntrabalho. \n\n\u00c0 Viviane Silva Pires, pela amizade e parceria, mesmo \u00e0 dist\u00e2ncia. \n\nAo meu grande amor Gustavo por ter chegado para alegrar ainda mais as nossas \n\nvidas e por compreender as aus\u00eancias da mam\u00e3e no final deste trabalho. \n\nAo Fl\u00e1vio, por tudo. \n\nAos meus pais, pela vida, dedica\u00e7\u00e3o, amor e por terem cuidado com tanto carinho \n\ndo Gustavo para que eu pudesse concluir este trabalho. \n\nAos meus sogros, por todo o carinho, amizade e compreens\u00e3o.   \n\n  \n\n \n\n\n\n \n6\n\nSum\u00e1rio \n \n \n\nLista de figuras................................................................................................... III\nLista de tabelas.................................................................................................. IV\nLista de abreviaturas e s\u00edmbolos..................................................................... V\nResumo............................................................................................................... VI\nAbstract............................................................................................................... \n1 INTRODU\u00c7\u00c3O.................................................................................................. \n\nVII\n1\n\n2 OBJETIVOS...................................................................................................... 5\n3 REVIS\u00c3O DA LITERATURA............................................................................ 9\n3.1 Aspectos bot\u00e2nicos........................................................................................ 11\n3.2 Aspectos etnofarmacol\u00f3gicos........................................................................ 12\n3.3 Aspectos biol\u00f3gicos, farmacol\u00f3gicos e toxicidade.........................................  13\n3.3.1 Atividade antioxidante................................................................................. 13\n3.3.2 Atividade antimicrobiana............................................................................. 16\n3.3.3 Atividade antiedematog\u00eanica...................................................................... 19\n3.3.4 Atividades hepatoprotetora e gastroprotetora............................................. 22\n3.3.5 Atividade antiviral........................................................................................ 23\n3.3.6 Toxicidade de esp\u00e9cies do g\u00eanero Baccharis............................................ 24\n3.4 Composi\u00e7\u00e3o qu\u00edmica do g\u00eanero Baccharis................................................... 25\n3.4.1 \u00d3leos vol\u00e1teis.............................................................................................. 25\n3.4.2 Sesquiterpenos........................................................................................... 26\n3.4.3 Diterpenos................................................................................................... 28\n3.4.4 Triterpenos e saponinas............................................................................. 29\n3.4.5 Compostos fen\u00f3licos................................................................................... 30\n3.4.5.1 Flavon\u00f3ides.............................................................................................. 30\n3.4.5.2 Outros compostos fen\u00f3licos..................................................................... 32\nCAP\u00cdTULO 1 - An\u00e1lise cromatogr\u00e1fica de esp\u00e9cies do g\u00eanero Baccharis \n\ndo Sul do Brasil............................................................................... 35\nPublica\u00e7\u00e3o - Differentiation of South Brazilian Baccharis species by TLC\u2026\u2026. 37\nCAP\u00cdTULO 2 - Isolamento e elucida\u00e7\u00e3o estrutural das subst\u00e2ncias \n\npresentes na fra\u00e7\u00e3o n-BuOH de B. articulata e B. usterii........... 45\nPublica\u00e7\u00e3o a ser submetida - Phytochemical analysis of n-Butanol fractions \n\nfrom Baccharis articulata and Baccharis usterii................................ \n47\n\nCAP\u00cdTULO 3 - An\u00e1lise da atividade antioxidante dos extratos, fra\u00e7\u00f5es e \nsubst\u00e2ncias isoladas a partir das partes a\u00e9reas de B. \narticulata e B. usterii....................................................................... 63\n\nPublica\u00e7\u00e3o a ser submetida - Antioxidant activity of Baccharis articulata and \nBaccharis usterii extracts and their isolated compounds\u2026\u2026\u2026\u2026\u2026 65\n\nCAP\u00cdTULO 4 - Avalia\u00e7\u00e3o da atividade antibacteriana de B. articulata, B. \nspicata, B. trimera e B. usterii.......................................................  83\n\nPublica\u00e7\u00e3o \u2013 Screening of antibacterial activity of South Brazilian Baccharis \nspecies\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026. 85\n\n4 DISCUSS\u00c3O GERAL....................................................................................... 91\n5 CONCLUS\u00d5ES................................................................................................. 97\nBIOGRAFIA.......................................................................................................... 125\n\n\n\n \n7\n\n \n\nLista de figuras \n \n \n\n Revis\u00e3o da literatura \nFigura 1: B. articulata, B. spicata, B. trimera e B. usterii...................................... 12\nFigura 2: Estruturas de tricotecenos macroc\u00edclicos de B. coridifolia.................... 27\nFigura 3: Diterpenos em B. articulata, B. trimera e B. spicata............................. 29\nFigura 4: Flavon\u00f3ides isolados de B. articulata e B. trimera................................ 31\nFigura 5: Glicos\u00eddeos do \u00e1cido caf\u00e9ico isolados de B.dracunculifolia.................. 32\nFigura 6: Subst\u00e2ncia Ba II isolado de B. articulata............................................... 33\nFigura 7: Compostos fen\u00f3licos isolados de B. usterii e B. trimera....................... 33\n Cap\u00edtulo 1  \nFigura 1: Perfil cromatogr\u00e1fico dos extratos aquosos das esp\u00e9cies de \n\nBaccharis com anisalde\u00eddo sulf\u00farico/aquec. 100\u00b0C/UV366 nm................. 40\nFigura 2: Perfil cromatogr\u00e1fico dos extratos aquosos das esp\u00e9cies de \n\nBaccharis com reagente natural/UV366 nm.............................................. 40\nFigura 3: Perfil cromatogr\u00e1fico dos extratos n-BuOH das esp\u00e9cies de \n\nBaccharis com anisalde\u00eddo sulf\u00farico/aquec. 100\u00b0C............................... 41\n Cap\u00edtulo 2 \nFigura 1: Structures of Ba III, Ba IV, BuF1 and BuF2 compounds\u2026\u2026\u2026\u2026\u2026\u2026.. 61\n Cap\u00edtulo 3 \nFigura 1:  TRAP profile of n-butanol fraction from B. articulata and its isolated \n\ncompounds (A) and n-butanol fraction from B. usterii, its sub-fractions \nand isolated compounds (B)\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026. 78\n\nFigura 2: TAR index (I0/I) of n-butanol fraction from B. articulata and its isolated \ncompounds (A) and n-butanol fraction from B. usterii, its sub-fractions \nand isolated compounds (B)\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026. 79\n\nFigura 3: TBARS levels of n-butanol fraction from B. articulata and its isolated \ncompounds (A) and n-butanol fraction from B. usterii, its sub-fractions \nand isolated compounds (B)\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026.  80\n\nFigura 4: Structures of Ba III, Ba IV, BuF1 and BuF2 compounds\u2026\u2026\u2026\u2026\u2026\u2026.. 81\n  \n  \n  \n\n \n\n\n\n \n8\n\n \n\nLista de tabelas \n \n \n\n Revis\u00e3o da literatura \nTabela 1: Diterpenos encontrados em esp\u00e9cies do g\u00eanero Baccharis............... 28\n Cap\u00edtulo 2 \nTabela 1: 13C and 1H-NMR data for Ba III and Ba IV compounds....................... 59\nTabela 2: 13C and 1H-NMR data for BuF1 and BuF2 compounds\u2026\u2026\u2026\u2026\u2026\u2026.. 60\n Cap\u00edtulo 4 \nTabela 1: Results of screening of Baccharis extracts/fractions using disk \n\ndiffusion method\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 87\nTabela 2: Results of MBC of active extracts from Baccharis species\u2026\u2026\u2026\u2026\u2026 88\n \n\n\n\n \n9\n\nLista de Abreviaturas e S\u00edmbolos \n\n \n\nAcOEt - Acetato de etila \nbrs - broad singlet (simpleto largo) \nn-BuOH - n-butanol \n? - Valor de deslocamento qu\u00edmico em ppm no espectro de \n\nresson\u00e2ncia magn\u00e9tica nuclear \n?C - Valor de deslocamento qu\u00edmico em ppm no espectro de \n\nresson\u00e2ncia magn\u00e9tica nuclear de carbono 13 \n?H - Valor de deslocamento qu\u00edmico em ppm no espectro de \n\nresson\u00e2ncia magn\u00e9tica nuclear de hidrog\u00eanio \nHOAc - \u00e1cido ac\u00e9tico \nCCD - Cromatografia em camada delgada \nCH2Cl2 - Diclorometano \nCHCl3 - Clorof\u00f3rmio \nCL \nCq \n\n- chemiluminescence (quimioluminesc\u00eancia) \n- Carbono quatern\u00e1rio \n\nd - Dupleto \ndd - Duplo dupleto \nDEPT - Distortion less enhancement by polarization transfer \nEtOH - Etanol \nES-MS - Espectrometria de massas com ioniza\u00e7\u00e3o por electrospray \nFAB-MS - Espectroscopia de massas por bombardeamento r\u00e1pido de \u00e1tomos\nGli - Glicose \nHMBC - Heteronuclear multiple bond connectivity \nHMQC - Heteronuclear multiple quantum coherence \nJ - Constante de acoplamento \n\nMetanol-d4 - Metanol deuterado \nPBS - Tamp\u00e3o salina-fosfato \nRf - Raz\u00e3o de frente \nRMN de 13C - Resson\u00e2ncia magn\u00e9tica nuclear de carbono 13 \nRMN de 1H - Resson\u00e2ncia magn\u00e9tica nuclear de hidrog\u00eanio \ns - Simpleto \nTBARS - Subst\u00e2ncias reativas ao \u00e1cido tiobarbit\u00farico \nsh - shoulder (ombro) \nTRAP - Potencial antioxidante total \nTAR \nt \n\n- Reatividade antioxidante total \n- Tripleto \n\nUV - Ultravioleta \n \n\n\n\n \n1 0\n\nResumo \n\nO g\u00eanero Baccharis, Asteraceae, compreende mais de 500 esp\u00e9cies distribu\u00eddas \nexclusivamente no continente Americano. No Brasil est\u00e3o descritas 120 esp\u00e9cies, \nsendo que, no Rio Grande do Sul, h\u00e1 relatos de setenta esp\u00e9cies distribu\u00eddas desde \na regi\u00e3o serrana at\u00e9 o litoral. Conhecidas popularmente como carquejas, muitas \ndestas plantas s\u00e3o utilizadas na medicina popular, apesar da sinon\u00edmia popular \ncomum e da dif\u00edcil identifica\u00e7\u00e3o bot\u00e2nica. Visando ampliar os estudos qu\u00edmicos e \nbiol\u00f3gicos com esp\u00e9cies do g\u00eanero Baccharis este trabalho teve como objetivos \nprosseguir os estudos fitoqu\u00edmicos de B. articulata, B. cylindrica B. spicata, B. \ntrimera e B. usterii, visando a diferencia\u00e7\u00e3o qu\u00edmica das mesmas atrav\u00e9s de \ncromatografia em camada delgada, avaliar a atividade antibacteriana de B. \narticulata, B. spicata, B. trimera e B. usterii, isolar e identificar os compostos \npresentes nas fra\u00e7\u00f5es n-BuOH de B. articulata e B. usterii e, ampliar as \ninvestiga\u00e7\u00f5es quanto \u00e0 atividade antioxidante dessas esp\u00e9cies. Os resultados \nobtidos permitiram detectar diferen\u00e7as qualitativas no perfil qu\u00edmico das amostras \ntestadas atrav\u00e9s da cromatografia em camada delgada e propor metodologia para \nsua diferencia\u00e7\u00e3o qu\u00edmica. A partir das fra\u00e7\u00f5es n-BuOH de B. articulata e B. usterii \nforam isoladas sete subst\u00e2ncias codificadas como: Ba III (4\u2019-O-?-D-glicopiranosil-3,5-\ndimet\u00f3xi-benzil-tetrahidro-2H-pirano-2-il-acetil-carbonato), Ba IV (4\u2019-O-?-D-\nglicopiranosil-3,5-di-met\u00f3xi-fenil-metanol), Ba V, Ba VI, BuF1 (\u00e1cido 4,5-O-[E]-di-\ncafeoilqu\u00ednico), BuF2 (7-hidr\u00f3xi-5,4\u2019-di-met\u00f3xi-flavona) e BuT1, respectivamente. As \nsubst\u00e2ncias Ba V, Ba VI e BuT1 encontram-se em elucida\u00e7\u00e3o estrutural. Quanto \u00e0 \natividade antioxidante verificou-se que as fra\u00e7\u00f5es n-BuOH de B.articulata e B. usterii \napresentaram efeito antioxidante na concentra\u00e7\u00e3o de 1,25 ?g/mL e mantiveram este \nefeito no decorrer do ensaio TRAP. As subst\u00e2ncias isoladas a partir da fra\u00e7\u00e3o n-\nBuOH de B. articulata n\u00e3o apresentam potencial antioxidante na mesma intensidade \nque a referida fra\u00e7\u00e3o. No \u00edndice TAR, verificou-se a reatividade instant\u00e2nea das \nfra\u00e7\u00f5es n-BuOH destas esp\u00e9cies, bem como da subst\u00e2ncia BuF1. Quanto a \ncapacidade protetora contra a peroxida\u00e7\u00e3o lip\u00eddica, as fra\u00e7\u00f5es n-BuOH, as \nsubst\u00e2ncias Ba III, Ba IV, Ba V, as sub-fra\u00e7\u00f5es fen\u00f3lica e terp\u00eanica (B. usterii) e a \nsubst\u00e2ncia BuF1 foram eficientes em proteger as c\u00e9lulas da peroxida\u00e7\u00e3o. Quanto \u00e0 \natividade antibacteriana verificou-se que a fra\u00e7\u00e3o n-BuOH de B. spicata \n(concentra\u00e7\u00e3o 1 mg/mL) foi ativa frente a S. aureus, E. coli, E. faecalis e E. faecium \n(CBM 50 mg/mL). A fra\u00e7\u00e3o n-BuOH de B. usterii na mesma concentra\u00e7\u00e3o \napresentou efeito contra S. aureus (CBM 25 mg/mL), E. faecalis e E. faecium (CBM \n50 mg/mL). Os extratos brutos (1 mg/mL) de B. trimera e B. usterii  foram ativos \nfrente a S. aureus (CBM 12,5 mg/mL e 25 mg/mL, respectivamente).O extrato bruto \ne as fra\u00e7\u00f5es de B. articulata n\u00e3o apresentaram atividade frente aos microrganismos \ntestados.  \n \nPalavras-chave: baccharis, antioxidante, fitoqu\u00edmica, antibacteriana \n\n\n\n \n1 1\n\nChemical constituents and biological analyses of Baccharis species  \nThe Baccharis genus, Asteraceae, is native to America, encompassing nearly 500 \nspecies of which approximately 120 are found in Brazil. Around 70 species were \ndescribed in the State of Rio Grande do Sul. Popularly known as \u201ccarquejas\u201d, aerial \nparts of Baccharis species are used in traditional medicine in spite of the difficult \nbotanical differentiation among them. In order to continue the phytochemical and \nbiological studies about Baccharis species, the objectives of this thesis were to \npropose a chemical differentiation by thin-layer chromatography of B.articulata, B. \ncylindrica B. spicata, B. trimera and B. usterii, to evaluation the antibacterial activity \nof B. articulata, B. spicata, B. trimera and B. usterii, the isolation and identification of \ncompounds from n-BuOH fractions of B. articulata and B. usterii and to evaluate their \nantioxidant activity. It was possible to propose a methodology to differentiate the \nBaccharis species studied herein by thin-layer chromatography.  From n-BuOH \nfractions of B. articulata and B. usterii were isolated seven compounds: Ba III (4-O-?-\nD-glucopiranosyl-3,5-dimethoxibenzyl-tetrahydro-2H-pyran-2-yl-acetyl-carbonate), Ba \nIV (4-O-?-D-glucopiranosyl-3,5-dimethoxyphenil-methanol), Ba V, Ba VI, BuF1 (4,5-\nO-[E]-dicaffeoylquinic acid), BuF2 (7-hydroxy-5,4\u2019-dimethoxy-flavone) e BuT1. \nStructural elucidation of Ba V, Ba VI and BuT1 compounds are in course. Regarding \nthe antioxidant activity, it was verified that the n-BuOH fractions from B.articulata and \nB. usterii showed antioxidant effect at concentration of 1.25 ?g/mL, which was \nmaintained during the analyzed period on TRAP experiment. The isolated \ncompounds did not show the same antioxidant potential than the n-BuOH fractions. \nTAR index showed the instantaneous reactivity of the n-BuOH fractions of these \nspecies and BuF1 compound. Regarding the capacity of to protect the cells from lipid \nperoxidation, the n-BuOH fractions, Ba III, Ba IV, Ba V compounds, the phenolic and \nterpenic sub-fractions (B. usterii) and BuF1 compound were efficient to protect the \ncells from lipid peroxidation. In relation to antibacterial activity it was verified that the \nn-BuOH fraction of Baccharis spicata (1 mg/mL) was effective against S. aureus, \nEscherichia coli, Enterococcus faecalis, and Enterococcus faecium (MBC 50 mg/mL). \nThe n-BuOH fraction of Baccharis usterii (1 mg/mL) was effective against S. aureus \n(MBC 25 mg/mL), Enterococcus faecalis, and Enterococcus faecium (MBC 50 \nmg/ml). The crude extract of Baccharis trimera (1 mg/mL) showed activity against S. \naureus (MBC 25 mg/mL and 12.5 mg/mL, respectively). Extract and fractions from B. \narticulata were not active against the microorganisms tested. \n \nKey-words: baccharis, antioxidante, fitoqu\u00edmica, antibacteriana \n \n\n\n\n \n1 2\n\n1 Introdu\u00e7\u00e3o \n\n \n\n          O g\u00eanero Baccharis pertence \u00e0 fam\u00edlia Asteraceae e compreende mais de 500 \n\nesp\u00e9cies distribu\u00eddas exclusivamente no continente Americano, sendo que a maior \n\nconcentra\u00e7\u00e3o destas encontra-se no Brasil, Argentina, Col\u00f4mbia, Chile e M\u00e9xico \n\n(BUDEL et al., 2005; VERDI et al., 2005). No Brasil est\u00e3o descritas 120 esp\u00e9cies, \n\nsendo que, no Rio Grande do Sul, h\u00e1 relatos de setenta esp\u00e9cies distribu\u00eddas desde \n\na regi\u00e3o serrana at\u00e9 o litoral (GIULIANO, 2001; BARROSO; BUENO, 2002). \n\nConhecidas popularmente como carquejas, muitas destas plantas s\u00e3o \n\nutilizadas indiscriminadamente pela popula\u00e7\u00e3o, uma vez que, aliado \u00e0 sinon\u00edmia \n\npopular comum, destaca-se a dif\u00edcil identifica\u00e7\u00e3o bot\u00e2nica, sobretudo para as \n\nesp\u00e9cies de caules alados. As esp\u00e9cies tri\u2013aladas, como B. trimera, B. cylindrica e \n\nB. usterii s\u00e3o muito dif\u00edceis de diferenciar na aus\u00eancia de flores, assim como as bi\u2013\n\naladas, B. articulata e B. gaudichaudiana, que s\u00e3o consideradas taxonomicamente \n\nsemelhantes (ZARDINI, 1984; GIULIANO, 2001; BARROSO; BUENO, 2002). \n\nDestaca-se, tamb\u00e9m, o elevado valor s\u00f3cio-econ\u00f4mico atribu\u00eddo \u00e0s esp\u00e9cies \n\ndeste g\u00eanero, que al\u00e9m de seu uso medicinal como estom\u00e1quicas, sua import\u00e2ncia \n\necol\u00f3gica, na produ\u00e7\u00e3o de pr\u00f3polis de elevada qualidade e na extra\u00e7\u00e3o de \u00f3leos \n\nessenciais empregados na ind\u00fastria de perfumaria, s\u00e3o tamb\u00e9m empregadas no \n\ncombate a eros\u00e3o e como plantas ornamentais (VERDI et al., 2005).  \n\nPor outro lado, outras esp\u00e9cies deste g\u00eanero podem ser consideradas plantas \n\ninvasivas de dif\u00edcil combate em pastagens, como B. neglecta e B. halimifolia, as \n\nquais s\u00e3o t\u00f3xicas para o gado em algumas regi\u00f5es do Texas e B. salicifolia, que \n\ninutiliza fontes de \u00e1gua na mesma regi\u00e3o (VERDI et al., 2005). J\u00e1 em pastagens Sul-\n\namericanas, os registros apontam para elevada toxicidade de B. megapotamica e B. \n\ncoridifolia, que acumulam tricotecenos, subst\u00e2ncias respons\u00e1veis pela morte de \n\nmuitos animais em pastagens brasileiras, uruguaias e argentinas (JARVIS et al., \n\n1991). \n\n Apesar de sua ampla utiliza\u00e7\u00e3o, como destacado acima, os estudos \n\nfitoqu\u00edmicos e biol\u00f3gicos com esp\u00e9cies do g\u00eanero Baccharis ainda s\u00e3o restritos, \n\nespecialmente se considerarmos o n\u00famero de esp\u00e9cies descritas, mesmo aquelas \n\nde uso difundido popularmente. Na literatura, os estudos desenvolvidos com \n\n\n\n \n1 3\n\ndiferentes esp\u00e9cies do g\u00eanero Baccharis, relatam a presen\u00e7a de diterpenos e \n\nflavon\u00f3ides como constituintes qu\u00edmicos majorit\u00e1rios, e as atividades \n\nantiedematog\u00eanica, antimicrobiana e antioxidante como as mais relevantes \n\n(PALACIOS et al., 1983; GIANELLO; GIORDANO, 1984; ADZET et al., 1991; GEN\u00c9 \n\net al., 1996). Outro fato a ser destacado \u00e9 que esta diversidade de representantes do \n\ng\u00eanero pode remeter a um grande potencial em metab\u00f3litos secund\u00e1rios e \n\natividades biol\u00f3gicas ainda inexploradas.  \n\nEm 2003, nosso grupo de pesquisa relatou a presen\u00e7a de um derivado do \n\n\u00e1cido caf\u00e9ico de car\u00e1ter in\u00e9dito (codificado como subst\u00e2ncia Ba II), isolado do \n\nextrato n-butan\u00f3lico de partes a\u00e9reas de B. articulata e identificado como \u00e9ster 4\u00b4-O-\n\n?-D-glicopiranosil-3,5-dimet\u00f3xi-benzil-cafeato, o qual apresentou elevada atividade \n\nantioxidante (TRAP) (De OLIVEIRA et al., 2003). \n\n Diante desses resultados, iniciamos an\u00e1lises preliminares do potencial \n\nantioxidante de extratos brutos e fracionados de outras esp\u00e9cies do g\u00eanero, como B. \n\nspicata, B. trimera e B. usterii, os quais apontaram um comportamento semelhante \n\nao observado para B. articulata, sendo os extratos n-butan\u00f3licos, mais ativos que os \n\ndemais extratos testados. Foi poss\u00edvel verificar tamb\u00e9m que os extratos n-\n\nbutan\u00f3licos de B. spicata, B. trimera e B. usterii, nas concentra\u00e7\u00f5es testadas, \n\napresentaram atividade similar ao Trolox\u00ae, subst\u00e2ncia empregada como refer\u00eancia \n\n(De OLIVEIRA et al., 2004). \n\nDessa forma, visando ampliar os estudos iniciados por nosso grupo de \n\npesquisa, este trabalho tem como objetivo prosseguir as an\u00e1lises fitoqu\u00edmicas \n\ndestas esp\u00e9cies, contribuindo assim, para a diferencia\u00e7\u00e3o qu\u00edmica das mesmas, \n\nampliar as investiga\u00e7\u00f5es quanto \u00e0 atividade antioxidante e avaliar a atividade \n\nantibacteriana dessas esp\u00e9cies, uma vez que n\u00e3o foram encontrados na literatura \n\ntrabalhos com tais esp\u00e9cies. \n\n\n\n \n1 4\n\n2 Objetivos \n\n \n\nO presente trabalho est\u00e1 dividido em quatro cap\u00edtulos, os quais contemplam \n\nos seguintes objetivos:  \n\n \n\nCAP\u00cdTULO 1 \u2013 An\u00e1lise cromatogr\u00e1fica de esp\u00e9cies do g\u00eanero Baccharis do sul do \nBrasil;  \n\nObjetivo: Diferenciar quimicamente atrav\u00e9s de cromatografia em camada \ndelgada B. articulata, B. cylindrica, B. spicata, B. trimera e B. usterii. \n\n \n\nCAP\u00cdTULO 2 \u2013 Isolamento e elucida\u00e7\u00e3o estrutural das subst\u00e2ncias presentes na \nfra\u00e7\u00e3o n-butan\u00f3lica de B. articulata e B. usterii; \n\nObjetivo: Isolar e identificar os compostos presentes no extrato n-butan\u00f3lico \nde B. articulata e B. usterii, visando \u00e0 atividade antioxidante.  \n\n \n\nCAP\u00cdTULO 3 \u2013 An\u00e1lise da atividade antioxidante dos extratos, fra\u00e7\u00f5es e subst\u00e2ncias \nisoladas a partir das partes a\u00e9reas de B. articulata e B. usterii;  \n\nObjetivo: Avaliar o potencial antioxidante dos extratos, fra\u00e7\u00f5es e subst\u00e2ncias \nobtidas dos extratos n- BuOH de B. articulata e B.usterii. \n\n \n\nCAP\u00cdTULO 4 \u2013 Avalia\u00e7\u00e3o da atividade antibacteriana de B. articulata, B. spicata, B. \ntrimera e B. usterii; \n\n Objetivo: Avaliar a atividade antibacteriana in vitro dos extratos e fra\u00e7\u00f5es \nobtidos a partir das partes a\u00e9reas de B. articulata, B. spicata, B. trimera e B. usterii.  \n\n\n\n \n1 5\n\n3 Revis\u00e3o da Literatura  \n\nA revis\u00e3o da literatura realizada neste trabalho empregou as seguintes bases de \n\ndados: MEDLINE, SCIENCE DIRECT, LILACS, SCIELO, SCOPUS e Web of \n\nScience no per\u00edodo de 1970 a 2007. \n\n \n\n3.1 Aspectos bot\u00e2nicos \n\n \n\nO g\u00eanero Baccharis pertence \u00e0 fam\u00edlia Asteraceae abrangendo mais de 500 \n\nesp\u00e9cies de ocorr\u00eancia exclusiva no continente Americano. Para o Brasil s\u00e3o \n\ndescritas aproximadamente 120 esp\u00e9cies distribu\u00eddas desde a Bahia at\u00e9 o Rio \n\nGrande do Sul, sendo que neste Estado s\u00e3o estimadas cerca de setenta esp\u00e9cies \n\n(ZARDINI, 1984; CORREIA-J\u00daNIOR et al., 1991; GIULIANO, 2001; BARROSO; \n\nBUENO, 2002; VERDI et al., 2005). \n\nBaccharis articulata (Lam.) Persoon (figura 1) \u00e9 uma esp\u00e9cie comum nos \n\ncampos secos e pedregosos de S\u00e3o Paulo ao Rio Grande do Sul, Uruguai, Paraguai \n\ne Argentina, sendo descrita como arbusto di\u00f3ico ramificado, com at\u00e9 um metro de \n\naltura, com ramos articulados, sem folhas na fase adulta, bialadas, com alas \n\nestreitas, planas, verde-acinzentadas e membranoso\u2013cori\u00e1ceas. Floresce na \n\nprimavera apresentando flores agrupadas em infloresc\u00eancia do tipo cap\u00edtulo, \n\ndispostas nas termina\u00e7\u00f5es dos ramos, perfumadas, unissexuais, com colora\u00e7\u00e3o \n\nbranca amarelada (BARROSO, 1976; FREIRE; URTUBEY, 1999).  \n\nBaccharis spicata (Lam.) Baillon (figura 1) \u00e9 descrita como arbusto, de folhas \n\nuni ou trinervadas. Os cap\u00edtulos s\u00e3o dispostos em glom\u00e9rulos, os caules se re\u00fanem \n\nem ramos foliosos que ocasionalmente podem aparecer isolados. As flores s\u00e3o \n\nestaminadas com poucos ramos, aderidos ou separados. As corolas s\u00e3o carpeladas \n\ncom \u00e1pice denticulado (GIULIANO, 2001). \n\nBaccharis trimera (Less.) A. P. de Candolle (figura 1) ocorre no sul do Brasil, \nBol\u00edvia, Uruguai, Paraguai e Argentina. Est\u00e1 classificada como arbusto ramificado, \n\ncom ramos articulados, trialados, planos, verde-acinzentados e membranoso\u2013\n\ncori\u00e1ceos. As flores s\u00e3o agrupadas em infloresc\u00eancia do tipo cap\u00edtulo, com \n\n\n\n \n1 6\n\ncolora\u00e7\u00e3o branca amarelada, com corolas carpeladas irregularmente denticuladas \n\n(BARROSO, 1976; FREIRE; URTUBEY, 1999; GIULIANO, 2001). \n\nBaccharis usterii Heering (figura 1) ocorre no Brasil nos Estados de Minas \n\nGerais, Rio de Janeiro, Rio Grande do Sul, Santa Catarina e S\u00e3o Paulo, sem registro \n\nem outros pa\u00edses. \u00c9 um arbusto ramificado, com cerca de 0,5 a 1 m de altura, ramos \n\ntrialados, com alas planas, glabras, com 0,5 a 1,5 cm de largura. As folhas s\u00e3o \n\novais, curtamente pecioladas, trin\u00e9rveas. Os cap\u00edtulos s\u00e3o dispostos em ramos \n\nespiciformes, ordenados em pan\u00edculas amplas. Possui aqu\u00eanio com cerca de 1 a 1,5 \n\nmm de comprimento (BARROSO; BUENO, 2002).   \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n \n \n \n \nFigura1: B.articulata, B. spicata, B. trimera e B. usterii \n(http://www.ib.unicamp.br/plant-aq-SP/img/plantas/Baccharis.html).   \n \n\nB. articulata (Lam.) Persoon \n\n \nB. usterii Heering \n\n \n\n \nB. trimera (Less.) A. P. de Candolle \n\nB. spicata(Lam.) Baillon\n\n\n\n \n1 7\n\n3.2 Aspectos etnofarmacol\u00f3gicos \n \nDiversas esp\u00e9cies de Baccharis s\u00e3o amplamente utilizadas na medicina \n\npopular.  Paralelamente a este fato, existe a sinon\u00edmia popular comum de carqueja \n\nempregada para classificar algumas dessas esp\u00e9cies. B. articulata e B. trimera s\u00e3o \n\ncomumente empregadas como hep\u00e1ticas, digestivas, t\u00f4nicas e diur\u00e9ticas (ZARDINI, \n\n1984; ADZET et al., 1991; GUPTA, 1995). \n\nN\u00e3o foram encontrados dados na literatura sobre a utiliza\u00e7\u00e3o popular de B. \n\nspicata e B. usterii, mas sabe-se que tamb\u00e9m s\u00e3o conhecidas popularmente com o \n\nnome de carqueja, assim como B. articulata e B. trimera. \n\n \n3.3 Aspectos biol\u00f3gicos, farmacol\u00f3gicos e toxicidade  \n\n  \n\nDiversas esp\u00e9cies do g\u00eanero Baccharis foram objeto de estudos biol\u00f3gicos, \n\nfarmacol\u00f3gicos e toxicol\u00f3gicos.  \n\nOs primeiros relatos de estudos biol\u00f3gicos do g\u00eanero Baccharis datam de \n\n1952, quando PAVAN realizou a determina\u00e7\u00e3o do \u00edndice de amargor, \u00edndice de \n\nforma\u00e7\u00e3o de espuma, atividades hemol\u00edtica e ictiot\u00f3xica, bem como avaliou a \n\ntoxicidade de extratos preparados por decoc\u00e7\u00e3o das partes a\u00e9reas de B. trimera. Os \n\nresultados revelaram que os extratos testados possu\u00edam elevado \u00edndice de amargor \n\ne de forma\u00e7\u00e3o de espuma, o que poderia ser indicativo da presen\u00e7a de saponinas e, \n\nestas subst\u00e2ncias poderiam ser respons\u00e1veis pela estimula\u00e7\u00e3o g\u00e1strica. \n\nPosteriormente, diversas esp\u00e9cies do g\u00eanero Baccharis foram avaliadas \n\nquanto as suas propriedades antioxidantes, antiedematog\u00eanicas, antimicrobianas, \n\nhepatoprotetoras e antiviral dentre outras atividades.  \n\n \n3.3.1 Atividade antioxidante \n\n \n\nDiversas esp\u00e9cies vegetais foram avaliadas quanto as suas propriedades \n\nantioxidantes. A maioria dessas esp\u00e9cies apresenta em sua constitui\u00e7\u00e3o qu\u00edmica \n\ncompostos fen\u00f3licos, como flavon\u00f3ides, antocianidinas e fenilpropan\u00f3ides, derivados \n\ndos \u00e1cidos caf\u00e9ico, p-cum\u00e1rico e clorog\u00eanico (CAO, 1999; HALLIWELL; \n\n\n\n \n1 8\n\nGULTERIDGE, 1999; LOPES et al., 1999; CARTROM et al., 2001; SAKIHAMA et al., \n\n2002).  \n\nEm rela\u00e7\u00e3o aos estudos com esp\u00e9cies de Baccharis, o primeiro relato \u00e9 de \n\nMONGELLI et al. (1997), os quais avaliaram as atividades antioxidante e citot\u00f3xica \n\nde diferentes extratos de B. coridifolia. A atividade antioxidante foi realizada \n\nempregando a indu\u00e7\u00e3o de quimioluminesc\u00eancia por hidroper\u00f3xido em homogenato \n\nde f\u00edgado de rato. O extrato aquoso apresentou atividade antioxidante com um IC50 \n\nde 141 ?g/mL e, os extratos diclorometano e metanol foram pr\u00f3-oxidantes (1000 \n\n?g/mL). Os estudos de citotoxicidade ser\u00e3o discutidos posteriormente neste \n\ntrabalho.  \n\n Ainda em 1997, DESMARCHELIER et al., utilizaram a mesma t\u00e9cnica citada \n\nacima e o ensaio com \u00e1cido tiobarbit\u00farico (TBARS) para avaliar a atividade \n\nantioxidante de extratos aquosos de dezenove plantas argentinas, incluindo entre \n\nestas, B. coridifolia, B. crispa e B. grisebach. Os autores verificaram que B. coridifolia \n\ne B. crispa apresentaram atividade antioxidante dose-dependente nas \n\nconcentra\u00e7\u00f5es de 10-1000 ?g/ml em ambos os ensaios realizados e B. grisebach \n\napresentou atividade pr\u00f3-oxidante nas mesmas concentra\u00e7\u00f5es.  \n\n HERAS et al. (1998) tamb\u00e9m investigaram a atividade antioxidante de plantas \n\nutilizadas na medicina popular do Equador, dentre estas, B. trinervis. O extrato \n\netan\u00f3lico obtido a partir das partes a\u00e9reas desta planta apresentou significativa \n\natividade antioxidante in vitro na dose de 100 ?g/ml, nos tr\u00eas testes empregados: \n\nperoxida\u00e7\u00e3o microssomal lip\u00eddica (inibi\u00e7\u00e3o de 74,8 +/- 1,3%), produ\u00e7\u00e3o de \n\nsuper\u00f3xido (inibi\u00e7\u00e3o de 78,5 +/- 1,3%) e xantina oxidase (inibi\u00e7\u00e3o de 24,7 +/- 3,1%). \n\n O extrato butan\u00f3lico de B. articulata e a subst\u00e2ncia Ba II (figura 6), derivada \n\ndo \u00e1cido caf\u00e9ico, identificada como \u00e9ster 4\u2019-O-?-D-glicopiranosil-3,5-dimet\u00f3xi-\n\nbenz\u00edlico, isolada como composto majorit\u00e1rio a partir deste extrato foram \n\nempregados em um estudo preliminar do potencial antioxidante. A subst\u00e2ncia Ba II \n\nfoi testada nas concentra\u00e7\u00f5es de 0,1, 0,2 e 2,0 mM no ensaio para avaliar o \n\npotencial antioxidante total (TRAP) e apresentou  atividade antioxidante similar ao \n\nTrolox\u00ae em concentra\u00e7\u00f5es equimolares. Tamb\u00e9m foi verificado perfil de atividade \n\nsemelhante entre esta subst\u00e2ncia e o extrato butan\u00f3lico. A subst\u00e2ncia Ba II, nas \n\nconcentra\u00e7\u00f5es de 0,2 e 2,0 mM, reduziu a forma\u00e7\u00e3o de subst\u00e2ncias reativas ao \n\n\n\n \n1 9\n\n\u00e1cido tiobarbit\u00farico (TBARS) e a mortalidade celular (em c\u00e9lulas de Sertoli) induzida \n\npor H2O2. A prote\u00e7\u00e3o contra o estresse oxidativo induzido pelo H2O2 foi superior ao \n\nTrolox\u00ae nas mesmas concentra\u00e7\u00f5es (De OLIVEIRA et al., 2003).  \n\n PAREJO et al. (2003) avaliaram a atividade antioxidante de B. pentlandii e B. \n\nplatypoda dentre outras plantas da fam\u00edlia Asteraceae de ocorr\u00eancia boliviana. Os \n\nautores prepararam um extrato bruto metan\u00f3lico atrav\u00e9s de macera\u00e7\u00e3o e um outro \n\nextrato originado da lavagem deste primeiro extrato com hexano. Al\u00e9m disso, foram \n\ntestadas tamb\u00e9m fra\u00e7\u00f5es hexano, diclorometano e acetato de etila de cada esp\u00e9cie. \n\nOs experimentos realizados avaliaram o conte\u00fado total de compostos fen\u00f3licos dos \n\nextratos, atividade antioxidante total, a atividade seq\u00fcestradora de radicais DPPH, \n\nhidroxila e super\u00f3xido e a estabilidade oxidativa. As fra\u00e7\u00f5es acetato de etila de todas \n\nas esp\u00e9cies testadas apresentaram maior conte\u00fado de compostos fen\u00f3licos, \n\nexpressos por GAE/mg (equivalentes do \u00e1cido g\u00e1lico por mg de extrato), sendo que \n\npara as esp\u00e9cies de Baccharis acima, os valores foram 207,5 \u00b1 8,8 e 292,3 \u00b1 14,5 \n\nGAE/mg. \n\nA atividade antioxidante total dos extratos expressa em percentual de inibi\u00e7\u00e3o, \n\npara as esp\u00e9cies de Baccharis testadas apresentou valores percentuais baixos \n\ncomparados \u00e0s subst\u00e2ncias de refer\u00eancia quercetina e 3-(t-butila)-4-hidr\u00f3xi-anisol \n\n(BHA) na ordem de 3,5 a 16 %. Quanto \u00e0 atividade seq\u00fcestradora de radicais livres, \n\no extrato bruto metan\u00f3lico de B. pentlandii exibiu um percentual de inibi\u00e7\u00e3o do \n\nradical super\u00f3xido de 93%. Quanto \u00e0 estabilidade oxidativa (prote\u00e7\u00e3o contra \n\nrancifica\u00e7\u00e3o), cujos resultados s\u00e3o apresentados como fator de prote\u00e7\u00e3o, a fra\u00e7\u00e3o \n\nacetato de etila de B. pentlandii mostrou resultado similar ao da quercetina e \n\nsuperior ao BHA (PAREJO et al., 2003). \n\nDe OLIVEIRA et al. (2004), avaliaram a atividade antioxidante de extratos \n\nbrutos e fracionados de B. spicata, B. trimera e B. usterii empregando as t\u00e9cnicas do \n\nTRAP e TBARS. Os resultados apontaram que os extratos n-BuOH de B. spicata e \n\nB. trimera, na concentra\u00e7\u00e3o de 25 ?g/ml, apresentaram maior potencial antioxidante \n\nque o Trolox (1 mM). Em Baccharis usterii observou-se que o extrato n-BuOH nesta \n\nconcentra\u00e7\u00e3o apresentou perfil de atividade similar ao Trolox. Os extratos n-BuOH \n\ndestas esp\u00e9cies, na concentra\u00e7\u00e3o de 2,5 ?g/ml inibiram a peroxida\u00e7\u00e3o lip\u00eddica \n\ncausando uma diminui\u00e7\u00e3o significativa na produ\u00e7\u00e3o de malondialde\u00eddo (MDA) no \n\n\n\n \n2 0\n\nensaio de TBARS e tamb\u00e9m foram capazes de proteger as c\u00e9lulas contra estresse \n\noxidativo induzido por H2O2.  \n\nRecentemente, SIM\u00d5ES-PIRES et al. (2005), realizaram o isolamento e \n\nidentifica\u00e7\u00e3o de compostos antioxidantes de B. trimera, B. crispa e B. usterii por \n\nHPLC-UV-MS/MS. Os autores isolaram, a partir dos extratos aquosos destas \n\nplantas, seis derivados do \u00e1cido qu\u00ednico (\u00e1cidos 3-O-[E]-cafeoilquinico, 5-O-[E]-\n\ncafeoilquinico, 4-O-[E]-cafeoil-1-metil-quinico, 4,5-O-[E]-di-cafeoilquinico, 3,4-O-[E]-\n\ndi-cafeoilquinico e 3,5-O-[E]-di-cafeoilquinico). Estes e seus extratos foram avaliados \n\nquanto as suas propriedades antioxidantes frente ao radical DPPH empregando \n\nbioautografia. Foram empregados quercetina e 2,6-di(t-butila)-4-metil-fenol (BHT) \n\ncomo subst\u00e2ncias de refer\u00eancia, e o DPPH foi empregado como agente revelador. \n\nOs autores verificaram que os seis compostos isolados, bem como seus extratos de \n\norigem, foram capazes de reduzir o radical DPPH. \n\nEm 2007, BRIGHENTE et al., avaliaram a atividade antioxidante frente ao \n\nradical DPPH e determina\u00e7\u00e3o do teor de compostos fen\u00f3licos totais atrav\u00e9s do \n\nm\u00e9todo de Folin-Ciocalteu de extratos hidroetan\u00f3licos, etan\u00f3licos e clorof\u00f3rmicos \n\ndas folhas, flores e ra\u00edzes de B. illinita e folhas e ra\u00edzes de B. platipoda, dentre \n\noutras plantas. Como subst\u00e2ncias de refer\u00eancia foram empregados os \u00e1cidos g\u00e1lico \n\ne asc\u00f3rbico. Os autores verificaram que a atividade seq\u00fcestradora do radical DPPH \n\ndos extratos etan\u00f3licos das folhas, flores e ra\u00edzes de B. illinita (IC50 4,0; 7,0 e 9,0 \n\n?g/ml, respectivamente) foi significativa em rela\u00e7\u00e3o ao \u00e1cido asc\u00f3rbico (IC50 8,4 \n\n?g/ml). Para os extratos etan\u00f3licos das folhas e ra\u00edzes de B. platipoda (IC50 9,0 \n\n?g/ml, para ambas os extratos) os autores tamb\u00e9m verificaram o mesmo perfil de \n\natividade. Al\u00e9m disso, em concord\u00e2ncia com esses resultados, os extratos que \n\napresentaram maior potencial antioxidante, tamb\u00e9m apresentaram o maior teor de \n\nfen\u00f3licos totais em rela\u00e7\u00e3o ao \u00e1cido g\u00e1lico (IC50 2,6 ?g/ml).  \n\n \n3.3.2 Atividade antimicrobiana \n\n \nPALACIOS et al. (1983) foram os primeiros a relatar atividade antimicrobiana \n\npara os extratos etan\u00f3licos de B. crispa e B. notosergila. Os autores prepararam um \n\nextrato hidroetan\u00f3lico na propor\u00e7\u00e3o 1:1 a partir das partes a\u00e9reas de B. crispa e B. \n\n\n\n \n2 1\n\nnotosergila. A verifica\u00e7\u00e3o da atividade antimicrobiana foi atrav\u00e9s de bioautografia, \n\nt\u00e9cnica que possibilita a observa\u00e7\u00e3o imediata da(s) subst\u00e2ncia(s) ativa(s). O  \n\nflavon\u00f3ide gencavanina (380 ?g) foi ativo frente a Bacillus subtilis, Micrococcus \n\nluteus e Staphylococcus aureus, enquanto que a apigenina (750 ?g) apresentou \n\natividade frente a Bacillus subtilis e Micrococcus luteus. \n\nOutra abordagem foi empregada por RAHALISON et al. (1995) para investigar \n\no efeito antimicrobiano de B. pedunculata. Os autores optaram por estudar um \n\nextrato apolar desta esp\u00e9cie, ao contr\u00e1rio do trabalho anteriormente citado, obtido \n\npor macera\u00e7\u00e3o com diclorometano, al\u00e9m de testar a atividade deste contra os \n\nfungos Candida albicans, Pityrosporum ovale, Aspergillus fumigatus, \n\nEpidermophytum floccosum, Microsporum canis, Microsporum gypseum, \n\nTrychophyton mentagrophytes e Cladosporium cucumerinum, atrav\u00e9s de \n\nbioautografia e dilui\u00e7\u00e3o em Agar Sabouraud.  \n\nA partir deste extrato foram isoladas quatro subst\u00e2ncias, o flavon\u00f3ide 5,7-\n\ndiidr\u00f3xi-6,4?-dimet\u00f3xi-flavona, n\u00e3o apresentou atividade frente aos microrganismos \n\ntestados, o flavon\u00f3ide 5, 4?-diidr\u00f3xi-3,6,7-triimet\u00f3xi-flavona (100 ?g) foi ativo frente a \n\nCandida albicans e Cladosporium cucumerinum, uma acetona acetil\u00eanica (10 ?g/ml) \n\nfoi ativa frente a Epidermophytum floccosum, Microsporum gypseum e Candida \n\nalbicans e, a cumarina ulopterol, frente a Epidermophytum floccosum (10 ?g/ml) e \n\nCladosporium cucumerinum (100 ?g) (RAHALISON et al., 1995). \n\nVER\u00c1STEGUI et al. (1996) empregaram o extrato etan\u00f3lico de B. glutinosa e \n\na t\u00e9cnica de dilui\u00e7\u00e3o em caldo para avaliar a atividade antimicrobiana frente aos \n\nseguintes microorganismos: Candida krusei, Candida albicans, Candida rugosa, \n\nCryptococcus neoformans, Cryptococcus laurentii, Cryptococcus albidus, \n\nMicrosporiun canis, Microsporium gypseum, Trichophyton tonsurans, Enterococcus \n\nflocosum, Sporotrix schenkii, Neisseria aster\u00f3ides, Neisseria brasiliensis, Salmonella \n\nthyphimurium, Shigella dysenteriae, Escherichia coli, Yersinia enterocolitica, Listeria \n\nmonocytogenes, Proteus vulgaris e Clostridium perfringens. O extrato foi preparado \n\ncom etanol a 80% a temperatura ambiente.   \n\nO extrato etan\u00f3lico de B. glutinosa foi ativo frente a Microsporium canis, \n\nMicrosporium gypseum, Trichophyton tonsurans, Enterococcus flocosum, Sporotrix \n\nschenkii, Neisseria aster\u00f3ides, Neisseria brasiliensis, Listeria monocytogenes, \n\n\n\n \n2 2\n\nProteus vulgaris e Clostridium perfringens, em concentra\u00e7\u00f5es que variaram de 10 a \n\n16 mg/mL (VER\u00c1STEGUI et al., 1996). \n\nEm 2001, COBOS et al., avaliaram a atividade antimicrobiana do \u00f3leo \n\nessencial de B. notosergila. Os autores empregaram cromatografia gasosa acoplada \n\na espectr\u00f4metro de massas (CG \u2013 EM) para analisar a composi\u00e7\u00e3o do \u00f3leo \n\nessencial obtido das partes a\u00e9reas da planta, identificando trinta e um compostos, \n\nsendo o ?-pineno, o limoneno, o ?-cariofileno e o spatulenol os majorit\u00e1rios. A \n\nt\u00e9cnica utilizada para o estudo da atividade antimicrobiana foi a difus\u00e3o em disco. O \n\n\u00f3leo foi ativo frente a Bacillus cereus, Staphylococcus aureus, Staphylococcus \n\nepidermidis e Candida albicans, nas concentra\u00e7\u00f5es de 10 e 50 ?L com CIM de 227 e \n\n454 ?g/mL. \n\nOs extratos hexano, diclorometano e metan\u00f3lico de B. grisebachii tamb\u00e9m \n\nforam avaliados quanto \u00e0 atividade antimicrobiana empregando m\u00e9todos de dilui\u00e7\u00e3o, \n\nfrente a E. colli, S. aureus (cepas sens\u00edveis e resistentes a meticilina), C. albicans, C. \n\nmeoformans, S. cerevisae, A. flavus, A. fumigatus, A. niger, M. canis, T. rubrum, E. \n\nfloccosum, M. gypseum e T. mentagrophytes. Os extratos hexano e diclorometano \n\nforam ativos frente a todos os fungos testados com CIM ? 25 a ? 1000 ?g/mL. \n\nTrychophyton rubrum foi o microorganismo mais suscept\u00edvel e C. neoformans foi \n\ninibida unicamente pelo extrato diclorometano da planta (600 ?g/mL). Este extrato \n\ntamb\u00e9m foi ativo contra S. aureus (sens\u00edvel/resistente a meticilina) com CIM de 125 \n\na ? 500 ?g/mL (FERESIN et al., 2001). \n\nEm 2003, FERESIN et al., ampliando seus estudos da atividade \n\nantimicrobiana de B. grisebachii, investigaram novamente o extrato diclorometano do \n\nqual isolaram doze subst\u00e2ncias. Destas, oito s\u00e3o derivadas do \u00e1cido p-cum\u00e1rico, \n\nduas s\u00e3o diterpenos tipo labdanos e duas s\u00e3o flavon\u00f3ides. O extrato e as \n\nsubst\u00e2ncias isoladas foram testados frente aos mesmos microorganismos \n\nempregados no trabalho anteriormente citado e a t\u00e9cnica de verifica\u00e7\u00e3o da atividade \n\nantimicrobiana tamb\u00e9m foi a mesma.  \n\nO diterpeno labda-7,13E-dien-2?,15-diol, foi ativo frente a M. canis, T. rubrum, \n\nE. floccosum, M. gypseum e T. mentagrophytes, com CIM entre 12,5 e 50 ?g/mL. \n\nEsta subst\u00e2ncia tamb\u00e9m apresentou atividade frente S. aureus (cepas sens\u00edveis e \n\nresistentes a meticilina) com CIM de 125 ?g/mL. Os derivados do \u00e1cido p-cum\u00e1rico \n\n\n\n \n2 3\n\nforam ativos principalmente frente a E. floccosum, T. rubrum e T. mentagrophytes \n\ncom CIM entre 50 e 250 ?g/mL. Todos os compostos testados n\u00e3o apresentaram \n\natividade frente a E. coli (FERESIN et al., 2003).  \n\n \n\n3.3.3 Atividade antiedematog\u00eanica \n\n  \n\nEm 1987, SALAMA et al. determinaram a atividade antiedematog\u00eanica dos \n\nextratos metan\u00f3lico, clorof\u00f3rmico e et\u00e9reo das folhas de B. decussata atrav\u00e9s da \n\nindu\u00e7\u00e3o de edema plantar por dextrano em ratas, empregando fenilbutazona como \n\nsubst\u00e2ncia de refer\u00eancia. Os extratos foram administrados aos animais por via \n\ng\u00e1strica na dose de 10 mg/kg. Os resultados apontaram que os extratos metan\u00f3lico \n\ne et\u00e9reo apresentaram efeito antiedemat\u00f4genico maior que a subst\u00e2ncia de \n\nrefer\u00eancia na dose de 65 mg/kg. \n\nBaccharis crispa e B. articulata tamb\u00e9m foram analisadas quanto \u00e0 atividade \n\nantiedematog\u00eanica por ADZET et al. (1991), atrav\u00e9s da indu\u00e7\u00e3o de edema plantar \n\npor carragenina em ratas, utilizando como subst\u00e2ncia de refer\u00eancia, naproxeno. O \n\nextrato aquoso das partes a\u00e9reas de cada uma dessas esp\u00e9cies foi administrado \n\nintraperitonialmente na dose de 100 mg/kg de peso do animal. O extrato aquoso de \n\nB. articulata n\u00e3o produziu atividade significativa em rela\u00e7\u00e3o \u00e0 subst\u00e2ncia de \n\nrefer\u00eancia nas tr\u00eas medidas realizadas. Para B. crispa, as medidas realizadas no \n\nextrato aquoso na terceira e quinta horas transcorridas da administra\u00e7\u00e3o, apontaram \n\npercentual de inibi\u00e7\u00e3o de 32,85 e 30,00% respectivamente. \n\nGEN\u00c9 et al. (1992) investigaram a a\u00e7\u00e3o antiedematog\u00eanica dessas mesmas \n\nesp\u00e9cies e, tamb\u00e9m, de B. trimera. Os autores empregaram a mesma t\u00e9cnica do \n\ntrabalho anterior, por\u00e9m os extratos aquosos dessas plantas foram administrados \n\npor via oral e intraperitoneal (100 mg/kg) \u00e0s ratas. Os resultados apontam que os \n\nextratos aquosos de B. articulata e B. crispa n\u00e3o produziram efeito \n\nantiedematog\u00eanico quando comparados ao naproxeno na dose de 5 mg/kg. O \n\nextrato aquoso de B. trimera administrado via intraperitoneal  produziu um \u00edndice de \n\ninibi\u00e7\u00e3o de edema de 61,34%, sendo superior ao efeito produzido pelo naproxeno \n\n(47,14%).   \n\n\n\n \n2 4\n\nP\u00c9REZ et al. (1995) avaliaram a atividade antiedematog\u00eanica do extrato \n\ndiclorometano obtido a partir das partes a\u00e9reas de B. incarum. Os autores tamb\u00e9m \n\nempregaram a metodologia de indu\u00e7\u00e3o de edema plantar com carragenina em ratos \n\nWistar. O extrato foi administrado via intraperitonial na dose de 100 mg/kg e o \n\nnaproxeno na dose de 5 mg/Kg aos animais testados.  Os resultados apontaram que \n\no extrato diclorometano de B. incarum produziu um efeito inibit\u00f3rio de 44,5%, sendo \n\nsuperior ao naproxeno que foi de 25,9%. \n\nOs extratos diclorometano, aquoso e metan\u00f3lico obtidos por macera\u00e7\u00e3o das \n\npartes a\u00e9reas de B. tucumanensis tamb\u00e9m foram avaliados por MUSCHIETTI et al. \n\n(1996), quanto \u00e0 a\u00e7\u00e3o antiedematog\u00eanica, por via t\u00f3pica, na dose de 1 mg/orelha, e \n\nintraperitoneal, na dose de 100 mg/Kg. Seus efeitos foram comparados \u00e0 \n\nindometacina na dose de 2,5 mg/kg. A metodologia empregada foi a indu\u00e7\u00e3o de \n\nedema com carragenina e com \u00f3leo de Croton sp. nas orelhas dos animais. Edema \n\nsubplantar tamb\u00e9m foi induzido por carragenina e os extratos foram administrados via \n\nintraperitoneal. Foi observado que os extratos aquoso e metan\u00f3lico produzem \u00edndices \n\nde inibi\u00e7\u00e3o de 28,1 e 55,3%, respectivamente, sendo superiores ao da indometacina \n\n(19,1%), ao contr\u00e1rio do extrato diclorometano, cujo \u00edndice inibit\u00f3rio foi de 14%. \n\nQuando os extratos foram administrados via t\u00f3pica e o edema induzido com \u00f3leo de \n\nCroton sp., foi verificado que os extratos aquoso, metan\u00f3lico e diclorometano \n\napresentam \u00edndices inibit\u00f3rios de 58, 93,4 e 100%, respectivamente, produzindo um \n\nefeito antiedematog\u00eanico superior ao da indometacina (49%) (MUSCHIETTI et al., \n\n1996). \n\nGEN\u00c9 et al. (1996) investigaram as atividades antiedematog\u00eanica, analg\u00e9sica \n\ne ulcerog\u00eanica da fra\u00e7\u00e3o butan\u00f3lica obtido a partir de um extrato aquoso das partes \n\na\u00e9reas de B. trimera. Para a avalia\u00e7\u00e3o da atividade antiedematog\u00eanica, os autores \n\nutilizaram o m\u00e9todo de indu\u00e7\u00e3o de edema plantar em ratos com carragenina e \n\ndextrano e administraram o extrato, via intraperitoneal, nas doses de 40 e 80 mg/kg. \n\nO naproxeno (5 mg/kg) foi empregado como subst\u00e2ncia de refer\u00eancia. Para a \n\navalia\u00e7\u00e3o da atividade ulcerog\u00eanica foram empregadas solu\u00e7\u00f5es aquosas da fra\u00e7\u00e3o \n\nbutan\u00f3lica de B. trimera, nas doses de 50 e 100 mg/kg. Transcorridas quatro horas \n\nda administra\u00e7\u00e3o do extrato aquoso e da fra\u00e7\u00e3o butan\u00f3lica, os est\u00f4magos dos \n\nanimais foram removidos e examinados ao microsc\u00f3pio. A atividade analg\u00e9sica foi \n\navaliada mediante administra\u00e7\u00e3o da fra\u00e7\u00e3o butan\u00f3lica de B. trimera nas doses de 50 \n\n\n\n \n2 5\n\ne 100 mg/kg, via intraperitoneal, trinta minutos ap\u00f3s a estimula\u00e7\u00e3o do processo \n\ndoloroso com \u00e1cido ac\u00e9tico 0,8% na dose de 1 mL/100 g, via intraperitoneal. Os \n\nresultados demonstraram que h\u00e1 um efeito dose dependente no edema induzido por \n\ncarragenina, evidenciado no aumento da inibi\u00e7\u00e3o do edema com o aumento da dose \n\nda fra\u00e7\u00e3o butan\u00f3lica.  \n\nO percentual de inibi\u00e7\u00e3o do edema da fra\u00e7\u00e3o butan\u00f3lica de B. trimera, nas \n\ndoses de 40 e 80 mg/Kg foi superior ao naproxeno. Quando a indu\u00e7\u00e3o do edema foi \n\nconduzida fra\u00e7\u00e3o para se obter efeito inibit\u00f3rio, como observou-se na dose de 100 \n\nmg/kg que foi capaz de produzir inibi\u00e7\u00e3o do edema superior a metisergida na dose \n\nde 1 mg/kg. Quanto \u00e0 atividade ulcerog\u00eanica os resultados demonstram que a fra\u00e7\u00e3o \n\nbutan\u00f3lica de B. trimera foi capaz de produzir pequenas \u00falceras, conforme o \n\naumento da dose administrada (GEN\u00c9 et al., 1996). Os autores relataram o \n\nfracionamento bioguiado pelo experimento de indu\u00e7\u00e3o de edema plantar, da fra\u00e7\u00e3o \n\nbutan\u00f3lica de B. trimera originando uma fra\u00e7\u00e3o ativa composta por uma mistura de \n\nsaponinas identificadas por hidr\u00f3lise como derivadas do \u00e1cido equinoc\u00edstico. Esta \n\nfra\u00e7\u00e3o produziu um efeito inibit\u00f3rio na dose de 3,5 mg/kg via intraperitoneal de \n\n48,3%, enquanto que a indometacina na dose de 2,5 mg/kg apresentou um \n\npercentual de inibi\u00e7\u00e3o de 72,6% (GEN\u00c9 et al., 1996). \n\nHERAS et al. (1998) investigaram a atividade antiedematog\u00eanica do extrato \n\netan\u00f3lico de B. trinervis obtido a partir das partes a\u00e9reas da planta. Os autores \n\ntamb\u00e9m empregaram a indu\u00e7\u00e3o de edema por carragenina em pata de rato, sendo a \n\nadministra\u00e7\u00e3o do extrato realizado por via oral, na dose de 1,25 g/kg, utilizando como \n\nve\u00edculo uma mistura de Tween 80, etanol e \u00e1gua na propor\u00e7\u00e3o (2:2:20, v/v), ap\u00f3s 1 \n\nhora da indu\u00e7\u00e3o do edema. A fenilbutazona (2,5 mg/kg) foi empregada como \n\nsubst\u00e2ncia de refer\u00eancia. O edema produzido foi medido em 3, 5 e 7 horas ap\u00f3s o \n\ntratamento com o extrato.  Os resultados indicaram que o extrato testado, nas tr\u00eas \n\nmedidas realizadas, produziu efeito inferior ao da fenilbutazona. Os \u00edndices inibit\u00f3rios \n\nforam de 12,6, 32,9 e 21,8% para o extrato etan\u00f3lico de B. trinervis e 71,4, 66,6 e \n\n59,2% para a fenilbutazona. \n\nGIANELLO et al. (1999) investigaram a atividade antiedematog\u00eanica dos \n\nflavon\u00f3ides 7,3\u2019-dimetil-\u00e9ter-luteolina, homoeridictiol e eridictiol isolados a partir do \n\nextrato acet\u00f4nico das partes a\u00e9reas de B. calliprinos e B. rhetinodes. As subst\u00e2ncias \n\nforam administradas via intraperitoneal na dose de 75 mg/kg e seus efeitos foram \n\n\n\n \n2 6\n\ncomparados a fenilbutazona, 1, 3, 5 e 7 horas ap\u00f3s a indu\u00e7\u00e3o do edema. Os \n\nresultados apontaram que o flavon\u00f3ide 7,3\u2019-dimetil-\u00e9ter-luteolina foi o composto mais \n\nativo, atingindo \u00edndices inibit\u00f3rios de 18, 32, 40 e 13%, nas quatro medidas \n\nrealizadas, enquanto que os \u00edndices observados para a fenilbutazona foram 19, 44, \n\n40 e 37%.  \n\nCIFUENTE et al. (2001) estudaram a atividade antiedematog\u00eanica de B. \n\nmedullosa e B. rufescens atrav\u00e9s de indu\u00e7\u00e3o de edema plantar em ratos com \n\ncarragenina, empregando fenilbutazona como subst\u00e2ncia de refer\u00eancia. Foi \n\npreparado um extrato bruto acet\u00f4nico das partes a\u00e9reas das plantas o qual, depois \n\nde evaporado o solvente e retomado em \u00e1gua, foi submetido a sucessivos \n\nparticionamentos em n-hexano, clorof\u00f3rmio e acetato de etila. O extrato bruto, as \n\nfra\u00e7\u00f5es e a subst\u00e2ncia de refer\u00eancia foram administradas via intraperitoneal nas \n\ndoses de 80 mg/kg, e o edema plantar medido ap\u00f3s 1, 3, 5 e 7 horas transcorridas \n\nda administra\u00e7\u00e3o do agente flog\u00edstico. A fra\u00e7\u00e3o n-hexano de B. medullosa e o extrato \n\nacet\u00f4nico e a fra\u00e7\u00e3o clorof\u00f3rmica de B. rufescens apresentaram percentual de \n\ninibi\u00e7\u00e3o de edema m\u00e1ximo ap\u00f3s 5 horas de 64, 52 e 50% respectivamente, \n\nenquanto que a fenilbutazona apresentou um percentual de 48% no mesmo per\u00edodo.  \n\n \n3.3.4 Atividades hepatoprotetora e gastroprotetora \n\n \nSOICKE; LENG\u2013PESCHLOW (1987) avaliaram a a\u00e7\u00e3o hepatoprotetora do \n\nextrato acetato de etila obtido a partir das partes a\u00e9reas de B. trimera e dos \n\nflavon\u00f3ides quercetina, luteolina, nepetina, apigenina e hispidulina, isolados do \n\nmesmo. O extrato e os flavon\u00f3ides isolados foram administrados via intraperitoneal \n\nnas doses de 10 e 50 mg/kg, ap\u00f3s processo de ressuspens\u00e3o em salina com Tween \n\n20 e centrifuga\u00e7\u00e3o, sendo apenas o sobrenadante utilizado. A atividade \n\nhepatoprotetora foi identificada em ratos intoxicados com 3,4 mg/kg de faloidina via \n\nintraperitoneal. Transcorrida 1 hora da administra\u00e7\u00e3o da faloidina, o extrato \n\naumentou a sobreviv\u00eancia dos animais. O composto isolado mais ativo foi a \n\nhispidulina, aumentando o \u00edndice de sobreviv\u00eancia para 80%.  \n\nBAGGIO et al. (2003) publicaram um estudo sobre o efeito gastroprotetor de \n\nextratos brutos hidroalco\u00f3lico e aquoso de B. illinita. Foram induzidas les\u00f5es \n\ng\u00e1stricas agudas nos ratos com o uso de etanol 70% (grupo 1), indometacina (20 \n\n\n\n \n2 7\n\nmg/kg, via subcut\u00e2nea) (grupo 2) e estresse (induzido por anestesia com \u00e9ter at\u00e9 a \n\nimobiliza\u00e7\u00e3o) (grupo 3), caracterizando tr\u00eas grupos teste distintos. Os animais foram \n\nsacrificados uma hora ap\u00f3s o tratamento no grupo 1, seis horas no grupo 2 e tr\u00eas \n\nhoras no grupo 3. Os est\u00f4magos foram removidos e a mucosa lavada e examinada \n\npara a quantifica\u00e7\u00e3o  das les\u00f5es. O extrato hidroalco\u00f3lico administrado nas doses de \n\n1 a 6 g/kg via oral, n\u00e3o produziu sinais de toxicidade nos animais e protegeu-os \n\ncontra les\u00f5es produzidas por etanol. Os autores conclu\u00edram que estas plantas \n\napresentaram um efeito protetor contra les\u00f5es da mucosa g\u00e1strica envolvendo os \n\nfatores naturais de prote\u00e7\u00e3o da mesma como a manuten\u00e7\u00e3o do muco, fluxo de \n\nbicarbonato e sangue.  \n\n \n3.3.5 Atividade antiviral \n\n \n Baccharis trinervis e B. teindalensis foram submetidas a um screening de \n\natividade antiviral in vitro contra o HSV-1 (v\u00edrus do Herpes simplex tipo I), VSV (v\u00edrus \n\nda estomatite vesicular) e poliov\u00edrus tipo 1 atrav\u00e9s da avalia\u00e7\u00e3o do efeito citop\u00e1tico \n\nsobre c\u00e9lulas HeLa (c\u00e9lulas de carcinoma cervical humano). O extrato aquoso de B. \n\ntrinervis apresentou o potencial de inibi\u00e7\u00e3o contra a replica\u00e7\u00e3o do HSV\u20131 de 100%, \n\nnas concentra\u00e7\u00f5es de 50 \u2013 200 ?g/mL, sem apresentar efeito citot\u00f3xico. O extrato \n\netan\u00f3lico de B. teindalensis (50 \u2013 125 ?g/mL) inibiu a replica\u00e7\u00e3o do VSV. Nenhum \n\nextrato foi efetivo sobre a replica\u00e7\u00e3o do poliov\u00edrus tipo 1 (ABAD et al., 1999a). \n\nExtratos etan\u00f3lico e aquoso de B. genistelloides e B. rubricaulis tamb\u00e9m \n\nforam submetidos \u00e0 avalia\u00e7\u00e3o da atividade antiviral empregando a mesma t\u00e9cnica e \n\nfrente aos  os mesmos v\u00edrus do trabalho anterior. O extrato aquoso de B. \n\ngenistelloides inibiu a replica\u00e7\u00e3o do HSV\u20131 nas concentra\u00e7\u00f5es de 25 \u2013 50 ?g/mL, \n\nbem como a replica\u00e7\u00e3o do VSV nas concentra\u00e7\u00f5es de 25 \u2013 125 ?g/mL (ABAD et al., \n\n1999b). \n\nPALOMINO et al. (2002), realizaram um estudo de atividade antiviral contra o \n\nHIV (v\u00edrus da imunodefici\u00eancia humana) com extratos aquosos e etan\u00f3licos de B. \n\ntrinervis, B. teindalensis, B. genistelloides e B. rubricaulis. Unicamente o extrato \n\naquoso (10 - 400 ?g/mL) de B. trinervis apresentou potente atividade inibit\u00f3ria contra \n\neste v\u00edrus in vitro no ensaio MTT, e nenhum efeito citot\u00f3xico foi observado mesmo \n\n\n\n \n2 8\n\nna maior concentra\u00e7\u00e3o empregada. Este extrato foi submetido a fracionamento \n\npreliminar em coluna cromatogr\u00e1fica com Sephadex LH-20, sendo obtidas quatro \n\nfra\u00e7\u00f5es, as quais tamb\u00e9m foram submetidas ao mesmo ensaio. As duas primeiras \n\nfra\u00e7\u00f5es eluidas da coluna inibiram a replica\u00e7\u00e3o do HIV em c\u00e9lulas MT-2 (linfoma \n\nhumano) infectadas, sem apresentar efeitos citot\u00f3xicos, nas concentra\u00e7\u00f5es de 10 a \n\n200 ?g/mL. \n\nMONTANHA et al. (2004) verificaram a atividade antiviral contra o v\u00edrus HSV-\n\n1 (cepas KOS, ATCC e AC-R) em c\u00e9lulas Vero de extratos aquosos e \n\nhidroalco\u00f3licos de B. articulata, B. cylindrica, B. conyzoides, B. erigeroides, B. \n\nerioclata, B. megapotamica, B. mesoneura, B. patens, B. pseudotenuifolia, B. \n\npunctulata, B. radicans, B. semiserrata, B. spicata B. trimera, B. trinervis, B. uncinella \n\ne B. usterii dentre outras plantas. Os resultados (efeito citop\u00e1tico \u2013 CPE) indicaram \n\nque o extrato aquoso (1,25 mg/mL) e hidroetan\u00f3lico (0,5 mg/mL) de B. erioclata  foi \n\nativo frente as tr\u00eas cepas virais avaliadas. Para o extrato hidroetan\u00f3lico de B. \n\nmegapotamica (0,005 mg/mL) foi verificada atividade anti-herp\u00e9tica frente a cepa \n\nKOS, enquanto que o extrato hidroetan\u00f3lico de B. uncinella (1,25 mg/mL) foi ativo \nfrente as cepas KOS e AC-R. \n\n \n\n3.3.6 Toxicidade de esp\u00e9cies do g\u00eanero Baccharis  \n\n \nAs esp\u00e9cies do g\u00eanero Baccharis, sobre as quais existe maior n\u00famero de \n\nestudos quanto \u00e0 toxicidade s\u00e3o B. coridifolia e B. megapotamica. Tal propriedade \n\nvincula-se a presen\u00e7a de tricotecenos macroc\u00edclicos nessas esp\u00e9cies.  \n\n Os primeiros relatos s\u00e3o da d\u00e9cada de 70 quando TOKARNIA e \n\nDOBEREINER (1976) e DOBEREINER et al. (1976) relataram seus estudos de \n\nintoxica\u00e7\u00e3o experimental de bovinos, ovinos e coelhos por B. coridifolia, \n\ndemonstrando que tal planta poderia causar a morte desses animais. J\u00e1 nas \n\nd\u00e9cadas de 80 e 90 outros autores descobriram que o respons\u00e1vel pela intoxica\u00e7\u00e3o \n\ndos animais por B. coridifolia era a presen\u00e7a de micotoxinas t\u00f3xicas conhecidas \n\ncomo tricotecenos macroc\u00edclicos (HABERMEHL et al., 1985, 1989; JARVIS et al., \n\n1987b, 1988, 1991, 1996; RIZZO et al., 1997). Tamb\u00e9m foi relatada a presen\u00e7a de \n\n\n\n \n2 9\n\ntricotecenos em B. megapotamica (KUPCHAN et al., 1971, 1977; JARVIS et al., \n\n1987a) e em B. artemisoides (RIZZO et al., 1997).   \n\nMONGELLI et al. (1997) verificaram que o extrato diclorometano de B. \n\ncoridifolia (1 mg/mL) inibiu o crescimento das c\u00e9lulas KB (c\u00e9lulas do carcinoma oral \n\nepiderm\u00f3ide humano) em 78%. Os estudos da atividade antioxidante deste e outros \n\nextratos desta planta foram relatados anteriormente. \n\nEm 2000, MONGELLI et al. estudaram a atividade citot\u00f3xica dos extratos \n\ndiclorometano e metan\u00f3lico das partes a\u00e9reas de B. grisebachii, usada na medicina \n\npopular da Argentina contra o c\u00e2ncer. Os extratos da planta foram testados frente a \n\numa linhagem de c\u00e9lulas KB (c\u00e9lulas de carcinoma oral epiderm\u00f3ide humano), \n\nquanto \u00e0 inibi\u00e7\u00e3o de tumores superiores de ves\u00edcula e intera\u00e7\u00e3o com DNA. Os \n\nextratos cuja ED50 foram menores que 50 ?g/mL foram considerados ativos em \n\nrela\u00e7\u00e3o aos primeiros testes. O extrato diclorometano de B. grisebachii foi inativo \n\nfrente \u00e0s c\u00e9lulas KB, apresentando um ED50 maior que 200 ?g/mL, apresentou \n\natividade inibit\u00f3ria dos tumores superiores de ves\u00edcula na ordem de 60% e n\u00e3o foi \n\ncapaz de interagir com DNA, pois o \u00edndice de diminui\u00e7\u00e3o da absortividade do \n\ncomplexo DNA - verde de metila foi inferior a 20%. O extrato metan\u00f3lico n\u00e3o \n\napresentou atividade nos testes realizados.  \n\n \n3.4 Composi\u00e7\u00e3o qu\u00edmica do g\u00eanero Baccharis \n\n \n3.4.1 \u00d3leos vol\u00e1teis \n\n \nEstudos demonstram uma grande diversidade quanto \u00e0 composi\u00e7\u00e3o de \u00f3leos \n\nvol\u00e1teis em esp\u00e9cies do g\u00eanero Baccharis.  \n\nMOLT; TRKA (1983) identificaram mirceno, p\u2013cimeno, ?3\u2013careno, ?-\n\nfelandreno, cariofileno, ?, ?, ?-elemeno, espatulenol e di-hidrocinamato de etila no \n\n\u00f3leo vol\u00e1til de B. dracunculifolia. \n\nEm Baccharis articulata (Lam.) Persoon e Baccharis crispa foram identificados \n\n?-pineno, cis\u2013cariofileno, ?-guaieno, ?-elemeno, ?-cadineno e aromadendreno \n\n(TONN et al., 1987).  \n\n\n\n \n3 0\n\n Das partes a\u00e9reas de B. ochracea foram caracterizados terpinen-4-ol, \n\ncariofileno, ?-cariofileno e germacreno-D (SOBOTTKA, 1992).  \n\n LOAYZA et al. (1995) analisaram B. salicifolia, B. latifolia e B. dracunculifolia \n\ncoletadas em diferentes \u00e1reas de cultivo relatando a presen\u00e7a de quatro grupos de \n\ncompostos, monoterpenos, monoterpenos oxigenados, sesquiterpenos e \n\nsesquiterpenos oxigenados, como a germacrona e o ledol.  \n\nFERRACINI et al. (1995) investigaram a composi\u00e7\u00e3o dos \u00f3leos vol\u00e1teis em 7 \n\nesp\u00e9cies do g\u00eanero Baccharis. Foram relatadas as presen\u00e7as de ?-cariofileno em B. \n\ndracunculifolia, ?-pineno, limoneno, ?-cariofileno e espatulenol em B. erioclata, ?-\n\ncadineno, (E)\u2013nerolidol e espatulenol em B. myriocephala, espatulenol em B. \n\nplatipoda e B. tridentada e ?-cariofileno e ?- adineno em B. vincaefolia. \n\nA composi\u00e7\u00e3o de \u00f3leos vol\u00e1teis de tr\u00eas esp\u00e9cies do g\u00eanero Baccharis foi \n\ndescrita por ZUNINO et al. (1998) relatando como constituintes majorit\u00e1rios de B. \n\narticulata o ?-cariofileno e o (E)-nerolidol, de B. myrtilloides o germacreno-D e de B. \n\nrufescens, o limoneno e o (E)-nerolidol. \n\nBAILAC et al. (2001) relataram a composi\u00e7\u00e3o do \u00f3leo vol\u00e1til de B. coridifolia, \n\ndestacando como componentes majorit\u00e1rios isocariofileno, ?-cariofileno, \u00f3xido de \n\ncariofileno e ?-selineno. \n\nCOBOS et al. (2001) avaliaram a composi\u00e7\u00e3o do \u00f3leo vol\u00e1til de B. notosergila. \n\nForam identificados ?-pineno, limoneno, ?-cariofileno e espatulenol. Os autores \n\ntamb\u00e9m verificaram que este \u00f3leo apresentou moderada atividade antimicrobiana. \n\nAinda em 2001, ZUNINO et al. identificaram trans\u2013nerolidol, cadinol e \n\ncubenol, como constituintes principais em B. cordobensis. \n\nNo mesmo ano, a partir do \u00f3leo vol\u00e1til de B. uncinella, FRIZZO et al. \n\nobtiveram ?-pineno, ?-pineno, limoneno, espatulenol, globulol, (E)-nerolidol, \n\nbiciclogermacreno e terpinen-4-ol. \n\n\n\n \n3 1\n\n3.4.2 Sesquiterpenos \n\n \n\nOs sesquiterpenos mais importantes relatados para o g\u00eanero Baccharis s\u00e3o \n\nos tricotecenos. Essas subst\u00e2ncias representam o mais importante grupo de \n\nmicotoxinas, respons\u00e1veis por um grande n\u00famero de relatos de intoxica\u00e7\u00f5es em \n\nanimais e em humanos. Os tricotecenos s\u00e3o amplamente estudados devido sua \n\npotencial atividade citot\u00f3xica sobre alguns tipos de c\u00e9lulas tumorais, sobretudo em \n\nc\u00e9lulas sang\u00fc\u00edneas e tamb\u00e9m por suas propriedades antibi\u00f3ticas (KUPCHAN, 1977; \n\nJARVIS et al.,  1986, 1987b, 1991, 1996; RIZZO et al., 1997; VARASCHIN et al., \n\n1998).  \n\nEstes compostos encontram-se principalmente em B. coridifolia e B. \n\nmegapotamica estando divididos em duas categorias, os tricotecenos simples, como \n\nas toxinas T2 e HT\u20132, descritos por MIROCHA et al. (1988; 1989) e os tricotecenos \n\nmacroc\u00edclicos, baccharinoides, roridinas e verrucarinas (figura 2) (HABERMEHL et \n\nal., 1985; JARVIS et al., 1986, 1987, 1991, 1996; VARASCHIN et al., 1998).  \n\nRIZZO et al. (1997) tamb\u00e9m descreveram a presen\u00e7a das roridinas A, E e D \n\nem B. artemisioides, sendo este o \u00fanico relato da presen\u00e7a destas subst\u00e2ncias em \n\noutra esp\u00e9cie do g\u00eanero Baccharis. \n\nPor outro lado, os tricotecenos tamb\u00e9m s\u00e3o relatados em fungos do g\u00eanero \n\nMyrothecium sp., os quais, muitas vezes, encontram-se associados \u00e0s esp\u00e9cies do \n\ng\u00eanero Baccharis. Inicialmente, acreditava-se que a produ\u00e7\u00e3o destas subst\u00e2ncias \n\nocorria devido \u00e0 intera\u00e7\u00e3o planta-fungo, entretanto, os pesquisadores verificaram \n\nque plantas n\u00e3o infectadas por estes fungos tamb\u00e9m produzem tricotecenos \n\n(JARVIS et al., 1989, 1991; ROSSO et al., 2000; GARCIA et al., 2002). \n\n \n\n \n\n \n\n \n\nFigura 2: Estruturas de tricotecenos macroc\u00edclicos de B. coridifolia (JARVIS et al., \n1988). \n \n\n \n\nH3C\n\nR1\n\nO\n\nCH3\nO\n\nO\n\nO\n\nO\n\nO\n\nO\nCH3\n\nHO\n\nCH2\nR2\n\nH\n\n \n\nroridina A: R1=CHOHCH3CH2; R2=CH=CCH3CH2 \n\nroridina D: R1=CHOCCH3CH2; R2=CH=CCH3CH2 \n\nroridina E: R1=H; R2=CH=CCH2CH3 \nverrucarina A: R1=CHOHCHCH; R2=R3=O \n\nverrucarina J: R1=CH=CCH3; R2=R3=O \n\n\n\n \n3 2\n\n3.4.3 Diterpenos \n\n  \n\nOs diterpenos constituem a classe de compostos mais abundante em \n\nesp\u00e9cies do g\u00eanero Baccharis, sendo relatados para a maioria das esp\u00e9cies (tabela \n\n1). As estruturas dos diterpenos relatados para as esp\u00e9cies de interesse neste \n\ntrabalho est\u00e3o representadas na figura 3. \n\nTabela 1:  Diterpenos encontrados em esp\u00e9cies do g\u00eanero Baccharis \n\nTipos de Diterpenos \n(n\u00facleo b\u00e1sico) \n\nEsp\u00e9cies Refer\u00eancias \n\nclerodanos \n \n\nB. artemisioides \nB. articulata \n\nB. boliviensis  \nB. gilliessii \n\nB. myrsinites  \nB. obtusifolia  \nB. peruviana  \nB. pingraea  \nB. trimera \n\nB. tricuneata \nB. rhetinoides \nB. salicifolia \nB. santelicis \n\nB. sarothroides \nB. vaccinoides  \n\nB. crispa  \nB. lejia  \n\nB. flabellata \nB. gaudichaudiana \n\n \n\nTONN et al., 1982. \nSTAPEL et al., 1980; DAI et al., 1993 \n\nZDERO et al., 1989 \nLI et al., 1997 \n\nZDERO et al., 1986. \nZDERO et al., 1986 \n\nARRIAGA - GINER et al., 1986. \nZDERO et al., 1986. \nZDERO et al., 1989. \n\nWAGNER et al., 1978. \nZDERO et al., 1989. \nZDERO et al., 1986. \nZDERO et al., 1991. \nZDERO et al., 1989.  \nCE\u00d1AL et al., 1997  \nLABBE et al., 1991. \n SAAD et al., 1988;  \n\nHIKAWCZUK et al., 2002. \nAKAIKE et al., 2003; GUO et al., \n\n2006, 2007. \nLabdanos \n\n \n\nB. boliviensis \nB. gaudichaudiana \n\n B. latifolia  \nB. paniculata  \n\nB. pedunculata \nB. petiolata \nB. pingraea \nB. salicifolia  \n\nB. sternbergiana \nB. polifera  \n\nZDERO et al., 1989. \nFULLAS et al., 1992. \nZDERO et al., 1989. \n\nFAINI; CASTILLO, 1990. \nJAKUPOVIC et al., 1991. \n\nZDERO et al., 1991. \nZDERO et al.,1986;W\u00c4CHTER et al., \n\n1999 \nZDERO et al., 1986. \nZDERO et al., 1989. \nZDERO et al., 1986 \n\nDer. Geranilgeraniol \n\n \n \n \n \n\nB. ochraceae SCHENKEL et al., 1997. \n\n \n\nH\n\nH\n\nOH\n\n H\nOH\n\nCH3\n\nCH3\n\n  \nCH3\n\nCH3\n\nO\n\nO\nO OR\n\n \n\n\n\n \n3 3\n\n \n\nFigura 3: Diterpenos em B. articulata, B. trimera e B. spicata (STAPEL et al., 1980; \nZDERO et al., 1989; DAI et al., 1993; GALLARDO et al., 1996). \n \n\n3.4.4 Triterpenos e saponinas \n\n \n\nOs triterpenos s\u00e3o encontrados em algumas esp\u00e9cies do g\u00eanero Baccharis, \n\nsendo o mais comum representante dessas subst\u00e2ncias o \u00e1cido olean\u00f3lico, descrito \n\npor SILVA et al. (1971) em B. rhomboidales. Essa subst\u00e2ncia tamb\u00e9m \u00e9 relatada em \n\nB. gilliessi (GIANELLO; GIORDANO, 1984), B. salicifolia (WARNING et al., 1986), B. \n\nO O\n\nO\n\n R\n\nO\n\nH\n\nO\n\nH\n\n \n \n\nOH\n\nOH\n\nO\nCH3O\n\nH\nH\n\n \n\nO O\n\nO\n\n R\n\nO\n\nH\n\nO\n\nH\n\n \n\nBaccharis articulata \n \n\narticulina  R=H \n \n\nacetato de articulina  \nR= CH3OCO- \n\nBaccharis articulata \n \n\n15,16-ep\u00f3xi-7?,18-diidr\u00f3xi-\n15-met\u00f3xi-ent-cleroda-3-\n\neno   \n \n\nBaccharis articulata \n \n\nR=OH (8?-hidr\u00f3xi-7-oxo-\nent-cleroda-3-en-15,18-\ndi\u00e1cido-16,19-dilactona) \n\n \nR=H (7-oxo-16,19-diidr\u00f3xi-\n3,4-desidroclerodan-15,20-\n\ndi\u00e1cido-dilactona) \n \n\n \n \n\nO\nOH\n\nO\n\nO\nO\n\n \n\nO\n\nO\n\nO\nO\n\nO\n\nH\n\nH\n\nH\n\n \n\nO\n\nO\nO\n\nO\n\nOH\n\nO\n\nH\n\nH\n\n \n \n\nBaccharis trimera \n \n\nlactona diterp\u00eanica \n\nBaccharis spicata \n \n\nbacchotriconeatina A \n\nBaccharis spicata \n6?-hidr\u00f3xi-\n\nbacchotricuneatina A \n\n\n\n \n3 4\n\npatagonica (RIVERA et al., 1988), B. flabellata (SAAD et al., 1988) e B. linearis (HE \n\net al., 1996; ARGANDO\u00d1A et al., 1993).  \n\nA presen\u00e7a de saponinas \u00e9 mencionada por PAVAN (1952) e SALAMA et al. \n\n(1987) atrav\u00e9s da determina\u00e7\u00e3o do \u00edndice de espuma e do poder hemol\u00edtico em B. \n\ntrimera e B. decussata.  \n\nGEN\u00c9 et al. (1996) detectaram a presen\u00e7a de cinco saponinas em B. trimera, \n\nsendo que apenas a aglicona da saponina majorit\u00e1ria, obtida atrav\u00e9s de hidr\u00f3lise \n\n\u00e1cida da fra\u00e7\u00e3o bruta, foi identificada como derivada do \u00e1cido equinoc\u00edstico.  \n\n N\u00e3o foram encontrados na literatura relatos da presen\u00e7a dessas subst\u00e2ncias \n\nem B. articulata, B. spicata e B. usterii. \n\n \n3.4.5 Compostos fen\u00f3licos  \n\n \n3.4.5.1 Flavon\u00f3ides  \n\n \nEm Baccharis sarothroides destacam-se flavon\u00f3ides com atividade citot\u00f3xica, \n\ncomo a centauredina e 3,4\u2019-di-met\u00f3xi-3\u2019,5,7-tri-hidr\u00f3xi-flavona (KUPCHAN; \n\nBAUERSCHMIDT, 1971). \n\nA partir das partes a\u00e9reas de B. crispa foram isolados e identificados a \n\ngencavanina, apigenina, 7,4\u2019-dimetilapigenina, 5-hidr\u00f3xi-7,4\u2019-di-met\u00f3xi-flavona e 5, \n\n3\u2019-di-hidr\u00f3xi-7,4\u2019-dimetil-flavona (BANDONI et al., 1978; PALACIOS et al., 1983; \n\nGIANELLO; GIORDANO, 1984). \n\n Em Baccharis gilliessi e B. myrtilloides foi caracterizado o flavon\u00f3ide jaceidina \n\n(GIANELLO; GIORDANO, 1984). \n\n Al\u00e9m desses, ainda s\u00e3o citados flavon\u00f3ides para B. petiolata (isoramnetina e \n\ndesmetoxicentauredina), B. confertifolia (7,4\u2019-di-metil-naringenina, 7,3\u2019,4\u2019-tri-metil-\n\neriodictiol, 7,3\u2019-di-metil-eriodictiol, 3\u2019,4\u2019-di-metil-eridictiol e escopoletina), B. \n\npaniculata (3,7-di-metil-quercetina, isoramnetina e 7-metil-eriodictiol) e B. concava \n\n(cirsimaritina) (ZAMORANO et al., 1987; FAINI; CASTILLO, 1990), B. angustifolia \n\n(isoquercitrina) (WAGNER et al., 1972), B. grisebachii (pectoolinaringenina e \n\nnevadencina) (GIANELLO; GIORDANO, 1987), B. ochracea (isoquercitrina) \n\n\n\n \n3 5\n\n(SCHENKEL et al., 1997), B. glutinosa (5,7-di-hidr\u00f3xi-flavanona) (MIYAKADO et al., \n\n1976), B. magellanica (hispidulina e escopoletina) (RIVERA et al., 1988), B. \n\ncalliprinos (7,3\u2019-di-metil-\u00e9ter- luteolina, homoeriodictiol e eridiotictiol-3\u2019,4\u2019-di-metil-\n\n\u00e9ter), B. rethinoides (7,3\u2019-di-metil-\u00e9ter-luteolina) (GIANELLO et al., 1999).  \n\nPara Baccharis trinervis s\u00e3o descritos pectolinaringenina, salvigenina e \n\npenduletina (SHARP et al., 2001). \n\n A distribui\u00e7\u00e3o de flavon\u00f3ides nas esp\u00e9cies de interesse neste estudo \u00e9 \n\nbastante diversificada. Especificamente para Baccharis articulata foram \n\ncaracterizados os flavon\u00f3ides gencavanina, acacetina, 7,4\u2019-di-metil-apigenina, \n\ncirsimaritina e salvigenina (GIANELLO; GIORDANO, 1984). Para B. trimera foram \n\ndescritos eupatorina, cirsimaritina, hispidulina, canferol, luteolina, nepetina, \n\nquercetrina, 5-hidr\u00f3xi-3,\u20194\u2019,6,7-tetra-met\u00f3xi-flavona, 3-O-metil-quercetina e \n\napigenina, dentre outros (HERZ et al., 1977; SANTOS FILHO et al., 1980; DAILY et \n\nal., 1984; SOICKE; PESCHLOW, 1987; MELLO, 1989; RENDON; VILA, 1995; GEN\u00c9 \n\net al., 1996).  A figura 4 apresenta os flavon\u00f3ides descritos para estas esp\u00e9cies. \n\n Para as demais esp\u00e9cies n\u00e3o foram encontrados relatos da ocorr\u00eancia \n\ndestas subst\u00e2ncias. \n\n \n\n \n\n \n \n\n \n \nFigura 4: Flavon\u00f3ides isolados de B. articulata e B. trimera (GIANELLLO; \nGIORDANO, 1984; ARRIAGA-GINER, 1986; SOICKE; PESCHLOW, 1987; MELLO, \n1989; RENDON; VILA, 1995; GEN\u00c9 et al., 1996). \n\nEsp\u00e9cie Nome R1 R2 R3 R4 R5 \n\n acacetina H H H CH3 H \n 7,4\u00b4- dimetil-apigenina CH3 H H CH3 H \n\nB. articulata cirsimaritina  CH3 CH3 H H H \n salvigenina CH3 CH3 H CH3 H \n gencavanina  CH3 H H H H \n quercetina \n\nluteolina \nOH \nOH \n\nH \nH \n\nOH \nH \n\nOH \nOH \n\nOH \nOH \n\nB. trimera nepetina OH CH3O H OH OH \n apigenina OH H H OH H \n hispidulina OH CH3O H OH H \n\nR5\n\nR4\n\nR3R2\n\nR1 O\n\nOH O\n\n\n\n \n3 6\n\n3.4.5.2 Outros compostos fen\u00f3licos  \n\n  \nDerivados do \u00e1cido caf\u00e9ico tamb\u00e9m s\u00e3o encontrados em algumas esp\u00e9cies \n\ndo g\u00eanero Baccharis. NAGATANI et al. (2001) relataram o isolamento de dez novos \n\nglicos\u00eddeos derivados do \u00e1cido caf\u00e9ico (dracunculifos\u00eddeos) a partir das partes \n\na\u00e9reas de B. dracunculifolia. Estes consistem em ?-D\u2013glicopiranos\u00eddeos ou  \n\nacrescidos de um grupo (E) cafeoil (figura 5). \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n \nFigura 5: Glicos\u00eddeos do \u00e1cido caf\u00e9ico (dracunculifos\u00eddeos A - J) isolados de B. \ndracunculifolia (NAGATANI et al., 2001). \n\n \n\nEm 2003, De OLIVEIRA et al. isolaram do extrato n-BuOH de B. articulata \n\numa subst\u00e2ncia derivada do \u00e1cido caf\u00e9ico, identificada como \u00e9ster 4\u2019-O-?-D-\n\nglicopiranosil-3,5-dimet\u00f3xi-benzil caf\u00e9ico, (figura 6) sendo esta de car\u00e1ter in\u00e9dito. \n\nOCH2\n\nO\nHO\n\nHO\nO\n\nOH\n\nOH\n\nOH\n\nOH\nO\n\nHO\nA\n\n \n\nOH\n\nO\nHO\n\nO\n\nB\n\nO\n\nHO\nOH\n\nO\n\nC\n\nOCH3\n\nO\n\nH3CO\n\nD O\nHOE\n\nO O\n\nO\n\nHO\n\nO\n\nOH\n\nOH\n\nOH\n\nHOCH2\nF\n\n \n\nO\nG\n\n \nO\n\nH\n \n\nO\nI\n\n \n\nO\n\nO\nHO\n\nJ\n\n \n\n?-D\u2013glicopiranos\u00eddeos-(E)-cafeoil ?-D\u2013apiofuranosil-(1?6)-?-D\u2013glicopiranos\u00eddeo-(E)-cafeoil \n\nOCH2\n\nO\nHO\n\nHO\nO\n\nOH\n\nOH\n\nOH\n\nR\n\nOH\n\nOH\n\nO\n\nO\n\nO\n\nOH\n\nCH2\n\nO\n\nHO\n\nRO\n\nOH\n\nOH\n\nOH\n\nCH2\n\n\n\n \n3 7\n\n  \n\n \n \n \n \n \n \n \nFigura 6: Subst\u00e2ncia Ba II (\u00e9ster 4\u2019-O-?-D-glicopiranosil-3,5-dimet\u00f3xi-benzil cafeato), \nisolado de B. articulata (De OLIVEIRA et al., 2003). \n\n \n\nSIM\u00d5ES-PIRES et al. (2005), realizaram o isolamento e identifica\u00e7\u00e3o de \n\ncompostos antioxidantes de B. trimera, B. crispa e B. usterii por HPLC-UV-MS/MS. \n\nOs autores investigaram os extratos aquosos obtidos das partes a\u00e9reas destas \n\nplantas, identificando seis derivados do \u00e1cido qu\u00ednico (\u00e1cidos 3-O-[E]-cafeoilquinico, \n\n5-O-[E]-cafeoilquinico, 4-O-[E]-cafeoil-1-metil-quinico, 4,5-O-[E]-di-cafeoilquinico, \n\n3,4-O-[E]-di-cafeoilquinico e 3,5-O-[E]-di-cafeoilquinico), os quais apesar de j\u00e1 \n\nconhecidos na literatura, foram citados pela primeira vez para esp\u00e9cies do g\u00eanero \n\nBaccharis (figura 7). Al\u00e9m disso, tamb\u00e9m s\u00e3o relatadas as presen\u00e7as dos \n\nflavon\u00f3ides isoquercitrina, quercetina e nepetina no extrato de B. trimera. A an\u00e1lise \n\nincluiu a compara\u00e7\u00e3o do perfil cromatogr\u00e1fico por HPLC dos extratos aquosos \n\ndestas plantas.  \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \nFigura 7: Compostos fen\u00f3licos isolados de B. usterii e B. trimera (SIM\u00d5ES-PIRES et \nal., 2005). \n\n1    R1= OH  R3= cafeoil   R4= H   R5= H \n2    R1= OH  R3= H  R4= H   R5= cafeoil \n3    R1= OCH3  R3=H  R4= cafeoil R5= H \n4    R1= OH  R3= cafeoil R4= cafeoil   R5= H \n5    R1= OH  R3= H R4= cafeoil   R5= cafeoil \n6    R1= OH  R3= cafeoil R4= H  R5= cafeoil  \n\nR3O\n\nHO\n\nOR4\nOR5\n\nCOR1\n= \n\nOH\nOH\n\nO\n\nE - Cafeoil\n\nO\n\nOH\n\nOHO\n\nO\n\nCH3O\n\nCH3O\n\nO\n\nOH\n\nOH\n\nOH\n\nHO\n\n1'\n\n2'3'\n\n4'\n\n5' 6'\n\n1\n\n2 3\n\n4\n\n56\n\n77'\n\n8\n9\n\n8'\n\n9'\n\n1''\n\n2''3''\n\n4''\n5''\n\n6''\n\nHO\n\nIsoquercitrina\n\nOH\n\nOH\nO\n\nOOH\n\nO glicose\n\nHO\n\nQuercetina\n\nO\n\nOOH\n\nOH\n\nOH\n\nOH\n\nH3CO\n\nHO\n\nNepetina\n\nOH\n\nOH\nO\n\nOOH\n\nOH\n\n\n\n \n3 8\n\nCap\u00edtulo 1  \n\n \n\nJournal of Liquid Chromatography &amp; Related Technologies, 29: 2603\u20132609, \n2006. \n\nCopyright # Taylor &amp; Francis Group, LLC \nISSN 1082-6076 print/1520-572X online \n\nDOI: 10.1080/10826070600916609 \n \n\nDifferentiation of South Brazilian Baccharis Species by TLC \n\n \n\nSimone Quintana de Oliveira, Gisele Barbon and Grace Gosmann \n\nFaculdade de Farm\u00e1cia, Universidade Federal do Rio Grande do Sul (UFRGS), \n\nPorto Alegre, Brazil \n\nS\u00e9rgio Bordignon \n\nCurso de Biologia, Universidade Luterana do Brasil (ULBRA), Canoas, \n\nRS, Brazil, and Curso de Ci\u00eancias Biol\u00f3gicas, Centro Universit\u00e1rio La Salle \n\n(UNILASALLE), Canoas, Brazil \n\n \n\nAbstract: The Baccharis species, known in Brazil as \u201ccarquejas\u201d are used for \n\ndigestive disorders in folk medicine. Phytochemical studies reported the presence of \n\nphenolic and terpenoid compounds as the main constituents and the literature also \n\ndescribes anti-inflammatory, antioxidant, and antimicrobial activities for the Baccharis \n\nspecies. Due to difficult botanical characterization, the development of chemical \n\ndifferentiation of these plants is important. In this paper, we present the chemical \n\ncharacterization of five native Baccharis species to Southern Brazil by TLC, using \n\njust one mobile phase and two colors reagents. \n\n \n\nKeywords: Baccharis, TLC, Phenolic compounds, BaII compound, Control quality \n\n\n\n \n3 9\n\nINTRODUCTION \n\nThe genus Baccharis (Asteraceae) is exclusive to America, encompassing nearly \n\n400 species of which approximately 120 grow in Brazil. Around 70 species in the \n\nState of Rio Grande do Sul [1\u20133] are described. Popularly known as \u201ccarquejas\u201d, \n\nBaccharis species aerial parts are used in traditional medicine, mainly for digestive \n\ndisorders.[4] Previous studies reported the presence of phenolic compounds as \n\nflavonoids and phenolic acids,[5,6] diterpenes and saponins.[7\u20139] Their \n\npharmacological and biological properties are described as anti-inflammatory, \n\nanalgesic, antioxidant, and antibacterial for the Baccharis species.[4,9 \u2013 11] Although \n\ntheir use is traditional, the botanical differentiation among these species is complex, \n\nthe correct nomenclature, the synonyms of the members, and especially botany \n\nmorphology is controversial. It is very difficult for the correct identification of the three \n\nwinged species, such B. trimera, B. cylindrica, and B. usterii[3,4,12] in the absence of \n\nflowers. On the other hand, B. articulata is considered to be a very close \n\ntaxonomically related species to B. gaudichaudiana, both two-winged species.[8] \n\nConsidering that, recently, we reported the isolation and identification of BaII \n\ncompound (4\u2019-O-?-D-glucopyranosyl-3\u2019,5\u2019-dimethoxybenzyl-caffeate) from B. \n\narticulata, and this compound showed antioxidant properties comparable to Trolox,[6] \n\nBaII could be used as a good chemical marker for this species. Altogether, \n\nconsidering that these species are used as medicinal plants, often without correct \n\nidentification, the development of fast and easy TLC methodology may contribute \n\nsignificantly to the differentiation between these plants and to their control quality as \n\nraw materials. Herein, we report a chemical characterization by thin-layer \n\nchromatography (TLC) of B. articulata, B. cylindrica, B. spicata, B. trimera, and B. \n\nusterii, native species to the State of Rio Grande do Sul, Brazil.  \n\n \n\nEXPERIMENTAL \n\n \n\nPlant Material \n\nAerial parts of B. articulata (Lam.) Person (BA), B. cylindrica (Less.) DC (BC), B. \n\nspicata (Lam.) Baillon (BS), B. trimera (Less.) DC (BT), and B. usterii Heering (BU) \n\nwere collected in Porto Alegre, State of Rio Grande do Sul, Brazil. Herbarium \n\n\n\n \n4 0\n\nspecimens are on deposit in the Herbarium of the Botany Department of \n\nUniversidade Federal do Rio Grande do Sul, Porto Alegre, Brazil. Each plant material \n\nwas air dried and powdered separately. \n\n \n\nReference Substance \n\nPure BaII compound (4\u2019-O-?-D-glucopyranosyl-3\u2019,5\u2019-dimethoxybenzyl-caffeate) was \n\npreviously isolated from B. articulata.[6] \n\n \n\nPreparation of Plant Extracts \n\nThe aqueous extracts from Baccharis species were prepared, separately, by \n\ndecoction of the plant material (1g, 2 x 100 mL) during 30 min. Part of each aqueous \n\nextract was evaporated under reduced pressure. The other part of each aqueous \n\nextract was partitioned, separately, using n-BuOH of which the solvent was \n\nevaporated under reduced pressure. Yields of each extract, i.e., of the Baccharis \n\nspecies (aqueous extract/n-BuOH fraction, mg): B. articulata (200/178), B. cylindrica \n\n(253/117), B. spicata (230/104), B. trimera (290/200), and B. usterii (270/90) were as \n\ngiven here. Fifteen mL of each sample, dissolved in MeOH (10 mg/mL), was applied \n\nto a TLC plate as a band, at the starting line.  \n\n \n\nThin-Layer Chromatographic Analysis \n\nPhytochemical profiles of Baccharis species were established by thin-layer \n\nchromatography (TLC) on silica gel plates (Merck F254, 20 x 20 cm) using as mobile \n\nphase chloroform-ethanol-acetic acid (CHCl3:EtOH:HOAc, 60:40:6, v/v). The mobile \n\nphase was allowed to migrate 15 cm from the starting line. Detections were \n\nperformed using, separately, two colours of reagents: anisaldehyde-H2SO4, heating \n\nto 100\u00b0C, and diphenylboryloxyethylamine 1% in methanol, followed by PEG 400 \n\n(5%, w/v) (Natural Reagent).[13] Spots were observed under visible light and long-\n\nwave UV light after being sprayed by the coloured reagents.  \n\nFigures 1 and 2 are photographed chromatographs in long-wave UV light. Figure 3 is \n\na photographed chromatograph in visible light. \n\n\n\n \n4 1\n\nRESULTS AND DISCUSSION \n\n \n\nConsidering the large use of Baccharis species in folk medicine, and the \n\nmorphological similarity of some native species from Southern Brazil, an analytical \n\nmethod to differentiate these species was developed. The extracts of plants were \n\nprepared in order to obtain polar compounds, considering their popular uses,[4] So, \n\naqueous extracts and a n-BuOH fraction were used in our TLC analysis. A quick and \n\neconomical method that had been performed to obtain the differentiation of these \n\nBaccharis species through their phytochemical profiles is described. \n\nFigure 1 presents the chromatographic profile of aqueous extracts from the \n\nBaccharis species using silicagel 60 plates GF254, CHCl3:EtOH:HOAc (60:40:6, v/v) \n\nas mobile phase, anisaldehyde-H2SO4, heating to 100\u00b0C as colour reagent, and \n\nvisualisation under UV light, 356 nm. It is possible to verify that some extracts have \n\nimportant characteristics. B. articulata has a major blue spot (Rf 0.6) not detectable \n\nelsewhere and identified as BaII compound. Additionally, it was also possible to \n\ndifferentiate B. trimera aqueous extract that shows two yellow spots (Rf 0.6 and 0.8) \n\nand B. usterii with two major spots (one red and another one brown), at Rf 0.7 and \n\n0.5, respectively. B. spicata has one yellow spot at Rf 0.2. B. cylindrica extract did \n\nnot show any characteristic using this chromatographic condition.  \n\n \n \n \n \n \n \n \n \n \n \n \nFigure 1. TLC profile of aqueous extract from Baccharis species. Chromatographic \nsystem: Si gel GF254, CHCl3:EtOH:HOAc (60:40:6, v/v), anisaldehyde-H2SO4 then \nheating (100\u00b0C)/UV356. For sample codes see Experimental section. \n\n\n\n \n4 2\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\nFigure 2. TLC profile of aqueous extract from Baccharis species. Chromatographic \nsystem: Si gel GF254, CHCl3:EtOH:HOAc (60:40:6, v/v), natural reagent/UV356. For \nsample codes see Experimental section. \n \n\nFigure 2 shows the chromatographic profile of Baccharis species using the same \n\nchromatographic conditions of Figure 1, except the natural reagent as colour reagent \n\nwas used. Using this reagent, it is possible to observe the profile of the phenolic \n\ncompounds present in the aqueous extracts. First, it is clear to observe that B. \n\ncylindrica aqueous extract does not present phenolic compounds. B. articulata, B. \n\nspicata, B. trimera, and B. usterii extracts can be differentiated through their \n\nchromatographic profile. \n\nFigure 3 presents the pattern of n-BuOH fractions from Baccharis species using \n\nsilicagel plates GF254, CHCl3:EtOH:HOAc (60:40:6, v/v) as mobile phase and \n\nanisaldehyde-H2SO4 then heating (100\u00b0C) as colour reagent. A predominance of \n\npolar compounds with terpenoid colour characteristic was observed at all studied \n\nspecies. B. articulata is the only species presenting the BaII compound (Rf. 0.6). \n\nAnother important characteristic is that the B. usterii chromatographic profile showed \n\nthree major violet spots undetectable in the other species. In relation to the other \n\nBaccharis species, B. cylindrica has an important quantity of terpenoid compounds. \n\nThrough the use of one mobile phase, and changing only the colour reagent, it was \n\npossible to differentiate the five South Brazilian Baccharis species studied herein. It \n\nis possible to observe qualitative and quantitative differences on the chemical profile \n\nof aqueous extract and a n-BuOH fraction from these species.  \n\n\n\n \n4 3\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \nFigure 3. TLC profile of n-BuOH fraction from Baccharis species. Chromatographic \nsystem: Si gel GF254, CHCl3:EtOH:HOAc (60:40:6, v/v), anisaldehyde-H2SO4 then \nheating (100\u00b0C). For sample codes see Experimental section. \n \n\nAlthough the botanical differentiation among these plants is complex due to \n\nmorphological similarity, their chemical profiles can be easily differentiated by the \n\nchromatographic conditions presented herein. Accordingly, terpenoids and phenolic \n\ncompounds can be used as quality markers in the identification of the species \n\nstudied herein. Especially, the BaII compound could be used as a quality marker in \n\nthe identification of B. articulata. \n\n \n\nACKNOWLEDGMENTS \n\nWe are grateful to Marcos Sobral (UFRGS) for collecting and identifying part of the \n\nplant material. This work was supported by CNPq (Brazil) and FAPERGS (Brazil). \n\n \n\n\n\n \n4 4\n\nREFERENCES \n\n1. Barroso, G.H. Compositae: Subtribo Baccharidinae Hoffmann. Estudo das \n\nesp\u00e9cies ocorrentes no Brasil. Rodriguesia 1976, 28, 28\u201353. \n\n2. Freire, S.E.; Urtubey, E. Compuestas medicinales de la prov\u00edncia biogeogr\u00e1fica \n\npampeana: Claves para su determinaci\u00f3n e iconografias. Parte I: Compuestas \n\nespinosas (grupo 1) y compuestas con tallos alados (grupo 2). Acta Farm. \n\nBonaerense 1999, 18, 191\u2013199. \n\n3. Barroso, G.M.; Bueno, O.L. Compostas. 5. Subtribo Baccharidinae. I Parte. In \n\nFlora Ilustrada Catarinense; Reis, A., Ed.; Herb\u00e1rio Barbosa Rodrigues: Itaja\u00ed, 2002; \n\n1065. \n\n4. Zardini, E.M. Etnobot\u00e1nica de Compuestas Argentinas com especial referencia a \n\nsu uso farmacol\u00f3gico (primera parte). Acta Farm. Bonaerense 1984, 3, 77\u201399. \n\n5. Gianello, J.C.; Giordano, O.S. Examen quimico en seis especies del genero \n\nBaccharis. Rev. Latinoam. Quim. 1984, 15, 84\u201386. \n\n6. De Oliveira, S.Q.; Dal Pizzol, F.; Gosmann, G.; Guillaume, D.; Moreira, J.C.F.; \n\nSchenkel, E.P. Antioxidant activity of Baccharis articulata extracts: isolation of a new \n\ncompound with antioxidant activity. Free Rad. Res. 2003, 37, 555\u2013559. \n\n7. Zdero, C.; Bohlmann, F.; King, R.M.; Robinson, H. Diterpene glycosides and other \n\nconstituents from Argentinian Baccharis species. Phytochemistry 1986, 25, 2841\u2013\n\n2855. \n\n8. Dai, J.; Suttisri, R.; Bordas, E.; Soejarto, D.D.; Kinghorn, D. Clerodane \n\nditerpenoids from Baccharis articulata. Phytochemistry 1993, 34, 1087\u20131090. \n\n9. Gene, R.M.; Casta\u00f1a, C.; Adzet, T.; Marin, E.; Parella, T.; Ca\u00f1igueral, S. \n\nAntiinflammatory and analgesic activity of Baccharis trimera: Identification of active \n\nconstituents. Planta Med. 1996, 62, 232\u2013335. \n\n10. De Oliveira, S.Q.; Dal Pizzol, F.; Moreira, J.C.F.; Schenkel, E.P.; Gosmann, G. \n\nAntioxidant activity of Baccharis spicata, Baccharis trimera and Baccharis usterii. \n\nActa Farm. Bonaerense 2004, 23, 365\u2013368. \n\n11. De Oliveira, S.Q.; Trentin, V.H.; Kappel, V.D.; Barelli, C.; Gosmann, G.; \n\nReginatto, F.H. Screening of antibacterial activity of South Brazilian Baccharis \n\nspecies. Pharm. Biol. 2005, 43, 434\u2013438. \n\n\n\n \n4 5\n\nCap\u00edtulo 2 - Isolamento e elucida\u00e7\u00e3o estrutural das subst\u00e2ncias presentes na \nfra\u00e7\u00e3o n-butan\u00f3lica de B. articulata e B. usterii  \n\n \n\n \n\nPhytochemical analysis of n-Butanol fractions from Baccharis articulata \n\nand Baccharis usterii \n\nSimone Q. de Oliveira,a Gisele Barbon,a Claiton L. Lencina,b Viviane S. Pires,b Pascal Sonnet \n\nb and Grace Gosmann*,a  \n\na Faculdade de Farm\u00e1cia, Universidade Federal do Rio Grande do Sul, Av. Ipiranga 2752, \n\n90610-000 Porto Alegre-RS, Brazil \nb Facultes de M\u00e9decine and Pharmacie, Universit\u00e9 de Picardie Jules Verne, Amiens, France \n\n*e-mail:grace.gosmann@ufrgs.br \n\n \n\n \n\n \n\nAbstract \n\nBaccharis articulata and Baccharis usterii, members of Asteraceae are native species to \n\nSouth Brazil, Paraguay, Uruguay and Argentina. Their aerial parts have been used in folk \n\nmedicine as diuretic and digestive. In recent years there is a rapid increase in the information \n\navailable on the structures and pharmacological activities of novel compounds isolated and \n\nidentified from this genus. Herein, we report the isolation and characterization of two new \n\ncompounds from n-BuOH fraction of B. articulata (4\u2019-O-?-D-glucopiranosyl-3,5-\n\ndimethoxibenzyl-tetrahydro-2H-pyran-2-yl-acetyl-carbonate and 4\u2019-O-?-D-glucopiranosyl-\n\n3,5-dimethoxybenzyl-methanol) and two compounds from B. usterii (4,5-O-[E]-\n\ndicaffeoylquinic acid, a known substance  and 7-hydroxy-5,4\u2019-dimethoxy-flavone, a new \n\ncompound). These compounds were characterized by ESMS, UV, NMR (1H, 13C, HMBC and \n\nHMQC) and also by comparison with literature data.  \n\n \n\n \n\nKeywords: Baccharis, isolation and structural elucidation, phenolic compounds  \n\n \n\n(artigo a ser submetido) \n\n\n\n \n4 6\n\nIntroduction \n\nBaccharis articulata and Baccharis usterii, members of Asteraceae are native species to \n\nSouth Brazil, Paraguay, Uruguay and Argentina. Their aerial parts have been used in folk \n\nmedicine as diuretic and digestive.1 In recent years there was a rapid increase in the \n\ninformation available on the structures and pharmacological activities of novel compounds \n\nisolated and identified from this genus.2 About 150 compounds have been isolated and \n\nidentified from Baccharis species and the most prominent compounds are diterpenoids, \n\nflavonoids and phenolic acids derivatives, respectively.2-8 In our previous work, we reported \n\nthe isolation and identification of Ba II compound (4\u2019-O-?-D-glucopyranosyl-3\u2019,5\u2019-\n\ndimethoxybenzyl-caffeate) from B. articulata and this compound showed antioxidant \n\nproperties comparable to Trolox\u00ae. 8 \n\nHerein, we report the isolation and characterization of four compounds from n-BuOH fraction \n\nof B. articulata and B. usterii, respectively. Their structures were determined on basis of \n\nspectrometric analysis including ESMS, UV, NMR (1H, 13C, HMBC and HMQC) and also by \n\ncomparison with literature data. \n\n \n\nResults and discussion  \n\nConsidering the large use of Baccharis species in folk medicine, the discovery of new \n\nmolecules from these plants and information about their pharmacological activities are \n\nimportant by scientific knowledge about this genus. \n\nThe n-butanol fraction of B. articulata (4 g) was column chromatographed on silica gel using \n\na gradient of ethyl acetate\u2013methanol. Ba III compound (38 mg) was further purified by \n\nprecipitation with methanol.  \n\nBa III was isolated as an amorphous white solid. The structure of Ba III was assigned by a \n\ncombination of one and two-dimensional NMR methods, ESMS and data comparison of Ba II \n\ncompound, isolated and identified in our previous work.8 Ba III ESMS spectrum exhibited \n\nmolecular ion peak at m/z 539 [M + Na]+. This information together with the presence of 23 \n\nsignals in 13C-NMR spectrum suggested the molecular formula C23H32O13. The DEPT \n\nspectrum revealed two methoxyls, seven methylenes, eight methane and six quaternary carbon \n\natoms (table 1). The chemical shift of the three methylene groups (? 66.4, 69,2 and 61,5) \n\nevidenced that they were substituted by an oxygen atom. 1H-NMR spectrum exhibited one \n\nsinglet (6H) at ? 3.80 that  indicated the presence of two methoxyl groups. Two broad singlets \n\n\n\n \n4 7\n\nat ? 6.90 (2H) also suggested the presence of one tetrasubstituted aromatic nucleus.9 Analysis \n\nof the remaining signals suggested the presence of a sugar residue whose anomeric proton \n\nwas at ? 4.90 (d, J= 7.5 Hz, 1H) was typical of  ?-D-glucose.9-11 13C-NMR spectrum \n\nconfirmed the presence of two carbonyl functions (? 170.8 and 174.0), two methoxyl groups \n\n(? 56.0), two aromatic methine carbons (? 106.2) attributed to a symmetric nucleus \n\nsubstituted with two methoxy groups.9 The final structural assignment was established by \n\nheteronuclear 2D NMR experiments which showed correlations between the methylene \n\nhydrogens (? 5.10, H-7) and quaternary carbon of the tetrasubstituted aromatic nucleus (? \n\n133.1, C-4). Also observed correlations between anomeric carbon of  ?-D-glucose (H-1\u2019) and \n\nquaternary carbon of aromatic (? 135.6, C-1). The methylene hydrogens (? 4.30, H-9) showed \n\ncorrelations with carbonyl at (? 174.0, C-10). Therefore, Ba III (figure 1) was identified 4\u2019-\n\nO-?-D-glucopiranosyl-3,5-dimethoxibenzyl-tetrahydro-2H-pyran-2-yl-acetyl-carbonate, a \n\nnovel compound. \n\nBa IV substance (21 mg) was obtained by preparative TLC using dichloromethane-methanol \n\n(90:10, v/v). The ESMS spectrum exhibited molecular ion peak at m/z 369 [M + Na]+  \n\nindicating a molecular mass of 346. Considering the presence of 15 signals in 13C-NMR \n\nspectrum, the molecular formula C15H22O9 was suggested. The one and two-dimensional \n\nNMR spectra of Ba IV were very similar to those of Ba II8 and Ba III compounds. The 1H-\n\nNMR spectrum (table 1) showed a singlet at ? 6.70 (2H) indicating the presence of a \n\ntetrasubstituted aromatic nucleus.9 A signal at ? 3.85 (6H) indicated the presence of two \n\nmethoxyl groups. A doublet at ? 4.30 (J= 7.7 Hz, 1H) revealed the presence of an anomeric \n\nhydrogen of ?-D-glucose.12 The 13C-NMR experiment presented 15 signals, attributed to four \n\nquaternary carbons (? 153.2 and 138.7), two aromatic methines (? 104.0), five methine groups \n\nattributed to sugar (? 103.1, 76.9, 77.1, 70.6 and 74.0), two methylene groups (? 65.0 and \n\n61.7) and confirmed the presence of two methoxyl groups at (? 55.9). HMBC experiment \n\nshowed long-range correlations between the hydrogen signal at ? 3.85 (methoxyls) and \n\nquaternary carbons at ? 153.0 (C-6/C-2). Also it was possible observed long-range correlation \n\nbetween methylene group at ? 65.0 (C-7) and quaternary carbons at ? 138.0 (C-4) and 104.0 \n\n(C-5/C-3). Considering these data and the NMR data from Ba II and Ba III, it was possible to \n\nestablished to Ba IV the structure of 4\u2019-O-?-D-glucopiranosyl-3,5-dimethoxybenzyl-\n\nmethanol, a new compound. \n\n\n\n \n4 8\n\nThe n-butanol fraction of B. usterii (5 g) was subjected to gel permeation column \n\nchromatography on Sephadex LH-20 (Pharmacia) eluted with methanol affording a phenolic \n\n(1.5 g) and terpenic (2.8 g) sub-fractions. The phenolic sub-fraction, after purification by \n\ncolumn chromatography on silica RP-18, originated two compounds, BuF1 (30 mg) and \n\nBuF2 (18 mg). \n\nBuF1 compound was isolated as yellow solid. The UV spectral data showed absorption band \n\nat 370 nm in (NaOH) indicating a bathochromic shift of band II in relation to the absorption \n\nin methanol. Additionally, in aluminum chloride and aluminum chloride/hydrochloric acid \n\nprovided preliminary evidence for an ortho diphenol.13 ESMS experiment exhibited fragments \n\nm/z = 190, 163 and 353, respectively. Considering these informations and the analysis of \n\nNMR spectrum, it was established the presence of caffeic and quinic acids residues and \n\nmolecular mass of 516.  So, it was suggested the molecular formula of C25H24O12. The 1H-\n\nNMR spectrum showed signals at ? 6.80 (d, J= 8.1 Hz, 2H), 6.90 (d, J= 8.0 Hz, 1H), 7.00 (d, \n\nJ= 8.0 Hz, 1H) and 7.10 (s, 2H) suggesting the presence of two trisubstituted aromatic \n\nnucleus. Additionally, four doublets at ? 6.30, 6.40, 7.60 and 7.70 (4H) with coupling \n\nconstants, J= 15.8 Hz were attributed to trans olefinic hydrogens. The chemical shifts at ? \n\n5.20 and 5.80, suggested the position of esterification of quinic acid moiety with caffeic acid \n\nresidues, because these chemical shifts are characteristic of 4-/5- substitutions at quinic \n\nacid.14-15 The 13C-NMR experiment presented 25 signals attributed to seven quaternary \n\ncarbons (? 75.8, 126.4, 146.1, 148.2, 126.3, 145.9 and 145.2), six aromatic methine groups (? \n\n113.5, 113.6, 115.1, 121.6 , 121.7 and 113.7), seven methine groups (? 69.4, 68.1, 113.7, \n\n145.3 and 148.3), two methylene groups (? 39.5 and 37.4) and three carbonyls (? 179.0 and \n\n167.3(2x)).  Therefore, according these results and literature data BuF1 was identified as 4,5-\n\nO-[E]-dicaffeoylquinic acid, previously isolated from Baccharis usterii.16 \n\nBuF2 (18 mg) also was isolated from phenolic fraction as a yellow solid. ESMS spectrum \n\nexhibited molecular ion peak at m/z 321 [M + Na]+. This information together with the \n\npresence of 17 signals at 13C-NMR spectrum suggested the molecular formula of C17H14O5. \n\nThe 1H-NMR spectrum showed signals at ? 3.91 (s, 6H) indicating the presence of two \n\nmethoxyl groups. Four doublets at ? 6.40, 6.81 (J= 4 Hz, 2H) and 6.97 and 8.00 (J= 9 Hz, 4H) \n\nsuggested the presence of two aromatic nuclei. Additionally, the 13C-NMR spectrum showed \n\nseven quaternary carbons (? 165.96, 164.94, 162.32, 162.04, 158.07, 121.76 and 105.0), two \n\nmethoxyl groups (? 56.87), one carbonyl (? 182.75) and seven methine groups (?129.4, 116.8, \n\n105.0, 98.78, 93.51). The UV spectral data showed absorption band at 352 nm in (NaOAc) \n\n\n\n \n4 9\n\nindicating a bathochromic shift of band II in relation to the absorption in methanol, provided \n\npreliminary evidence for C-7 OH. Additionally, in aluminum chloride and aluminum \n\nchloride/hydrochloric acid did not showed changes in UV profile, suggesting the presence of \n\nC-5 methoxyl.3 Therefore, according to NMR and UV data, BuF2 was identified as 7-\n\nhydroxy-5,4\u2019-dimethoxy-flavone, a new compound.   \n\nAccording to literature, diterpenoids, flavonoids and other phenolic compounds, have been \n\nreported as the major constituents of Baccharis species. About 120 species were studied in \n\nrelation to chemical constituents. Other wise, there are few phytochemical studies about B. \n\narticulata and B. usterii.17 In our previous work, it was reported the isolation and \n\nidentification of 4\u2019-O-?-D-glucopyranosyl-3\u2019,5\u2019-dimethoxybenzyl-caffeate from n-butanol \n\nfraction of B. articulata.8 To this species, it was also isolated clerodane diterpenes and \n\nflavonoids from dichloromethane and ethyl acetate extracts, respectively.18-19 As far as we \n\nknow, B. usterii there is only one paper about characterization of dicaffeoylquinic derivatives \n\nfrom the aqueous extract.16 Herein, we reported the isolation and characterization of four \n\ncompounds from n-BuOH fractions of B. articulata and B. usterii. From B. usterii we confirm \n\nthe presence of 4,5-O-[E]-dicaffeoylquinic acid16 and the new flavone, 7-hydroxy-5,4\u2019-\n\ndimethoxy-flavone (BuF2). Considering that the occurrence of flavonoidal aglycones is a \n\ncharacteristic from Baccharis genus17 and the common pardon of methoxyl substitution in C-\n\n7/C-6 (A ring) and C-4\u2019 (B ring) BuF2 compound having a different pardon of methoxyl \n\nsubstitution in C-5.17 On the other hand, the compounds isolated from B. articulata presented \n\nstructural similarity to the BaII compound,8 previously isolated for us from n-butanol fraction \n\nof B. articulata.  \n\n \n\nConclusions \n\nBaccharis genus presented a considerable number of species distributed at the American \n\ncontinent. Considering the large use in folk medicine, the scientific knowledge about these \n\nspecies is valuable. This study presented the isolation and structural elucidation of three new \n\ncompounds and one known compound from B. articulata and B. usterii. Additionally, the \n\nBaccharis genus is a rich source of active compounds that, after careful scientific \n\ninvestigation, could be used to the development of new drugs. \n\n \n\n\n\n \n5 0\n\nExperimental \n\nGeneral experimental procedures \n\nESMS analysis was performed on a Micromass-Waters Q-TOF Ultima spectrometer. \n\nUltraviolet absorbance measurements were obtained on a Shimadzu UV-2201 \n\nspectrophotometer. NMR spectra were recorded on a Bruker Avance 500 spectrometer (125-\n\n500 MHz). \n\n \n\nPlant material \n\nAerial parts of B. articulata (Lam.) Person and B. usterii Heering were collected in Porto \n\nAlegre, State of Rio Grande do Sul, Brazil, in May 2005. The voucher specimens were \n\nidentified by Dr. S\u00e9rgio Bordignon (UNILASALLE) and herbarium specimens are on deposit \n\nin the Herbarium of the Botany Department of Universidade Federal do Rio Grande do Sul, \n\nPorto Alegre, Brazil. Each plant material was air dried and powdered separately. \n\n \n\nExtraction and isolation \n\nPlant material (1.5 kg) was macerated in ethanol 70% (plant\u2013solvent, 1:10, w/v) (2 X 10 \n\ndays). The crude extract was obtained after filtration and evaporation of the ethanol under \n\nvacuum. Aqueous residues were partitioned separately with dichloromethane, ethyl acetate \n\nand n-butanol (3 x 200 ml, respectively). Each fraction was evaporated separately to dryness \n\nunder reduced pressure. \n\nThe n-butanol fraction of B. articulata (4 g) was column chromatographed on silica gel \n\n(Merck\u00ae, 70-230 mesh) using a gradient of ethyl acetate\u2013methanol to obtain Ba III (4-O-?-D-\n\nglucopiranosyl-3,5-dimethoxibenzyl-tetrahydro-2H-pyran-2-yl-acetyl-carbonate) (38 mg) that \n\nwas further purified by precipitation with methanol. A fraction rich in Ba IV compound was \n\nobtained by column chromatographic on silica gel (Merck\u00ae, 70-230 mesh) using a gradient of \n\ndichorometane\u2013ethanol as a solvent. Ba IV (4-O-?-D-glucopiranosyl-3,5-dimethoxybenzyl- \n\nmethanol) (21 mg) was further purified by preparative TLC using dichloromethane-methanol \n\n(90:10, v/v). The n-butanol fraction of B. usterii (5 g) was subjected to gel permeation column \n\nchromatography on Sephadex LH-20 (Pharmacia) eluted with methanol and affording a \n\nphenolic (1.5 g) and a terpenic (2.8 g) sub-fraction. Two compounds were isolated from \n\nphenolic sub-fraction after purification by column chromatography on silica RP-18 (EMD\u00ae, \n\n230-400 mesh) using a gradient of water-methanol, BuF1 (4,5-O-[E]-dicaffeoylquinic acid) \n\n(30 mg) and BuF2 (7-hydroxy-5,4\u2019-dimethoxy-flavone) (18 mg).  \n\n\n\n \n5 1\n\nBa III \nWhite amorphous powder. ESMS m/z: 539, 421, 178 and 116 [M+Na]+, (C23H32O13). For 1H \n\nand 13C-NMR data see Table 1. \n\nBa IV \nWhite amorphous powder. ESMS m/z: 369, 236 and 231[M+Na]+, (C15H22O9). For 1H and \n13C-NMR data see Table 1. \n\nBuF1 \n\nYellow solid. UV ?max/nm: 235s; 244; 295s; 330 (MeOH), 262; 310; 370  (NaOH), 234; 244; \n\n300s; 330 (NaOAc), 251; 310s; 340 (NaOAc/H3BO3), 256; 310s; 348 (AlCl3), 246; 300s; 330 \n\n(AlCl3+HCl).  ESMS m/z: 190, 163, 353 and 516 [M\n+], (C25H24O12). For 1H and 13C-NMR \n\ndata see Table 2. \n\nBuF2 \n\nYellow solid. UV ?max/nm: 333; 268; 209 (MeOH), 333; 268; 209 (NaOH), 333; 268; 209 \n\n(NaOAc), 352; 346; 301; 276; 206 (NaOAc/H3BO3), 333; 268; 209 (AlCl3), 333; 268; 209 \n\n(AlCl3+HCl).  ESMS m/z: 257 and 298 [M+], (C17H14O5). For \n1H and 13C-NMR data see \n\nTable 2. \n\n\n\n \n5 2\n\nReferences \n\n \n\n1 . Zardini, E. M.; Acta Farm. Bonaerense 1984, 3, 77. \n\n \n\n2. Abad, M.  J.;  Bermejo, P.; Arkivoc 2007, vii, 76.  \n\n \n\n3. Dai, J.; Suttisri, R.; Bordas, E.; Soejarto, D. D.; Kinghorn, D.; Phytochemistry 1993, 34, \n\n1087.  \n\n \n\n4 .  Akaike, S.; Sumino, M.; Sekine, T.; Seo, S.; Kimura, N.; Ikegami, F.; Chem. Pharm. Bull. \n\n2003, 51, 197. \n\n \n\n5. Guo, Y.; Li, Y.; Xu, J.; Watanabe, R.; Oshima, Y.; Yamakuni, T.; Ohizumi, Y.;  J. Nat. \n\nProd. 2006, 69, 274. \n\n \n\n6. Cifuente, D. A.; Borkowwski, E. J.; Sosa, M. E.; Gianello, J. C.; Giordano, O. S.; Tonn, C. \n\nE.; Phytochemistry 2002, 61, 899. \n\n \n\n7. Feresin, G. E.; Tapia, A.; Gimenez, A.; Ravelo, A. G.; Zacchino, S.; Sortino, M.; \n\nHirschmann, G. S.; J. Ethnopharmacol. 2003, 89, 73. \n\n \n\n8. De Oliveira, S. Q., Dal Pizzol, F., Gosmann G.; Guillaume, D.; Moreira, J. C. F.; Schenkel, \n\nE. P.; Free Radical Res. 2003, 37, 555.  \n\n \n\n9. Kijima, H., Ide, T., Otsuka, H., Ogimi, C., Hirata, E., Takushi, A. and Takeda, Y.; \n\nPhytochemistry 1997, 44, 1551. \n\n \n\n10. Shoyama, Y., Hatano, K., Nishioka, I. and Yamagishi, T.; Phytochemistry 1986, 26, 2965. \n\n \n\n11. Ekabo, O.A., Farnsworth, N.R., Santisuk, T. and Reutrakul, V.; Phytochemistry 1993, 32, \n\n747. \n\n \n\n12. Agrawal, P.K. Phytochemistry 1992, 31, 3307.  \n\n \n\n\n\n \n5 3\n\n13. Mabry, T.J., Markham, K.R. and Thomas, M.B. The Systematic Identification of \n\nFlavonoids Springer: New York, 1970. \n\n \n\n14. Pauli, G. F.; Poetsch, F.; Nahrstedt, A. Phytochem. Analysis 1998, 9, 177. \n\n \n\n15. Merfort, I. Phytochemistry 1992, 31, 2111. \n\n \n\n1 6 .  Sim\u00f5es-Pires, C. A.; Queiroz, E. F.; Henriques, A. T; Hostettmann, K.; Phytochem. \n\nAnalysis 2005, 16, 307. \n\n \n\n17. Verdi, L.G.; Brighente,  I.M.C.; Pizzolatti, M.G.; Quim. Nova, 2005, 28, 85.  \n\n  \n\n18. Gianello, J. C.; Giordano, O. S.; Rev. Latino. Quim. 1984, 15, 84.  \n\n \n\n19. Stapel, G.; Men?en, H. G.; Snatzke, G. ; Planta Med. 1980, 39, 366. \n\n\n\n \n5 4\n\nTable 1. 13C and 1H-NMR data for Ba III and Ba IV compounds (500 \u2013 125 MHz, ?, \n\nmethanol-d4).  \n\n \n \n\n\u00a7under methanol-d4 signal \n\n                Ba III                Ba IV \nPosition 13C 1H 13C 1H \n\n1\u2019 133.1  138.0  \n2\u2019 106.2 6.77 brs (2H) 153.0  \n3\u2019 153.2  104.0 6.70 s (2H) \n4\u2019 135.6  138.0  \n5\u2019 153.2  104.0 6.70 s (2H) \n6\u2019 106.2 6.77 brs (2H) 153.0  \n7\u2019 66.4 5.10 s (2H) 65.0 4.60 s (2H) \n8\u2019 170.8    \n9\u2019 174.0    \n10\u2019 69.2 4.30 brs (2H)   \n11 49.0\u00a7 3.40 s (1H)   \n12 47.2 2.60 brs (2H)   \n13 24.4 1.80 m (1H)/2.10 m (1H)    \n14 39.9 2.00 m (2H)   \n15 45.3 3.00 m (1H)/3.20 m (2H)    \n\n2x OCH3 56.0 3.90 brs (6H) 55.9 3.85 brs (6H) \nGlucose      \n\n1\u2019\u2019 104.1 4.90 d (1H) J= 7.5 Hz 103.1 4.30 d (1H) J= 7.7 Hz \n2\u2019\u2019 74.6 3.50 m (1H) 74.0 3.15 m (1H) \n3\u2019\u2019 76.8 3.40 m (2H) 76.9 3.30 m (1H)/3.40 m (1H) \n4\u2019\u2019 70.1 3.40 m (2H)    70.6 3.30 m (1H)/3.40 m (1H) \n5\u2019\u2019 77.3 3.20 m (2H) 77.1 3.30 m (1H)/3.40 m (1H) \n6\u2019\u2019 61.5 3.70 m (2H)/3.80 m (2H) 61.7 3.85 brs (2H)/3.72m (2H) \n\n\n\n \n5 5\n\nTable 2. 13C and 1H-NMR data for BuF1 (methanol-d4) and BuF2 (DMSO-d6) compounds \n\n(500 \u2013 125 MHz).  \n\n \n\n                BuF1             BuF2 \nPosition 13C 1H 13C 1H \n\n1 75.8    \n2 37.4 2.40 m (2H) 164.9  \n3 69.4 4.30 s (1H) 105.0 6.89 s (1H) \n4 69.4 5.20 s (1H) J= 9 Hz 182.7  \n5 68.1 5.80 m (1H) 165.9  \n6 39.5 2.20 m (1H)/2.30 m (1H) 98.7 6.40 d (1H) J= 4 Hz \n7 179.0  162.0  \n1\u2019 126.4  93.5 6.81 d (1H) J= 4 Hz \n2\u2019 113.5 7.10 s (1H) 162.3  \n3\u2019 146.1  105.0  \n4\u2019 148.2  121.7  \n5\u2019 115.1 6.80 d (2H) J= 8.1 Hz 129.4 8.00 d (2H) J= 9 Hz \n6\u2019 121.6 7.00 d (1H) J= 8.0 Hz 116.8 6.97 d (2H) J= 9 Hz \n7\u2019 148.3 7.70 d (1H) J= 15.8 Hz 158.0  \n8\u2019 113.7 6.40 d (1H) J= 15.8 Hz   \n9\u2019 167.3    \n10\u2019 167.3    \n1\u201d 126.3    \n2\u201d 113.6 7.10 s (1H)   \n3\u201d 145.9    \n4\u201d 145.2    \n5\u201d 115.1 6.80 d (2H) J= 8.1 Hz   \n6\u201d 121.7 6.90 d (1H) J= 8.0 Hz   \n7\u201d 145.3 7.60 d (1H) J= 15.8 Hz   \n8\u201d 113.7 6.30 d (1H) J= 15.8 Hz   \n\n2 x OCH3   56.8 3.91 s (6H) \n     \n\n \n\n\n\n \n5 6\n\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \nFigure 1. Chemical structures of Ba III, Ba IV, BuF1 and BuF2 compounds. \n \n \n \n \n \n\n6 5\n\n4\n\n32\n\n1\n\nO\n\nOH\n\nOH\n\nO\n\nOH\n\nO\nHOOC\n\nOH\n\nOH\n\nO\n\n9'\n\n10'\n\n7\n7'\n\n8'\n\n6' 5'\n\n4'\n\n3'2'\n\n1'\n\n1\" 2\"\n\n3\"\n\n4\"5\"\n\n6\"\n\n7\"8\"\n\nHO\n\nBuF1 \n\n6'\n\n5'\n\n4'\n\n3'\n\n2'\n\n1'\n\n10\n\n9\n8\n\n7\n\n6\n5 4\n\n3\n\n2\n\nHO\n\nOCH3\n\nO\n\nOOCH3\n\nBuF2 \n\nBa III \n\nO\n\n9\n10 O\n\n8\n7\n\n6'5\n\n4'\n\n3' 2'\n\n1'O\n\nOH\n\nOH\n\nOH\n\nOH\n\nCH3O\n\nCH3 O\n\nO O\n\nO\n\nO 2\n\n3 4\n\n5\n\n6\n1''\n\n2''3''\n\n4''\n\n5''6''\n\n'\n'\n\n' '\n'\n\nB IV\n\nHO\nCH3O\n\nCH3O\n\nO OHO\n\nOH\n\nOH\n\nOH\n\n1'\n\n2'3\n\n4'\n\n5 6'\n7\n\n'\n\n' '\n\n1''\n\n2''3''\n\n4''\n\n5''\n\n6''\n\n\n\n \n5 7\n\nCap\u00edtulo 3 An\u00e1lise da atividade antioxidante dos extratos, fra\u00e7\u00f5es e subst\u00e2ncias \nisoladas a partir das partes a\u00e9reas de B. articulata e B. usterii \n\n \n\nAntioxidant activity of Baccharis articulata and Baccharis usterii extracts and their \n\nisolated compounds \n\nSimone Q. de Oliveira,a Gisele Barbon,a Virg\u00ednia D. Kappel, b Claiton L. Lencina,c Pascal \n\nSonnet, c Jos\u00e9 Cl\u00e1udio F. Moreirab and Grace Gosmann*,a  \n\na Faculdade de Farm\u00e1cia, Universidade Federal do Rio Grande do Sul, Porto Alegre-RS, \n\nBrazil \nb Departamento de Bioqu\u00edmica, Universidade Federal do Rio Grande do Sul, Porto Alegre-\n\nRS, Brazil   \nc Facultes de M\u00e9decine and Pharmacie, Universit\u00e9 de Picardie Jules Verne, Amiens, France \n\n*e-mail:grace.gosmann@ufrgs.br \n\n \n\nAbstract \n\nBaccharis articulata and Baccharis usterii, members of Asteraceae, are native species to \n\nSouth Brazil, Paraguay, Uruguay and Argentina. Their aerial parts have been used in folk \n\nmedicine as diuretic and digestive1. As a continuation of our research on this genus, we now \n\nreport the evaluation of antioxidant effect through TRAP and TBARS of n-butanol fractions \n\nand isolated compounds from B. articulata (Ba III, Ba IV, Ba V and Ba VI) and B. usterii \n\n(BuF1, BuF2 and BuT1). In the TRAP assay we used a final concentration of 1.25 ?g/ml for \n\nall samples and it was possible to observe an antioxidant effect to n-butanol fractions of these \n\nspecies. Among isolated compounds, the BuF1, a caffeoylquinic derivative, seems to have an \n\nimportant contribution to the total antioxidant capacity of n-butanol fraction from B. usterii. \n\nThe n-butanol fractions, Ba III, Ba IV, Ba V and BuF1 compounds studied in this work at \n\n40.0 ?g/ml were efficient to protect to the lipid peroxidation on TBARS experiment. The \n\nestablished use of B. articulata and B. usterii preparations in folk medicine for treatment of a \n\nvariety of disorders might be attributed, to some degree, to the antioxidant activity of \n\ncompounds described herein, specially BuF1 compound from B. usterii. \n\n \n\nKeywords: Baccharis, antioxidant activity, n-butanol fraction, BuF1 \n\n \n\n(artigo a ser submetido) \n\n\n\n \n5 8\n\nINTRODUCTION \n\nBaccharis articulata and Baccharis usterii, members of Asteraceae, are native species to \n\nSouth Brazil, Paraguay, Uruguay and Argentina. Their aerial parts have been used in folk \n\nmedicine as diuretic and digestive1. Previous studies reported the identification of phenolic \n\ncompounds and diterpenes as major constituents of these plants2-8. There is an increasing \n\ninterest in the antioxidant effects of compounds derived from herbs that could be relevant in \n\nrelation to their nutritional effects and their role in health and disease. A large number of \n\nstudies have demonstrated that phenolic compounds as flavonoids and phenolic acids \n\nderivatives posses antioxidant properties and might play a role in prevention of various \n\npathophysiological processes9. These compounds are free radical scavengers because phenolic \n\ngroups are excellent nucleophiles and are also able to quench lipid peroxidation, acting as \n\nchain break antioxidants10. Recently, we could demonstrated that Ba II compound (4\u2019-O-?-D-\n\nglucopyranosyl-3\u2019,5\u2019-dimethoxybenzyl-caffeate) isolated from the n-butanol fraction of B. \n\narticulata aerial parts, at concentrations of 0.2 and 2.0 mM, had antioxidant activity \n\ncomparable to Trolox\u00ae8. We also investigated the antioxidant activity crude dichloromethane, \n\nethanol and aqueous extracts from B. spicata, B. trimera and B. usterii through the evaluation \n\nof total antioxidant potential (TRAP), the prevention of formation of thiobarbituric acid \n\nreactive species (TBARS) induced by hydrogen peroxide and by determination of the \n\nprotection of Sertoli cells against hydrogen peroxide induces cell damage11. Fractions from \n\nthis aqueous extract (dichloromethane, ethyl acetate, n-butanol and aqueous residue) were \n\nalso evaluated. Aqueous extracts from B. spicata and B. trimera, at a concentration of 25 \n\n?g/mL, showed a higher antioxidant activity when compared to Trolox\u00ae (1 mM) and aqueous \n\nextract from B. usterii exhibit similar activity. In TBARS, ethanol and aqueous extracts and n-\n\nbutanol fractions were effective in the prevention of lipid peroxidation by inhibiting the \n\nformation of thiobarbituric acid reactive species and cell mortality induced by hydrogen \n\nperoxide11. Moreover, Baccharis grisebachi12, Baccharis trimera, Baccharis crispa and \n\nBaccharis usterii13 showed activity as free radical scavengers by the DPPH decoloration \n\ntest,12-13 suggesting that the folk use of B. articulata and B. usterii could be associated with \n\nthese antioxidant properties. \n\nThus, as a continuation of our research, we now report the evaluation of antioxidant effect \n\nthrough TRAP and TBARS (using egg yolk homogenates as lipid media) of n-butanol \n\nfractions and isolated compounds from B. articulata and B. usterii. Additionally the structures \n\n\n\n \n5 9\n\nof the isolated compounds were determined on basis of spectrometric analysis including \n\nESMS, UV, NMR (1H, 13C, HMBC and HMQC) and also by comparison with literature data. \n\n \n\nRESULTS AND DISCUSSION \n\nAntioxidant activity \n\nIn this work, B. articulata and B. usterii fractions and isolated compounds were studied for \n\ntheir activity as scavengers of free radicals and inhibitors of lipid peroxidation in vitro, by \n\nusing TRAP and TBARS assays, respectively. In our previous studies, we observed that the n-\n\nbutanol fractions of these species presented antioxidant activity using the same tests.8,11Also \n\nBa II compound, isolated from the n-butanol fraction of B. articulata aerial parts, presented \n\nantioxidant activity comparable to Trolox8. Considering these results, this paper presents the \n\nevaluation of other isolated compounds of n-butanol fractions from B. articulata and B. \n\nusterii.  \n\nThe total reactive antioxidant potential assay (TRAP) was determined using a method based \n\non the quenching of luminol-enhanced chemiluminescence derived from the thermolysis of a \n\nwater-soluble azo compound, AAPH (2,2\u2019-Azobis(2-methylpropionamidine)dihydrochloride), \n\nused as a reliable and quantifiable source of alkyl peroxyl radicals. This widely used assay has \n\nproved to be a simple, sensitive and reproducible method that can be used to determine the \n\nantioxidant capacity in complex mixtures such as plant extracts14-16. The TAR index was \n\nobtained from the initial decrease in the luminescence associated with the additive \n\nincorporation of the sample to the AAPH\u2013luminol system and it indicates the initial reactivity \n\nof the sample when compared to Trolox.\u00ae14-16 Evaluation of TRAP level of n-butanol fraction \n\nfrom B. articulata and isolated compounds (Ba III, Ba IV, Ba V and Ba VI) are shown in \n\nFigure 1A. The chemiluminescence (CL) profiles obtained after addition of 10 ?l of Trolox\u00ae \n\n(final concentration 200 nM), used as a standard, of fractions and isolated compounds (final \n\nconcentration 1.25 ?g/mL) are presented. The TRAP profiles observed and the CL decrease \n\nfollowing addition of the plant extracts and isolated compounds were qualitatively different to \n\nthat obtained when Trolox\u00ae was used. The n-butanol fraction showed antioxidant activity \n\nhigher than Trolox\u00ae and isolated compounds (p<0.05). Besides, the extract showed \n\ninstantaneous reduction of CL and it maintained this activity during the analyzed period. \n\nThese properties were not observed to isolated compounds. Ba III, Ba V and Ba VI exhibited \n\ncapacity in reducing the luminol-enhanced chemiluminescence, on similar levels that Trolox\u00ae, \n\n\n\n \n6 0\n\naccording statistical analysis. On the other hand, Ba IV showed lower activity than Trolox \n\n(p<0.05). Comparing to TAR index results (Figure 2A), the fraction showed a significantly \n\nhigher TAR index than Trolox\u00ae and isolated compounds.  \n\nBased on these facts and considering that the phenomenon of additive or synergistic effects in \n\ncomplex plant extracts frequently causes loss or impairment of activity during bioguided \n\nfractionation17, our results led us to propose that the isolated compounds are not directly \n\nrelated with the detected antioxidant activity in the n-butanol fraction, and that possibly other \n\nmetabolites present in B. articulata could be responsible for this action. \n\nIn relation to TBARS experiment18 (Figure 3A), the n-butanol fraction and all isolated \n\ncompounds from B. articulata were efficient to protect the cells of lipid peroxidation causing \n\na significant decrease in MDA production, similar to control (p<0.05). \n\nRegarding the TRAP profiles of n-butanol fraction, phenolic and terpenic sub-fractions, \n\nBuF1, BuF2 and BuT1 compounds from B. usterii (Figure 1B) it was verified that CL \n\ndecreased following addition of the plant extracts and isolated substances were qualitatively \n\ndifferent to that obtained when Trolox\u00ae was used. The n-butanol fraction, phenolic and \n\nterpenic sub-fractions, BuF1 reduced instantaneously the luminol-enhanced \n\nchemiluminescence and maintained this activity during the analyzed period. The n-butanol \n\nfraction, phenolic and terpenic sub-fractions and BuF1 compound showed peroxyl scavenging \n\nproperties statistically different from Trolox (p<0.05). The TAR index (Figure 2B) suggest \n\nthat the n-butanol fraction, phenolic and terpenic sub-fractions and BuF1 compound had \n\ndifferent antioxidant reactivity (p<0.05) and that the BuF1 is significantly higher than \n\nTrolox\u00ae. The results obtained on TBARS assay (Figure 3B) indicated that the n-butanol \n\nfraction, phenolic and terpenic sub-fractions inhibited the lipid peroxidation similarly to \n\ncontrol. BuF1 showed higher activity than control (p<0.05), but presented similar activity that \n\nthe n-butanol fraction and phenolic and terpenic sub-fractions.  \n\nFigure 4 presented the chemical structures of compounds Ba III, Ba IV, BuF1 and BuF2. \n\nOn the basis of the data presented herein and in our previous works, the fractions and isolated \n\ncompounds from B. articulata and B. usterii showed antioxidant activity. In the TRAP assay \n\nwe used a final concentration of 1.25 ?g/ml for all samples and it was possible to observe a \n\nsignificant antioxidant effect to n-butanol fractions of these species. In our previous work we \n\nreported antioxidant properties for these fraction at 10008 and 25 ?g/ml.11 Among isolated \n\ncompounds, the BuF1, a caffeoylquinic derivative, previously reported,13 to have a \n\nconsiderable contribution to the total antioxidant capacity of n-butanol fraction from B. \n\n\n\n \n6 1\n\nusterii. The antioxidant potential of BuF1 was confirmed indicating their peroxyl scavenging \n\nproperties.  \n\nIn this work the n-butanol fraction and all isolated compounds from B. articulata and the n-\n\nbutanol fraction, phenolic and terpenic sub-fractions and BuF1 compound from B. usterii \n\nwere efficient to protect the cells of lipid peroxidation on TBARS experiment, and our results \n\nare in agreement to several studies that investigated the antioxidant activity against lipid \n\nperoxidation of several extracts rich in polyphenols.19-20 In addition, the chemical \n\nchromatographic profiles of B. articulata and B. usterii extracts present great chemical \n\ndiversity,21 like the presence of diterpenoids, flavonoids and phenolic acids derivatives \n\ncompounds,2-8 suggesting that various chemical groups could be associated with antioxidant \n\nproperties of B. articulata and B. usterii herein verified.  \n\nNowadays, Baccharis species continue to play an important role in the traditional medicine of \n\nmany modern cultures, being used for treatment of gastrointestinal and hepatic disorders.8,12,22 \n\nIn our opinion, the use of B. articulata and B. usterii preparations in folk medicine for \n\ntreatment of a variety of disorders might be attributed, to some degree, to the antioxidant \n\nactivity of compounds described herein, specially BuF1. \n\n \n\nStructural elucidation of Ba V, Ba VI and BuT1 compounds. The structural elucidation of \n\nBa V and Ba VI compounds from n-butanol fraction of B. articulata and BuT1 compound \n\nfrom B. usterii are under current analysis.  \n\n \n\nMATERIAL AND METHODS \n\n \n\nReagents. Thiobarbituric acid (TBA), luminol (3-aminophthalhydrazide), were purchased \n\nfrom Sigma Chemical Co. (St. Louis, MO). 2,2\u2019-Azobis(2-\n\nmethylpropionamidine)dihydrochloride (AAPH) and 6-hydroxy-2,5,7,8-tetramethylchroman-\n\n2-carboxylic acid (Trolox\u00ae) were purchased from Aldrich Chemical (Milwaukee, WI). The \n\nglycine was purchased from Nuclear (Diadema, SP, Brazil). Trichloroacetic acid (TCA) was \n\npurchased from Synth (Diadema, SP, Brazil). \n\n \n\nPlant material. Aerial parts of B. articulata (Lam.) Person and B. usterii Heering were \n\ncollected in Porto Alegre, State of Rio Grande do Sul, Brazil, in May 2005. The voucher \n\nspecimens were identified by Dr. S\u00e9rgio Bordignon (UNILASALLE) and herbarium \n\nspecimens are on deposit in the Herbarium of the Botany Department of Universidade Federal \n\n\n\n \n6 2\n\ndo Rio Grande do Sul, Porto Alegre, Brazil. Each plant material was air dried and powdered \n\nseparately. \n\n \n\nExtraction and isolation. Plant material (1.5 kg) was macerated in ethanol 70% (plant\u2013\n\nsolvent, 1:10, w/v) (2 X 10 days). The crude extract was obtained after filtration and \n\nevaporation of the ethanol under vacuum. Aqueous residues were partitioned with \n\ndichloromethane, ethyl acetate and n-butanol (3 x 200 ml, respectively). Each fraction was \n\nevaporated to dryness under reduced pressure separately. \n\nThe Ba III (4\u2019-O-?-D-glucopiranosyl-3,5-dimethoxibenzyl-tetrahydro-2H-pyran-2-yl-acetyl-\n\ncarbonate),  Ba IV (4\u2019-O-?-D-glucopiranosyl-3,5-dimethoxybenzyl-methanol), BuF1 (4,5-O-\n\n[E]-dicaffeoylquinic acid) and BuF2 (7-hydroxy-5,4\u2019-dimethoxy-flavone) isolation \n\nmethodology was previously reported.23 The isolation of Ba V, Ba VI and BuT1 is described \n\nbellow. The n-butanol fraction of B. articulata (4 g) was preliminarily chromatographed on \n\nsilica gel (Merck\u00ae, 70-230 mesh) column using a gradient of ethyl acetate\u2013methanol as a \n\nsolvent23. Ba V (13 mg) and Ba VI (15 mg) were obtained after RP-18 (EMD\u00ae, 230-400 \n\nmesh) column chromatographic using a gradient of water-methanol. From terpenic sub-\n\nfraction obtained previously of n-butanol fraction of B. usterii (5 g) 23 was purified the BuT1 \n\ncompound (13.5 mg) by column chromatography on silica RP-18 (EMD\u00ae, 230-400 mesh) \n\nusing a gradient of water-methanol and further purification by preparative TLC using n-\n\nbutanol-acetic acid-water (BAW) (12:2:1, v/v/v) as mobile phase. \n\n \n\nInstrumentation. ESMS analysis was performed on a Micromass-Waters Q-TOF Ultima \nspectrometer. Ultraviolet absorbance measurements were obtained on a Shimadzu UV-2201 \n\nspectrophotometer. NMR spectra were recorded on a Bruker Avance 500 spectrometer (125-\n\n500 MHz). The TRAP profile was obtained measuring the CL emission in a liquid \n\nscintillation counter (Wallac 1409), operating in the \u2018out of coincidence\u2019 mode, as counts per \n\nminute (CPM). \n\n \n\nAntioxidant activity. The in vitro antioxidant activity of the n-butanol fractions and isolated \n\nsubstances was estimated by the total reactive antioxidant potential (TRAP) and the total \n\nantioxidant reactivity (TAR), as previously described14-16. Briefly, the reaction mixture (4 \n\nmL), containing AAPH (10 mM) and luminol (4 mM) in glycine buffer (0.1 M), pH 8.6, was \n\nincubated at 21oC for 2 h. AAPH is a source of peroxyl radicals that react with luminol \n\n\n\n \n6 3\n\nyielding chemiluminescence (CL). The system was calibrated using the ?-tocopherol \n\nsynthetic analogue, Trolox\u00ae. The addition of 10 ?L of the n-butanol fractions and isolated \n\ncompounds (final concentration 1.25 ?g/mL) or of 10 ?L of Trolox\u00ae (final concentration 200 \n\nnM) decreases the CL proportionally to its antioxidant potential. The TRAP profile was \n\nobtained measuring the CL emission in a liquid scintillation counter (Wallac 1409), operating \n\nin the \u2018out of coincidence\u2019 mode, as counts per minute (CPM). The CL intensity was \n\nmonitored for 50 min after the addition of the extracts or Trolox\u00ae. The TAR index was \n\ndetermined by measuring the initial decrease of luminol luminescence calculated as the ratio \n\nIo/I where Io is the initial emission of CL (before the addition of the antioxidant) and I is the \n\ninstantaneous CL intensity after addition of an aliquot of the sample or the reference \n\ncompound (Trolox\u00ae).14-16 \n\n \n\nLipid peroxidation. Thiobarbituric acid-reactive species (TBARS) formation was used to \n\nevaluate lipid peroxidation using egg yolk homogenates as lipid media. The homogenate (1 \n\nml of 1%, w/v) and 0.1 ml of samples solubilised in buffer were added to a test tube and made \n\nup to 1.0 ml with distilled water. 100 ?L of AAPH (120 mM) was added to a number of \n\nsamples to induce lipid peroxidation. In order to precipitate the proteins of the media, 600 ?L \n\nof 15% trichloroacetic acid were added to 300 ?L of the egg yolk homogenates and \n\ncentrifuged at 1000g for 10 min. Then, 500 ?L of supernatant were mixed with 500 ?L of \n\n0.67% thiobarbituric acid. The reaction mixture was incubated in a boiling water bath for 20 \n\nmin, cooled to room temperature and the absorbance read at 532 nm.18 All samples tested in \n\nfinal concentration at 40 ?g/ml. The results were expressed as nmol MDA equivalents, \n\ncalculated according standard curve of TMP (tetramethoxylpropane) (2 ?M) (y = 0.1938x + \n\n0.0017) r2 = 0.9926.  \n\n \n\nStatistical analysis. Data were expressed as means \u00b1 standard deviation (SD) of triplicates \n\nfrom two independent experiments. Differences between treatments were compared by one-\n\nway ANOVA, followed by Tukey\u2019s test for approximately normally distributed variables. \n\nData analyses were performed using the SPSS 13.0 software package (SPSS Inc., Chicago, \n\nIL) and the statistical significance was set at the 0.05 level (two-tailed). \n\n\n\n \n6 4\n\nREFERENCES \n\n1 .  Zardini, E. M.; Acta Farm. Bonaerense 1984, 3, 77. \n\n \n\n2. Abad, M.  J.;  Bermejo, P.; Arkivoc 2007, vii, 76.  \n\n \n\n3. Dai, J.; Suttisri, R.; Bordas, E.; Soejarto, D. D.; Kinghorn, D.; Phytochemistry 1993, 34, \n\n1087.  \n\n \n\n4 .  Akaike, S.; Sumino, M.; Sekine, T.; Seo, S.; Kimura, N.; Ikegami, F.; Chem. Pharm. Bull. \n\n2003, 51, 197. \n\n \n\n5. Guo, Y.; Li, Y.; Xu, J.; Watanabe, R.; Oshima, Y.; Yamakuni, T.; Ohizumi, Y.;  J. Nat. \n\nProd. 2006, 69, 274. \n\n \n\n6. Cifuente, D. A.; Borkowwski, E. J.; Sosa, M. E.; Gianello, J. C.; Giordano, O. S.; Tonn, C. \n\nE.; Phytochemistry 2002, 61, 899. \n\n \n\n7. Feresin, G. E.; Tapia, A.; Gimenez, A.; Ravelo, A. G.; Zacchino, S.; Sortino, M.; \n\nHirschmann, G. S.; J. Ethnopharmacol. 2003, 89, 73. \n\n \n\n8. De Oliveira, S. Q., Dal Pizzol, F., Gosmann G.; Guillaume, D.; Moreira, J. C. F.; Schenkel, \n\nE. P.; Free Rad. Res. 2003, 37, 555.  \n\n \n\n9. Sarkar, A. &amp; Bhaduri, A.; Biochem. Bioph. Res. Co. 2001, 284, 173. \n\n \n\n1 0 .  Rice-Evans, C.; Miller, N. J.; Paganga, G. Trends Plant Sci. 1997, 2, 152. \n\n \n\n11. De Oliveira, S. Q., Dal Pizzol, F., Moreira, J. C. F.; Schenkel, E. P.; Gosmann, G.; Acta \n\nFarm. Bonaerense. 2004, 23, 365.  \n\n \n\n12. Tapia, A.; Rodriguez, J.; Theoduloz, C.; Lopez, S.; Feresin, F. G.; Schmeda-Hirschmann, \n\nG. J. Ethnopharmacol.2004, 95, 155.  \n\n \n\n\n\n \n6 5\n\n13. Sim\u00f5es-Pires, C. A.; Queiroz, E. F.; Henriques, A. T; Hostettmann, K.; Phytochem. \n\nAnalysis 2005, 16, 307. \n\n \n\n14. Lissi, E.; Salim-Hanna, M.; Pascual, C.; Del castillo, M.D. Free Radical Res. Comm. \n\n1992, 7, 299. \n\n \n\n15. Lissi, E., Salim-Hanna, M., Pascual, C., Del Castillo, M.D. Free Radical Biol. Med. 1995, \n\n18,153. \n\n \n\n16. Desmarchelier, C.; Repetto, M.; Coussio,J.; Llesuy, S.; Ciccia,G. Int. J. Pharm. 1997, \n\n35,288. \n\n \n\n17. Jassim, S.A.A.; Naji, M.A. Novel antiviral agents: a medicinal plant perspective J.Applied \n\nMicr. 2003, 95, 412. \n\n \n\n18. Ruberto, G.; Baratta, M. T.; Deans, S. G.; Dorman, H. J. D. Plant Med.  2000, 66, 687. \n\n \n\n19. Desmarchelier, C.; Lisboa Rom\u00e3o, R., Coussio, J.; Ciccia, G. J. Ethnopharmacol 1999, \n\n67, 69. \n\n \n\n20. Polydoro, M.; de Souza, K. C.; Andrades, M. E.; Da Silva, E. G.; Bonatto, F.; Heydrich, \n\nJ.; Dal-Pizzol, F.; Schapoval, E.E.S.; Bassani, V.L.; Moreira, J.C.F. Life Sci. 2004, 74, 2815. \n\n \n\n21. De Oliveira, S.Q.; Barbon, G.; Gosmann, G.; Bordignon, S.; J. Liq. Chromatogr.R. T. \n\n2006, 29, 2603. \n\n \n\n22. Schinella, G.R., Troiani, G., Da\u00b4vila, V., de Buschiazzo, P.M.; Tournier, V. H.; Biochem. \n\nBioph. Res. Co.  2000, 269, 357. \n\n \n\n23. cap\u00edtulo 2. \n\n \n\n \n\n \n\n \n\n\n\n \n6 6\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\nFigure 1. TRAP profile of n-butanol fraction from B. articulata and its isolated compounds \n\n(A) and n-butanol fraction from B. usterii, its sub-fractions and isolated compounds (B). \n\nChemiluminescence intensity (percentage of counts per minute-CPM) measured after addition \n\nof 10 ?l of Trolox (final concentration 200 nM) and the extracts and isolated compounds \n\n(final concentration 1.25 ?g/ml) to 4 ml of glycine buffer (0.1 M), pH 8.6, containing luminol \n\n(4 mM) and AAPH (10 mM) at 21 oC. Results are expressed as means \u00b1 S.D. of triplicates.  \n\n0 10 20 30 40 50\n0\n\n50\n\n100\n\n150\nn-BuOH B. articulata\nBa III\nBa IV\nBa V\nBa VI\nTrolox 200 nM\n\nTime (m)\n\n%\n C\n\nP\nM\n\n(A) \n\n0 10 20 30 40 50\n0\n\n50\n\n100\n\n150\nn-BuOH B. usterii\nPhenolic sub-fraction\nTerpenic sub-fraction\nBuF1\nBuF2\nBuT1\nTrolox 200 nM\n\nTime (m)\n\n%\n C\n\nPM\n\n(B) \n\n\n\n \n6 7\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\nFigure 2. TAR index (I0/I) of n-butanol fraction from B. articulata and its isolated \n\ncompounds (A) and n-butanol fraction from B. usterii, its sub-fractions and isolated \n\ncompounds (B). Date are mean \u00b1 S.D. of n=6. The values with the same letter indicate no \n\nsignificant differences by Tukey\u2019s test (p<0.05). \n\n \n\n \n\n n\n-B\n\nuO\nH \n\nfra\ncti\n\non\nBa\n\n III\nBa\n\n IV\nBa\n\n V\nBa\n\n V\nI\n\nTr\nolo\n\nx\n0\n\n50\n\n100\n\n150\n\nI0\n/I\n\n \n\n(A) \n\na \n\nb b b b \n\n \n\nTe\nrp\n\nen\nic \n\nsu\nb-f\n\nra\ncti\n\non\nBu\n\nF2\nBu\n\nT1\n\nn-\nBu\n\nOH\n fr\n\nac\ntio\n\nn\n\nPh\nen\n\noli\nc s\n\nub\n-fr\n\nac\ntio\n\nn\nBu\n\nF1\nTr\n\nolo\nx\n\n0\n\n100\n\n200\n\n300\n\n400\n\nI0\n/I\n\n  \n\nd\n\nc\n\nb b\n\n(B) \n\na \n\ne\n\n\n\n \n6 8\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\nFigure 3. Effect of n-butanol fraction from B. articulata and its isolated compounds (A) and \n\nn-butanol fraction from B. usterii, its sub-fractions and isolated compounds (B) (final \n\nconcentration of 40 ?g/ml) on TBARS levels. Control: 1000 ?l egg yolk homogenates and \n\n200 ?l TBA buffer. Results are expressed as mean \u00b1 S.D. of triplicates from two independents \n\nexperiments. Values with the same letter indicate no significant difference by Tukey\u2019s test \n\n(p<0.05). \n\nc cc\n\n   \n\n \n\nCo\nnt\n\nro\nl\n\nCo\nnt\n\nro\nl +\n\n A\nAP\n\nH\n\nn-\nBu\n\nOH\n fr\n\nac\ntio\n\nn\n\nPh\nen\n\noli\nc s\n\nub\n-fr\n\nac\ntio\n\nn\n\nTe\nrp\n\nen\nic \n\nsu\nb-\n\nfra\ncti\n\non\nBu\n\nF1\nBu\n\nF2\nBu\n\nT1\n0.00\n\n0.02\n\n0.04\n\n0.06\n\n0.08\n\nn\nm\n\no\nl M\n\nD\nA \n\ne\nqu\n\niv\nal\n\nen\nts\n\n \n\n a \n\n(B) \n\n c\n\nb\nb\n\na  a \n\n \n\nCo\nntr\n\nol\n\nCo\nnt\n\nro\nl +\n\n A\nAP\n\nH\nBa\n\n IV\nBa\n\n V\nBa\n\n III\nBa\n\n V\nI\n\nn-B\nuO\n\nH \nfra\n\ncti\non\n\n0.00\n\n0.02\n\n0.04\n\n0.06\n\nn\nm\n\no\nl M\n\nD\nA\n\n e\nqu\n\niv\nal\n\nen\nts\n\n \n\na\n b\n\naa a  \n\n(A) \n\n\n\n \n6 9\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\nFigure 4. Chemical structures of Ba III, Ba IV, BuF1 and BuF2 compounds. \n\n6 5\n\n4\n\n32\n\n1\n\nO\n\nOH\n\nOH\n\nO\n\nOH\n\nO\nHOOC\n\nOH\n\nOH\n\nO\n\n9'\n\n10'\n\n7\n7'\n\n8'\n\n6' 5'\n\n4'\n\n3'2'\n\n1'\n\n1\" 2\"\n\n3\"\n\n4\"5\"\n\n6\"\n\n7\"8\"\n\nHO\n\nBu F1 \n\n6'\n\n5'\n\n4'\n\n3'\n\n2'\n\n1'\n\n10\n\n9\n8\n\n7\n\n6\n5 4\n\n3\n\n2\n\nHO\n\nOCH3\n\nO\n\nOOCH3\n\nBu F2 \n\nBa III \n\nO\n\n9\n10 O\n\n8\n7\n\n6'5\n\n4'\n\n3' 2'\n\n1'O\n\nOH\n\nOH\n\nOH\n\nOH\n\nCH3O\n\nCH3 O\n\nO O\n\nO\n\nO 2\n\n3 4\n\n5\n\n6\n1''\n\n2''3''\n\n4''\n\n5''6''\n\n'\n'\n\n' '\n'\n\nB IV\n\nHO\nCH3O\n\nCH3O\n\nO OHO\n\nOH\n\nOH\n\nOH\n\n1'\n\n2'3\n\n4'\n\n5 6'\n7\n\n'\n\n' '\n\n1''\n\n2''3''\n\n4''\n\n5''\n\n6''\n\n\n\n \n7 0\n\nCap\u00edtulo 4 \u2013 Atividade antibacteriana de esp\u00e9cies do g\u00eanero Baccharis do Sul do Brasil \n\n \n\nAntibacterial Activity of South Brazilian Baccharis species \n\nV\u00e2nia H. Trentina, Virg\u00ednia Kappela, Simone Quintana de Oliveiraa, Cristiane Barellia, Grace \n\nGosmannb, Eloir Paulo Schenkelc and Fl\u00e1vio Reginattoa \n\na Curso de Farm\u00e1cia, Universidade de Passo Fundo, UPF, Passo Fundo, Brazil \n\nb  Faculdade de Farm\u00e1cia, Universidade Federal do Rio Grande do Sul, UFRGS, Porto Alegre, \n\nBrazil \n\nc Centro de Ci\u00eancias da Sa\u00fade, Universidade Federal de Santa Catarina, UFSC, Florian\u00f3polis, \n\nBrazil \n\nAbstract \n\nSouth Brazilian Baccharis species were studied for antibacterial activities against gram-\n\npositive and gram-negative bacterial using disc diffusion and broth dilution assays. The \n\nresults showed that the n-BuOH fraction (100 ?g) from B. usterii exhibited inhibitory activity \n\nagainst S. aureus, E. faecalis and E. faecium. The n-BuOH fraction of B. spicata (1000 ?g) \n\nwas effective against S. aureus, E. coli, E. faecalis and E. faecium. The crude extract of B. \n\ntrimera showed activity against S. aureus. The MBC obtained from n-BuOH fraction of B. \n\nspicata were 50 mg/mL against S. aureus, E. coli, E. faecalis and E. faecium.  From crude \n\nextract of B. trimera the MBC obtained were 25 mg/mL against S. aureus.  The n-BuOH \n\nfraction of B. usterii showed a MBC of 25 mg/mL against S. aureus and 50 mg/mL against E. \n\nfaecalis and E. faecium, while crude extract of this plant showed a MBC of 12.5 mg/mL \n\nagainst S. aureus. \n\n \n\nKeywords: Antimicrobial activity, Baccharis, disc-diffusion method, MBC, MIC \n\n\n\n \n7 1\n\nIntroduction \n\nThe multiple drug-resistant organisms, that are resistant to major classes of antibiotics, \n\ncreated an urgent need for new antibacterial agents (American Society of Microbiology, \n\n1995). Natural products from plants provide a tremendous variety of lead structures, which \n\nare used as templates for the development of new products by the pharmaceutical industry. \n\nWhile microbial products have been the mainstay of industrial natural products discovery \n\n(Borris, 1996), in recent years many researchers have turned to discover the scientific basis of \n\neffects related of the traditional folk medicine and some natural products have been approved \n\nas new antibacterial drugs (Cragg et al., 1997). \n\nSeveral species of Baccharis are used in folk medicine in form of infusions as curing \n\nwounds or locals infections and as digestives, suggesting a possible antibacterial activity \n\n(Palacios et al., 1983; Zardini, 1984; Gen\u00e9 et al., 1996).  \n\nB. anomala, B. crispa, B. glutinosa, B. grisebacchii, B. microdonta, B. notosergila e B. \n\npedunculata (Palacios et al., 1983; Anesini &amp; Perez, 1993; Rahalison et al., 1995; Ver\u00e1stegui \n\net al., 1996; Feresin et al., 2001; Coelho de Souza et al., 2004) and specially reports indicating \n\nthat the antibacterial activity described from Baccharis genus are attributed of flavonoids like \n\ngencawanin and apigenin (Palacios et al., 1983; Xu and Lee, 2001).  \n\n In the South of Brazil, the main species of Baccharis used folk medicine are B. \n\ntrimera and B. articulata for digestives properties (Ver\u00e1stegui et al., 1996; Oliveira et al., \n\n2003, Oliveira et al., 2004).  \n\nConsidering that are few chemical and pharmacological information of these plants, \n\nthe present study aimed carry out a screening of some native South Brazilian Baccharis \n\nspecies in order to detect new sources of antibacterial agents. \n\nMaterial and methods \n\nPlant material  \n\nThe aerial parts of B. articulata (Lam.) Persoon, B. trimera (Less) A. P. de Candolle were \n\ncollected in Camargo, State of Rio Grande do Sul, Brazil in April of 2003. The voucher \n\nspecimens were identified by Profa. Msc. Branca Severo from Universidade de Passo Fundo \n\nand are on deposited in the herbarium of Instituto de Ci\u00eancias Biol\u00f3gicas from this \n\nUniversity. B. spicata (Lam.) Bailon and B. usterii Heering were collected in Porto Alegre, \n\nState of Rio Grande do Sul, Brazil in February of 2002. The voucher specimens were \n\nidentified by Marcos Sobral from Universidade Federal do Rio Grande do Sul and are on \n\ndeposited in the herbarium of the Botanical Department of this University. \n\n\n\n \n7 2\n\n \n\nPreparation of plant extracts  \n\nAerial parts (50 g) of B. articulata, B. spicata, B. trimera and B. usterii were crushed and \n\nextracted under reflux (90\u00b0C) with 500 mL of ethanol 40\u00b0GL for 30 min. After cooling, each \n\nextract was filtered separately and the volume was adjusted to 500 mL with water being \n\nseparated in two fractions of 250 mL. One fraction was evaporated under reduced pressure to \n\ndryness to obtained the crude extract. The ethanol content of the  second fraction was \n\nremoved under reduced pressure, its volume was adjusted to 250 mL with water and this \n\naqueous suspension was successively partitioned (3 x 50 mL) with ethyl acetate  (yielding the \n\nethyl acetate fraction) and n-BuOH (yielding the n-BuOH fraction). These fractions were \n\nevaporated to dryness and re-dissolved with sterile water in concentrations of 50, 10, 5, 2.5 \n\nand 1.25 mg/mL to biological tests. \n\n \n\n\n\n \n7 3\n\nPhytochemical characterization of plants extracts by TLC \n\nThe presence of different constituents in crude extracts from B. articulata, B. spicata, B. \n\ntrimera and B. usterii was established by TLC on silica gel plates (Merck 60 F254 20 x 20 cm) \n\nusing as mobile phases CHCl3-EtOH-HOAc (100:40:6 v/v) and BAW (5:1:3 v/v). The \n\ndetections of this TLC were, respectively, chlorosulphonic acid-glacial acetic acid reagent \n\nspraying and heating from terpenoids and from phenolic compounds, fluorescence at 365 nm \n\nafter spraying with 1% diphenylboryloxyethylamine in CH3OH (Wagner, 1983). \n\n \n\nAntibacterial assays \n\nThe disc-diffusion method was used as a screening test for antibacterial activity. Filter paper \n\ndiscs (6 mm in diameter) impregnated with extracts solutions were placed on M\u00fceller-Hinton \n\nagar plates (Merck\u00ae), which have been inoculated with test organisms according to the \n\nstandard protocol described by the National Committee of Clinical Laboratory Standards \n\n(NCCLS) 2004.  The filter paper discs were impregnated with 20 ?L of the extracts solutions \n\nin order to obtain final concentrations of 1000, 200, 100, 50 and 25 ?g of extracts in the discs. \n\nThe microorganisms from the American Type Culture Collection used for the biological \n\nevaluation, were Staphylococcus aureus (ATCC 25923), Escherichia coli (ATCC 25922), \n\nPseudomonas aeruginosa (ATCC 27853), Enterococcus faecalis (ATCC 14506) and \n\nEnterococcus faecium (ATCC 10541) (Rios et al., 1988).  \n\nThe plates were incubated at 35\u00b0C (\u00b11\u00b0C) and after 18 h the diameters of the \n\ninhibition zones were measured. Filter paper discs containing sterile water without any test \n\ncompound were negative control and no inhibition was observed. Standard antibiotic disc \n\nwere selected according to the sensitivity of the bacterial tested. So ampicilin (10 ?g), \n\ncloranphenicol (30 ?g) and ceftazidin (30 ?g) were used (Rios et al., 1988). \n\n The minimum inhibitory concentration (MIC) of the extracts was determined by the \n\nmacrobroth diluition assay. The bacterial suspensions were diluted from the original \n\nsuspensions, which had a turbidity of 0.5 MacFarland standard (1.5 X 108 CFU/mL). The \n\ntubes were incubated at 35\u00b0C (\u00b11\u00b0C) for 18 h. For the evaluation of the active extract four \n\ndilutions at 100, 50, 25 and 12.5 mg/mL were prepared. MIC was determinate as the lowest \n\nconcentration of the extract that completely inhibited growth of the test organisms (Rios et al., \n\n1988; Mazzanti et al., 2000).   \n\n The tube that showed negative visible growth after 18 h of incubation was replated on \n\nBHI (brain-heart infusion) plates. The viability of bacteria was assessed from the forming \n\n\n\n \n7 4\n\ncolonies after 18 h incubation at 35\u00b0C (\u00b11\u00b0C). The lowest concentration of the extracts giving \n\nnegative growth of bacteria was recorded as the minimum bactericidal concentration (MBC) \n\n(Wongkham et al., 2001). \n\nResults and discussion    \n\nThe development of new drugs with antimicrobial properties has been the mainstay in recent \n\nyears. Natural products from plants and microorganisms traditionally have provided many \n\nlead compounds in the search for new drugs and medicines (Borris, 1996). \n\nResearch of antimicrobial activity of medicinal plant has encountered some problems \n\nbecause of the diversity of criteria and techniques employed and the lipophilic properties of \n\nsome samples. Diffusion and dilution methods have been employed to study the antimicrobial \n\nactivity of medicinal plants (Rios et al., 1988) \n\nConsidering the large use of the genus Baccharis in folk medicine as anti-\n\ninflammatory and antibacterial, and that literature did not present a screening of antibacterial \n\nactivity to native South Brazilian Baccharis species and the potential therapeutically \n\nimportance of the title plant, we decided to verify the antibacterial activity of B. articulata, B. \n\nspicata, B. trimera and B. usterii.  \n\nThe extracts of plants were prepared in order to obtained polar compounds considering \n\nethno-pharmacological uses of the plants in the rural areas to antibacterial activity. The \n\ninhibition zones diameters of sixteen extracts were measured and are shown in table 1. We \n\nverified that four extracts showed antibacterial activity displayed varying degrees and \n\nspecificity of inhibition against different bacterial species. \n\nThe n-BuOH fraction of B. usterii exhibited good activity against gram-positive \n\nbacteria (S. aureus, E. faecium and E. faecalis) in concentration of 1000 ?g, with a similar \n\ninhibition zone for E. faecalis when compared to positive control (ampicilin). The same \n\nfraction also has antibacterial activity in concentrations of 100 and 200 ?g, although with \n\ninhibition zone lower than positive control.  \n\nB. spicata showed activity against gram-positive (S. aureus, E. faecium and E. \n\nfaecalis) and gram-negative bacteria (E. coli) in concentration of 1000 ?g. However, herein, \n\nthe higher activity was verified against E. faecium, with similar inhibition zone to positive \n\ncontrol. \n\n\n\n \n7 5\n\nThe weakest activity was found with the crude extract of B. trimera and B. usterii \n\nagainst S. aureus, which showed in concentration of 1000 ?g, inhibition zone lower than \n\npositive control. \n\nTable 1 \n\nThe difference in the antibacterial spectra suggests that the active components present \n\namong fractions are different. TLC analyses of n-BuOH fractions of B. spicata and B. usterii \n\nshowed a predominance of polar compounds, mainly flavonoids and terpenoids, these \n\ncomponents, notwithstanding cannot be identified, probably could be contribute to the \n\ninhibitory effect displayed by these fractions (data not showed). \n\nNone of the extracts from B. articulata were active against microorganisms tested. \n\nUnfortunately none of the extracts tested showed activity against P. aeruginosa, which \n\nhave in clinical cases a high degree of resistant forms against different antibacterial drugs. \n\nThe extracts and fractions that showing antibacterial activity by the disc-diffusion-\n\nmethod were further tested by the macro broth dilution to determine the MICs. Considering \n\nthat in this method, turbidity is taken as an indication of bacterial density and that color of the \n\nactive extracts could be influence in the results obtained, we decided replated on BHI plates \n\nthe tubes that showed negative visible growth after 18 h of incubation, in order to obtain \n\nMBC of the extracts. \n\nThe MBC obtained for the active extracts were 50, 25 and 12.5 mg/ml, and that \n\nobtained for standard cloranphenicol was 4 mg/mL (table 2).  \n\nThese findings suggest that results obtained herein to crude extracts and fractions have \n\npotential antimicrobial activity, suggesting that this activity should be higher when the \n\ncompounds were isolated. \n\nTable 2 \n\n \n\nThe antibacterial activity presented herein to tested Baccharis species must not be \n\nconsidered high in relation to drugs used as references, but are similar to the results observed \n\nto B. glutinosa extract against Clostridium perfringens, Listeria monocytogenes, Proteus \n\nvulgaris and others microorganisms (Ver\u00e1stegui et al., 1996).  \n\nIn Baccharis species, the antibacterial activity was attributed to the presence of \n\nflavonoids as gencawanin and apigenin, and diterpenes (Palacios et al., 1983; Anesini and \n\nPerez, 1993; Rahalison et al., 1995; Ver\u00e1stegui et al., 1996; Cowan, 1999; Feresin et al., \n\n\n\n \n7 6\n\n2001). It was also reported the antibacterial activity of some chalcones, isoflavones and \n\nbiflavones (Xu and Lee, 2001). \n\nAlthough the literature confirms that flavonoids gencawanin and apigenin are present \n\nin extracts of B. articulata (Gianello and Giordano, 1984) and that these compounds are \n\npotential antimicrobial agents, our results showed no activity for this extract to the bacterium \n\ntested.  \n\nThis study presents a screening to antibacterial compounds from South Brazilian \n\nBaccharis species used in South American traditional medicine. Bioguided fractionation is \n\ncarried out using the active fraction detected herein in order to identify the active compounds.  \n\nAcknowledgements \n\nWe are grateful to Marcos Sobral (Programa de P\u00f3s-Gradua\u00e7\u00e3o em Ci\u00eancias Farmac\u00eauticas, \n\nUFRGS), Prof. Dr. S\u00e9rgio Bordignon (ULBRA) and Profa. Msc. Branca Severo (ICB-UPF) \n\nfor locating, colleting and identifying the plant material. This work was supported by \n\nFAPERGS (02/0057.0-PROADE2-RS/BRAZIL) and fellowship to GG CNPq (Brazil). \n\n\n\n \n7 7\n\n \n\nReferences \n\nAmerican Society of Microbiology (ASM) Task Force on Antibiotic Resistance. (1995) \n\nReport of the ASM Task Force on antibiotic resistance. Antimicrob. Agents Chemother 39 \n\n(suppl.): 2-23. \n\nAnesini C, Perez C (1993): Screening of plants used in Argentine folk medicine for \n\nantimicrobial activity. J Ethnopharmacol 39: 119-128.  \n\nBorris RP (1996): Natural products research: perspectives from a major pharmaceutical \n\ncompany. J Ethnopharmacol 51: 29-38.  \n\nCoelho de Souza G, Hass APS, von Poser GL, Schapoval EES, Elizabetsky E (2004): \n\nEthnopharmacological studies of antimicrobial remedies in the south of Brazil. J \n\nEthnopharmacol 90: 135-143. \n\nCowan MM (1999): Plant products as antimicrobial agents. Clin Microbiol Rev 12: 564-582.  \n\nCragg GM, Newmann DJ, Snader KM (1997): Natural products in drug discovery and \n\ndevelopment. J Nat Prod 60: 52-60. \n\nFeresin GE, Tapia  A, L\u00f3pez SN, Zacchino SA (2001): Antimicrobial activity of plants used \n\nin tradicional medicine of San Juan province, Argentine. J Ethnopharmacol 78: 103-107.  \n\nGen\u00e9, RM, Carta\u00f1\u00e1 C, Adzet T. Mar\u00edn E, Parella T, Ca\u00f1igueral S  (1996): Anti-inflammatory \n\nand analgesic activity of Baccharis trimera: Identification of active constituents. Planta Med  \n\n62: 232-235.  \n\nGianello JC, Giordano OS (1984): Examen quimico en seis especies del genero Baccharis. \n\nRevista Latinoamericana de Quimica 15: 84-86.  \n\nMazzanti G, Mascellino NT, Pattinelli L, Coluccia D, Manganario M, Saso L (2000): \n\nAntimicrobial investigation of semipurified fractions of Ginkgo biloba leaves. J \n\nEthnopharmacol 71: 83-88.  \n\nNational Committee of Clinical Laboratory Standards (2004): Performance Standards for \n\nAntimicrobial Disk Susceptibility Tests. Approved standard.  \n\nOliveira SQ, Dal-Pizzol F, Gosmann, G, Guillaume D, Moreira JCF, Schenkel EP (2003): \n\nAntioxidant activity of Baccharis articulata extracts: isolation of a new compound with \n\nantioxidant activity. Free Rad Res 37: 555-559. \n\n\n\n \n7 8\n\nOliveira SQ, Dal-Pizzol F , Moreira JCF, Schenkel EP, Gosmann G (2004): Antioxidant \n\nactivity of Baccharis spicata, Baccharis trimera and Baccharis usterii. Acta Farm \n\nBonaerense. In press \n\nPalacios P, Gutkind G, Rondina RVD, Torres R, Coussio JD (1983): Antimicrobial Activity \n\nof Baccharis crispa and Baccharis notosergila (II). Planta Med 49: 128.  \n\nRahalison L, Benathan M, Monod M, Frenk E, Gupta MP, Solis PN, Fuzzati N (1995): \n\nAntifungal Principles of Baccharis pedunculata. Planta Med 61: 360-362.  \n\nRios JL, Recios MC, Villar A (1988) Screening methods for natural products with \n\nantimicrobial activity: a review of the literature. J Ethnopharmacol 23: 127-149. \n\nVer\u00e1stegui MA, S\u00e1nchez CA, Heredia NL, Garcia-Alvarado JA (1996): Antimicrobial \n\nActivity of Extracts of Three Major Plants From the Chihuahuan Desert. J Ethnopharmacol \n\n52: 175-177. \n\nWagner H (1983): Drogenanalyse: D\u00fcnnschichtchromatographishe Analyse von \n\nArzneidrogen. Berlin, Springer Verlag, pp. 291-293. \n\nWongkham S, Laupattarakasaem P, Pienthaweechai K, Areejitranusorn P, Wongkham C, \n\nTchanitiswad T (2001): Antimicrobial activity of Streblus asper Leaf extract. Phytother Res \n\n15: 119-121 \n\nXu HX, Lee SF (2001): Activity of plant flavonoids against antibiotic-resistant bacteria. \n\nPhytother Res 15: 39-43. \n\nZardini EM (1984): Etnobot\u00e1nica de Compuestas Argentinas com especial referencia a su uso \n\nfarmacol\u00f3gico (primera parte). Acta Farm Bonaerense 3: 77-99.  \n\n  \n\n\n\n 7 9\n\nTable 1: Results of screening of extracts from Baccharis extracts/fractions using the disc-diffusion method. \n \n\n \n B. trimera B. spicata B. usterii \nDoses (?g) 1000 200 100 50 25 1000 200 100 50 25 1000 200 100 50 25 Extracts \n\nBacterial Positive \ncontrols \n\n(mm) \n\n   \n\n1S. aureus 28 12 - - - - - - - - - 12 - - - - \n2E.coli 26 - - - - - - - - - - - - - - - \n\n1E. faecium 27 - - - - - - - - - - - - - - - \n1E. faecalis 30 - - - - - - - - - - - - - - - \n\n \n \n\nCrude \nextract \n\n3P. aeruginosa 28 - - - - - - - - - - - - - - - \n1S. aureus 28 - - - - - - - - - - - - - - - \n\n2E.coli 28 - - - - - - - - - - - - - - - \n1E. faecium 28 - - - - - - - - - - - - - - - \n1E. faecalis 28 - - - - - - - - - - - - - - - \n\n \n \n\nEtOAc \nfraction \n\n3P. aeruginosa 27 - - - - - - - - - - - - - - - \n1S. aureus 27 - - - - - 15 - - - - 21 11 8 - - \n\n2E.coli 26 - - - - - 8 - - - - - - - - - \n1E. faecium 27 - - - - - 24 - - - - 16 11 9 - - \n1E. faecalis 29 - - - - - 10 - - - - 29 15 12 - - \n\n \n \n\nn-BuOH \nfraction \n\n3P. aeruginosa 25 - - - - -  - - - - - - - - - \n1S. aureus 28 - - - - - - - - - - - - - - - \n\n2E.coli 25 - - - - - - - - - - - - - - - \n1E. faecium 28 - - - - - - - - - - - - - - - \n1E. faecalis 29 - - - - - - - - - - - - - - - \n\n \n \n\nAqueous \nresidue \n\n 3P. aeruginosa 26 - - - - - - - - - - - - - - - \n Inhibition zone (mm)  \n\nPositive controls 1ampicilin  (10 ?g)       2cloranphenicol (30 ?g) 3ceftazidin (30  ?g) \n(-): Not showed activity  \n\n\n\n 8 0\n\nTable 2: Results of minimum bactericidal concentration (MBC) of active extracts from Baccharis species. \n  \n\nBacterial S.aureus E. coli E. faecium E faecalis P. aeruginosa \nPlants Extracts MBC (mg/mL) \n\nB. spicata n-BuOH fraction 50 50 50 50 - \nB. trimera Crude extract 25 - - - - \n\nCrude extract 12.5 - - - - B. usterii \nn-BuOH fraction 25 - 50 50 - \n\nCloranphenicol 4 mg/mL \n(-) Activity higher than 100 mg/ml \n\n\n\n 8 1\n\n\n\n4 Discuss\u00e3o Geral \n\n \n\nO g\u00eanero Baccharis (Asteraceae) possui import\u00e2ncia s\u00f3cio-econ\u00f4mica elevada \n\ndevido a sua utiliza\u00e7\u00e3o na medicina popular, sua import\u00e2ncia ecol\u00f3gica na produ\u00e7\u00e3o \n\nde pr\u00f3polis de elevada qualidade e, em contrapartida, por seus efeitos negativos na \n\nagricultura e pecu\u00e1ria, uma vez que algumas esp\u00e9cies s\u00e3o consideradas plantas \n\ninvasivas em pastagens e s\u00e3o t\u00f3xicas para os animais (JARVIS et al., 1991; VERDI \n\net al., 2005).   \n\n O presente trabalho d\u00e1 continuidade aos estudos realizados pelo nosso grupo \n\ncom B. articulata, B. spicata, B. trimera e B. usterii (DE OLIVEIRA et al., 2003; 2004) \n\nabordando estudos fitoqu\u00edmico e biol\u00f3gico, em especial as atividades antioxidante e \n\nantibacteriana. \n\n A partir das an\u00e1lises cromatogr\u00e1ficas foi poss\u00edvel estabelecer par\u00e2metros de \n\ndiferencia\u00e7\u00e3o entre B. articulata, B. cylindrica, B. spicata, B. trimera e B. usterii, \n\ncomparando-se valores de Rfs e a colora\u00e7\u00e3o desenvolvida pelas subst\u00e2ncias \n\npresentes nos extratos aquosos e n-BuOH frente aos agentes cromog\u00eanicos. Al\u00e9m \n\ndisso, destaca-se o fato de que atrav\u00e9s do emprego de um sistema cromatogr\u00e1fico \n\n(CHCl3:EtOH:HOAc, 60:40:6, v/v/v) e de dois agentes reveladores (reagente natural \n\ne anisalde\u00eddo sulf\u00farico) foi poss\u00edvel detectar diferen\u00e7as qualitativas no perfil qu\u00edmico \n\ndos extratos aquosos e n-BuOH destas esp\u00e9cies. \n\nA an\u00e1lise fitoqu\u00edmica das fra\u00e7\u00f5es n-BuOH de B. articulata e B. usterii permitiu \n\no isolamento de sete subst\u00e2ncias.  \n\nA partir de B. articulata foram isoladas as subst\u00e2ncias Ba III (4\u2019-O-?-D-\n\nglicopiranosil-3,5-dimet\u00f3xi-benzil-tetrahidro-2H-pirano-2-il-acetil carbonato), Ba IV \n\n(4\u2019-O-?-D-glicopiranosil-3,5-di-met\u00f3xi-benzil metanol), Ba V e Ba VI (cujas \n\nelucida\u00e7\u00f5es estruturais est\u00e3o em andamento). At\u00e9 o momento, cabe salientar que \n\nn\u00e3o foram encontrados relatos do isolamento de Ba III e Ba IV, portanto sugere-se \n\nque estas apresentam car\u00e1ter in\u00e9dito. \n\n Em rela\u00e7\u00e3o a B. usterii foram isoladas duas subst\u00e2ncias a partir da fra\u00e7\u00e3o \n\nfen\u00f3lica, subst\u00e2ncia BuF1 (\u00e1cido 4,5-O-[E]-di-cafeoilqu\u00ednico) cuja estrutura j\u00e1 \u00e9 \n\nconhecida e relatada para esta esp\u00e9cie (SIM\u00d5ES-PIRES et al., 2005) e a subst\u00e2ncia \n\n\n\n 9 8\n\nBuF2 (7-hidr\u00f3xi-5,4\u2019-di-met\u00f3xi-flavona) da qual n\u00e3o foram encontrados relatos. J\u00e1 a \n\npartir da fra\u00e7\u00e3o terp\u00eanica foi isolada a subst\u00e2ncia BuT1 cuja elucida\u00e7\u00e3o estrutural \n\nencontra-se em andamento.  \n\nEm rela\u00e7\u00e3o \u00e0s investiga\u00e7\u00f5es da atividade antioxidante para as esp\u00e9cies do \n\ng\u00eanero Baccharis, neste trabalho foi dada continuidade a estes estudos iniciados \n\npelo nosso grupo, como citado anteriormente, empregando-se as mesmas t\u00e9cnicas \n\nutilizadas previamente, por\u00e9m com uma modifica\u00e7\u00e3o em rela\u00e7\u00e3o ao ensaio TBARS o \n\nqual foi realizado em homogenato de gema de ovo e n\u00e3o mais em c\u00e9lulas de Sertoli.    \n\nAs fra\u00e7\u00f5es n-BuOH, as sub-fra\u00e7\u00f5es e subst\u00e2ncias isoladas (concentra\u00e7\u00e3o final \n\n1,25 ?g/ml) foram avaliadas quanto ao potencial antioxidante total (TRAP) e \n\nreatividade antioxidante total (TAR). Para a verifica\u00e7\u00e3o do potencial de inibi\u00e7\u00e3o da \n\nperoxida\u00e7\u00e3o lip\u00eddica (TBARS) atrav\u00e9s do qual avalia-se a inibi\u00e7\u00e3o da forma\u00e7\u00e3o de \n\nMDA (malonil-di-alde\u00eddo) todas as amostras foram testadas na concentra\u00e7\u00e3o de 40 \n\n?g/ml.  \n\nPara Baccharis articulata observou-se que a fra\u00e7\u00e3o n-BuOH (concentra\u00e7\u00e3o \n\nfinal 1,25 ?g/ml) foi capaz de inibir a forma\u00e7\u00e3o do radical peroxila praticamente de \n\nmodo instant\u00e2neo e de manter esta atividade durante todo o per\u00edodo do experimento \n\n(50 minutos). Al\u00e9m disso, esta fra\u00e7\u00e3o apresentou atividade significativamente maior \n\nque a subst\u00e2ncia de refer\u00eancia (Trolox) e que as subst\u00e2ncias isoladas a partir dela, \n\nBa III, Ba IV, Ba V e Ba VI (p<0,05). Em rela\u00e7\u00e3o a estas, Ba III, Ba V e Ba VI \n\napresentaram atividade similar ao Trolox (p<0,05). A reatividade instant\u00e2nea da \n\nfra\u00e7\u00e3o n-BuOH pode ser tamb\u00e9m verificada no \u00edndice TAR, no qual foi observado \n\nque n\u00e3o existe diferen\u00e7a significativa na reatividade imediata observada para as \n\nsubst\u00e2ncias isoladas (p&lt;0,05).  \n\nConsiderando o efeito aditivo ou sin\u00e9rgico, freq\u00fcentemente observado para \n\nextratos vegetais, resultam em uma menor atividade ap\u00f3s o fracionamento \n\nbioguiado, nossos resultados sugerem que os compostos isolados n\u00e3o est\u00e3o \n\ndiretamente relacionados com a atividade antioxidante observada, ou ainda, que \n\noutro metab\u00f3lito possa estar relacionado com esta a\u00e7\u00e3o.  \n\nEm nosso trabalho anterior, relatamos a atividade antioxidante da subst\u00e2ncia \n\nBa II (\u00e9ster 4\u2019-O-?-D-glicopiranosil-3,5-dimet\u00f3xi-benzil caf\u00e9ico), tamb\u00e9m obtida a \n\npartir da fra\u00e7\u00e3o n-BuOH de B. articulata, a qual apresentou atividade antioxidante \n\n\n\n 9 9\n\nsimilar a fra\u00e7\u00e3o n-BuOH e ao Trolox (DE OLIVEIRA et al., 2003). No entanto, neste \n\ntrabalho, as an\u00e1lises fitoqu\u00edmicas indicaram a aus\u00eancia desta subst\u00e2ncia na fra\u00e7\u00e3o \n\nn-BuOH da referida esp\u00e9cie, embora, esta fra\u00e7\u00e3o tenha apresentado atividade \n\nantioxidante, mesmo em uma concentra\u00e7\u00e3o menor (1,25 ?g/ml) que a testada em \n\nnosso trabalho anterior (1 mg/ml). \n\n Quanto \u00e0 inibi\u00e7\u00e3o da peroxida\u00e7\u00e3o lip\u00eddica, verificou-se que as subst\u00e2ncias Ba \n\nIII, Ba IV e Ba V foram capazes de proteger a membrana celular do processo \n\noxidativo de modo similar ao controle (p<0,05). Apenas a subst\u00e2ncia Ba VI n\u00e3o \n\napresentou diferen\u00e7a em rela\u00e7\u00e3o ao controle induzido.  \n\nPara B. usterii observou-se que a fra\u00e7\u00e3o n-BuOH, sub-fra\u00e7\u00f5es fen\u00f3lica e \n\nterp\u00eanica e a subst\u00e2ncia BuF1 reduziram instantaneamente a forma\u00e7\u00e3o do radical \n\nperoxila e, assim como foi observado para B. articulata, mantiveram esta atividade \n\ndurante todo o per\u00edodo de tempo do experimento. A subst\u00e2ncia BuF2 apresentou a \n\nmenor atividade quando comparada \u00e0s demais (p<0,05). A fra\u00e7\u00e3o n-BuOH, a sub-\n\nfra\u00e7\u00e3o fen\u00f3lica e a subst\u00e2ncia BuF1 apresentaram atividade antioxidante \n\nestatisticamente superior ao Trolox (p&lt;0,05). Na avalia\u00e7\u00e3o do \u00edndice TAR, \n\nconfirmou-se estes resultados. Al\u00e9m disso, tamb\u00e9m foi poss\u00edvel constatar que a \n\nfra\u00e7\u00e3o n-BuOH, sub-fra\u00e7\u00f5es fen\u00f3lica e terp\u00eanica foram capazes de proteger as \n\nc\u00e9lulas da peroxida\u00e7\u00e3o lip\u00eddica similarmente ao controle (p<0,05) e que BuF1 \n\napresentou atividade estatisticamente superior a este, mas semelhante a fra\u00e7\u00e3o n-\n\nBuOH e sub-fra\u00e7\u00f5es fen\u00f3lica e terp\u00eanica (p<0,05). As subst\u00e2ncias BuT1 e BuF2 n\u00e3o \n\nforam capazes de proteger as c\u00e9lulas do processo oxidativo (p<0,05). \n\nOs resultados obtidos para B. usterii no TRAP em rela\u00e7\u00e3o \u00e0 fra\u00e7\u00e3o n-BuOH \n\ndivergem, ligeiramente, daqueles obtidos em nossos resultados anteriores (De \n\nOLIVEIRA et al., 2004). No presente trabalho a fra\u00e7\u00e3o n-BuOH (concentra\u00e7\u00e3o final \n\n1,25 ?g/ml) apresentou maior atividade que o Trolox (200 nM). Nos nossos \n\nresultados anteriores, a fra\u00e7\u00e3o n-BuOH (concentra\u00e7\u00e3o final 2,5 ?g/ml) apresentou \n\nmenor potencial antioxidante que o Trolox (1 mM).  \n\nEsta diverg\u00eancia pode estar relacionada \u00e0 composi\u00e7\u00e3o qu\u00edmica da fra\u00e7\u00e3o n-\n\nBuOH desta planta que, embora apresente perfil cromatogr\u00e1fico semelhante ao \n\nverificado anteriormente, a concentra\u00e7\u00e3o das subst\u00e2ncias pode n\u00e3o ser a mesma, \n\numa vez que n\u00e3o foi utilizado o mesmo material de partida para a prepara\u00e7\u00e3o dos \n\nextratos.  \n\n\n\n 1 0 0\n\nAl\u00e9m disso, observamos que a subst\u00e2ncia BuF1 \u00e9 um derivado cafeoilqu\u00ednico \n\nNo presente trabalho tamb\u00e9m foi avaliada a atividade antibacteriana dos \n\nextratos brutos (hidroetan\u00f3licos) e fra\u00e7\u00f5es (AcOEt, n-BuOH e res\u00edduo aquoso) de B. \n\narticulata, B. spicata, B. trimera e B. usterii, frente \u00e0s bact\u00e9rias S. aureus, E. coli, E. \n\nfaecalis, E. faecium e P. aeruginosa.  \n\nA fra\u00e7\u00e3o n-BuOH de B. spicata na concentra\u00e7\u00e3o de 1 mg/ml mostrou-se ativa \n\nfrente a S. aureus, E. coli, E. faecalis e E. faecium (CBM 50 mg/ml). A fra\u00e7\u00e3o n-\n\nBuOH de B. usterii na mesma concentra\u00e7\u00e3o foi ativa contra S. aureus (CBM 25 \n\nmg/ml), E. faecalis e E. faecium (CBM 50 mg/ml). Em concentra\u00e7\u00f5es menores, 200 e \n\n100 ?g/ml, esta fra\u00e7\u00e3o foi ativa frente \u00e0s referidas bact\u00e9rias. Tamb\u00e9m foi poss\u00edvel \n\nverificar que os extratos brutos (1 mg/ml) de B. trimera e B. usterii  foram ativos \n\nfrente a S. aureus (CBM 12,5 mg/ml e 25 mg/ml, respectivamente). O extrato bruto e \n\nas fra\u00e7\u00f5es de B. articulata n\u00e3o apresentaram atividade frente aos microorganismos \n\ntestados. \n\nAs concentra\u00e7\u00f5es empregadas na avalia\u00e7\u00e3o da atividade antibacteriana \n\ndestas amostras s\u00e3o consideradas elevadas (1 mg/ml), quando se compara a uma \n\nsubst\u00e2ncia isolada. No entanto, a literatura demonstra que concentra\u00e7\u00f5es similares \n\nj\u00e1 foram empregadas para avaliar a atividade antimicrobiana de extratos de \n\nBaccharis glutinosa (VERASTEGUI et al., 1996).  \n\nEnfim, o conjunto dos resultados obtidos nesta tese aponta para o potencial \n\nbiol\u00f3gico das esp\u00e9cies estudadas, sobretudo, no que refere-se \u00e0 atividade \n\nantioxidante. Considerando o amplo emprego na medicina popular e a dif\u00edcil \n\ncaracteriza\u00e7\u00e3o bot\u00e2nica do g\u00eanero Baccharis, tamb\u00e9m houve uma importante \n\ncontribui\u00e7\u00e3o na diferencia\u00e7\u00e3o qu\u00edmica destas esp\u00e9cies, atrav\u00e9s das an\u00e1lises \n\ncromatogr\u00e1ficas e do isolamento de sete subst\u00e2ncias a partir de seus extratos, \n\ncontribuindo, tamb\u00e9m, para a amplia\u00e7\u00e3o do conhecimento cient\u00edfico do g\u00eanero.   \n\n\n\n 1 0 1\n\n5 Conclus\u00f5es  \n\n \n\nNo presente trabalho foram abordados aspectos qu\u00edmicos e biol\u00f3gicos de \n\nesp\u00e9cies do g\u00eanero Baccharis, al\u00e9m de uma extensa revis\u00e3o da literatura sobre este \n\ng\u00eanero. \n\nFoi verificado que o emprego do sistema cromatogr\u00e1fico (CHCl3:EtOH:HOAc, \n\n60:40:6, v/v/v) e de dois agentes reveladores com caracter\u00edsticas qu\u00edmicas \n\ndiferentes (reagente natural e anisalde\u00eddo sulf\u00farico) possibilitou detectar diferen\u00e7as \n\nqualitativas no perfil qu\u00edmico das amostras testadas.  \n\nA partir das fra\u00e7\u00f5es n-BuOH de B. articulata e B. usterii foram isoladas sete \n\nsubst\u00e2ncias codificadas como: Ba III, Ba IV, Ba V, Ba VI, BuF1, BuF2 e BuT1, \n\nrespectivamente.  \n\nAs subst\u00e2ncias Ba III e Ba IV foram identificadas como 4\u2019-O-?-D-glicopiranosil-\n\n3,5-dimet\u00f3xi-benzil-tetrahidro-2H-pirano-2-il-acetil-carbonato e 4\u2019-O-?-D-\n\nglicopiranosil-3,5-di-met\u00f3xi-benzil-metanol, respectivamente das quais, at\u00e9 o \n\nmomento, n\u00e3o foram encontrados relatos na literatura consultada, sugerindo-se, \n\nportanto, o car\u00e1ter in\u00e9dito de ambas. As subst\u00e2ncias Ba V e Ba VI encontram-se em  \n\nelucida\u00e7\u00e3o estrutural e, segundo os dados espectrosc\u00f3picos, pode-se sugerir que \n\napresentam caracter\u00edsticas de compostos de origem terp\u00eanica. \n\nEm rela\u00e7\u00e3o a B. usterii a subst\u00e2ncia BuF1 foi identificada como o \u00e1cido 4,5-O-\n\n[E]-di-cafeoilqu\u00ednico cuja estrutura j\u00e1 \u00e9 conhecida e relatada para esta esp\u00e9cie. A \n\nsubst\u00e2ncia BuF2 foi identificada como 7-hidr\u00f3xi-5,4\u2019-di-met\u00f3xi-flavona da qual \n\ntamb\u00e9m n\u00e3o foram encontrados relatos na literatura. Para a subst\u00e2ncia BuT1, cuja \n\nelucida\u00e7\u00e3o estrutural encontra-se em andamento, tamb\u00e9m \u00e9 poss\u00edvel sugerir um \n\ncar\u00e1ter terp\u00eanico.  \n\nAs fra\u00e7\u00f5es n-BuOH de B.articulata e B. usterii apresentaram alto efeito \n\nantioxidante e mantiveram este efeito no decorrer do ensaio TRAP. As subst\u00e2ncias \n\nisoladas a partir da fra\u00e7\u00e3o n-BuOH de B. articulata n\u00e3o apresentam potencial \n\nantioxidante na mesma intensidade que a referida fra\u00e7\u00e3o, fato que pode estar \n\nrelacionado  a uma poss\u00edvel a\u00e7\u00e3o sin\u00e9rgica destes compostos. \n\n\n\n 1 0 2\n\nOs resultados obtidos na avalia\u00e7\u00e3o do \u00edndice TAR, apontam para reatividade \n\ninstant\u00e2nea das fra\u00e7\u00f5es n-BuOH destas esp\u00e9cies, bem como da subst\u00e2ncia BuF1, \n\npreviamente isolada da fra\u00e7\u00e3o n-BuOH de B. usterii.  \n\nQuanto \u00e0 prote\u00e7\u00e3o contra peroxida\u00e7\u00e3o lip\u00eddica, verificou-se que as fra\u00e7\u00f5es n-\n\nBuOH, as subst\u00e2ncias Ba III, Ba IV, Ba V, as sub-fra\u00e7\u00f5es fen\u00f3lica e terp\u00eanica (B. \n\nusterii) e o composto BuF1 foram capazes de proteger as c\u00e9lulas contra a \n\nperoxida\u00e7\u00e3o lip\u00eddica no ensaio TBARS. \n\n No quarto cap\u00edtulo foi avaliada a atividade antibacteriana dos extratos brutos \n\n(hidroetan\u00f3licos) e fra\u00e7\u00f5es (AcOEt, n-BuOH e res\u00edduo aquoso) de B. articulata, B. \n\nspicata, B. trimera e B. usterii, frente \u00e0s bact\u00e9rias S. aureus, E. coli, E. faecalis, E. \n\nfaecium e P. aeruginosa.  \n\nA fra\u00e7\u00e3o n-BuOH de B. spicata (concentra\u00e7\u00e3o 1 mg/ml) foi ativa frente a S. \n\naureus, E. coli, E. faecalis e E. faecium (CBM 50 mg/ml).  \n\nA fra\u00e7\u00e3o n-BuOH de B. usterii na mesma concentra\u00e7\u00e3o apresentou efeito \n\ncontra S. aureus (CBM 25 mg/ml), E. faecalis e E. faecium (CBM 50 mg/ml).  \n\nOs extratos brutos (1 mg/ml) de B. trimera e B. usterii  foram ativos frente a S. \n\naureus (CBM 12,5 mg/ml e 25 mg/ml, respectivamente). \n\nO extrato bruto e as fra\u00e7\u00f5es de B. articulata n\u00e3o apresentaram atividade \n\nfrente aos microorganismos testados.  \n\n \n\n\n\n 1 0 3\n\n6 Refer\u00eancias \n \nADZET, T.; MARIN, E.; GEN\u00c9, R. M. Estudio de la actividad antiinflamatoria de \nespecies vegetales de origen centro y sudamericano. Dominguezia, v. 9, n. 1, p. 17-\n23, 1991. \n \n\nABAD, M. J.; BERMEJO, P.; S\u00c1NCHEZ, P. S.; CHIRIBOGA, X.; CARRASCO, L. \nAntiviral activity of some South American medicinal plants. Phytotherapy Research  \nv. 13,  p. 142-146, 1999a. \n \n \nABAD, M. J.; BERMEJO, P.; GONZALES, E.; IGLESIAS, I.; IRURZUN,  A.; \nCARRASCO, L. Antiviral activity of Bolivian plant extracts. General Pharmacology, \nv. 32, n. 4, p. 499-503, 1999b. \n \n\nAKAIKE, S.; SUMINO, M.; SEKINE, T.; SEO, S.; KIMURA, N.; IKEGAMI, F. A new \nent-clerodane diterpene from the aerial parts of Baccharis gaudichaudiana. \nChemical Pharmaceutical Bulletin, v. 51, n. 2, p. 197 \u2013 199, 2003. \n \n\nARGANDO\u00d1A, V. H.; FAINI, F. A. Oleanolic acid content in Baccharis linearis and its \neffects on Heliothis zea larvae. Phytochemistry, v. 33, n. 6, p. 1377-1379, 1993. \n \n\nARRIAGA-GINER, F. J.; WOLLENWEBER, E.; SCHOBER, I. DOSTAL, P.; BRAUN, \nS. 2?-hydroxyhautriwaic acid, a clerodane type diterpenoid and other terpenoids from \nthree Baccharis species. Phytochemistry, v. 25, n.3, p. 719-721, 1986. \n \n\nBAGGIO, C. H.; FREITAS, C. S.; RIECK, L.; MARQUES, M. C. A. Gastroprotective \neffects of a crude extract of Baccharis illinita DC in rats. Pharmacological \nResearch, v. 47, n. 1, p. 93\u201398, 2003.  \n \n \nBAILAC, P. N.; DELLACASA, A. D.; BERNASCONI, H. O. et al. Essential oil of \nfemale plants of Baccharis coridifolia De Candole. Journal of Essential Oil \nResearch, v. 13, n. 1, p. 23-24, 2001.  \n \n\nBANDONI, A. L.; MEDINA, J. E.; RONDINA, R. V. D.; COUSSIO, J. D. Genus \nBaccharis L. I: phytochemical analysis of a non polar fraction from B. crispa \nSprengel. Planta Medica, v. 34, n. 6, p. 328-331, 1978. \n \n \nBARROSO, G. H. Compositae \u2013 subtribo baccharidinae Hoffmann - estudo das \nesp\u00e9cies ocorrentes no Brasil. Rodriguesia, v. 28, n. 40, p. 7-273, 1976. \n\n\n\n 1 0 4\n\n \n \nBARROSO, G. H; BUENO, O. L. Compostas: subtribo baccharidinae. Flora \nilustrada catarinense. Itaja\u00ed: Herb\u00e1rio Barbosa Rodrigues, 2002. \n \n\nBRIGHENTE, I. M. C.; DIAS, M.; VERDI, L. G.; PIZZOLATTI, M. G. Antioxidant \nactivity and total phenolic content of some Brazilian species. Pharmaceutical \nBiology, v. 45, n. 2, p. 156-162, 2007. \n \n \nCAO, G; PRIOR, R. L. Antioxidant capacity and polyphenolic components of teas: \nimplications for altering in vivo antioxidant status. Experimental Biology and \nMedicine, v. 220, n. 4, p. 255 \u2013 261, 1999. \n \n\nCARTRON, E.; CARBONNEAU, M.-A.; FOURET, G.; DESCOMPS, B.; LEGER, \nC. L. Specific antioxidant activity of caffeoyl derivatives and others natural phenolic \ncompounds: LDL protection against oxidation and decrease in the proinflammatory  \nlysophosphatidylcholine production. Journal of Natural Products, v. 64, n. 4, p. 480 \n-486, 2001. \n \n \nCE\u00d1AL, J. P.; GIORDANO, O. S.; ROSSOMANDO, P. C. TONN, C. E. Neoclerodane \nditerpenes from Baccharis crispa. Journal of Natural Products, v. 60, n. 5, p. 490-\n492, 1997. \n \n \nCIFUENTE, D. A.; SIMIRGIOTIS, M. J.; FAVIER, L. S.; ROTELLI, A. E.;  PELZER, L. \nE.  Antiinflammatory activity from aerial parts of Baccharis medullosa, Baccharis \nrufescens and Laennecia sophiifolia in mice. Phytotherapy Research, v. 15, n. 6, p. \n529-531, 2001. \n \n \nCOBOS, M. I.; RODRIGUEZ, J. L.; OLIVA, M.; DEMO, M.; FAILLACI, S. M.; \nZYGADLO, J. A. Composition and antimicrobial activity of essential oil of Baccharis \nnotosergila. Planta Medica, v. 67, n. 1, p. 84-86, 2001. \n \n\nCORREIA-J\u00daNIOR, C.; MING, L. C.; SCHEFFER, M. C. Cultivo de Plantas \nMedicinais, Codimentares e Arom\u00e1ticas. Curitiba: EMATER, 1991. \n \n \nDAI, J.; SUTTISRI, R.; BORDAS, E. SOEJARTO, D. D.; KINGHORN, D. Clerodane \nditerpenoids from Baccharis articulata.  Phytochemistry, v. 34, n. 4, p. 1087-1090, \n1993. \n \n\nDAILY, A.; WAGNER, H.; SELIGMANN, O. Hispidolin and Stigmasta-7, 22-dien-3-ol \nfrom Baccharis genistelloides. Fitoterapia, v. 55, n. 4, p. 236-237, 1984. \n\n\n\n 1 0 5\n\n \n\nDe OLIVEIRA, S. Q., DAL PIZZOL, F., GOSMANN G.; GUILLAUME, D.; MOREIRA, \nJ. C. F.; SCHENKEL, E. P.  Antioxidant activity of Baccahris articulata. Isolation of its \nactive constituent. Free Radical Research, v. 37, n. 5, p. 555-559, 2003. \n \n \nDe OLIVEIRA, S. Q., DAL PIZZOL, F., MOREIRA, J. C. F.; SCHENKEL, E. P.; \nGOSMANN, G. Antioxidant activity of Baccahris spicata, Baccharis trimera and \nBaccharis usterii. Acta Farmac\u00e9utica Bonaerense, v. 23, n. 3, p. 365-368, 2004. \n \n\nDESMARCHELIER, C.; BERMUDEZ, M. J. N.; COUSSIO, J.; CICCIA, G.; BOVERIS, \nA. Antioxidant and prooxidant activities in aqueous extracts of Argentine plants. \nInternational Journal of Pharmacognosy, v. 35, n. 2, p. 116-120, 1997. \n \n\nDOBEREINER, J.; REZENDE, A. M. L.; TOKARNIA, C. H. Intoxica\u00e7\u00e3o experimental \npor Baccharis coridifolia em coelhos. Pesquisa Agropecu\u00e1ria Brasileira S\u00e9rie \nVeterin\u00e1ria, v. 11,  p. 27-35, 1976. \n \n \nFAINI, C. L. F.; CASTILLO, M. Diterpenoids from Chilean Baccharis Species. \nPhytochemistry, v. 29, n. 1, p. 324-325, 1990. \n \n\nFERESIN, G. E.; TAPIA, A.; L\u00d3PEZ, S. N.; ZACCHINO, S. Antimicrobial activity of \ntraditional medicine of San Juan province, Argentine. Journal of \nEthnopharmacology, v. 78, pp. 103-107, 2001. \n \n\nFERESIN, G. E.; TAPIA, A.; GIMENEZ, A.; RAVELO, A. G.; ZACCHINO, S.; \nSORTINO, M.; SCHMEDA-HIRSCHMANN, G. Constituents of the Argentinian \nmedicinal plant Baccharis grisebachii and their antimicrobial activity. Journal of \nEthnopharmacology, v. 89, pp. 73-80, 2003. \n \n \nFERRACINI, V. L.; PARAIBA, L. C.; FILHO, H. F. et al. Essential oils of seven \nBrazilian Baccharis species. Journal of Essential Oil Research, v. 7, n. 4, p. 355-\n367, 1995.  \n \n\nFREIRE, S. E.; URTUBEY, E. Compuestas medicinales de la provincia biogeogr\u00e1fica \npampeana: claves para su determinaci\u00f3n e iconograf\u00edas. Parte I: compuestas \nespinosas (grupo 1) y compuestas com tallos alados (grupo 2). Acta Farmaceutica \nBonaerense, v. 18, n. 3, p. 191-199, 1999. \n \n \n\n\n\n 1 0 6\n\nFRIZZO, C. D.; SERAFINI, L. A.; DELLACASA, E. LORENZO, D.; MOYNA, P. \nEssential oil of Baccharis uncinella DC. From southern Brazil. Flavour and \nFragrance Journal, v. 16, n. 4, p. 286-288, 2001. \n \n \nFULLAS, F.; SOEJARTO, D. D.; KINGHORN, A. D. A Bitter-Tasting Trihomolabdane \nArabinoside from Baccharis gaudichaudiana. Phytochemistry, v. 31, n. 7, p. 2543-\n2545, 1992. \n \n \nGALLARDO, O.; TONN, C. E.; NIETO, G.; MORALES, B. GIORDANO, O. S. \nBioactive neo-clerodane diterpenoids toward Tenebrio molitor larvae from Teucrium \nnudicaule and Baccharis spicata (Lam.) Beill. Natural Products Letters, v. 8, p. 189-\n197, 1996. \n \n \nGARCIA, C. C.; ROSSO, M. L.; BERTONI, M. D.; MAIER, M. S.; DAMONTE, E. B. \nEvaluation of the antiviral activity against junin virus of macrocyclic trichothecenes \nproduced by the hypocrealean epibiont of Baccharis coridifolia. Planta Medica, v. 68, \nn. 3, p. 209 \u2013 212, 2002. \n \n\nGEN\u00c9, R. M.; CARTA\u00d1\u00c1, C.; ADZET, T.; MARIN, E.; PARELLA, T.; A\u00d1IGUERAL, S. \nAnti-inflammatory and analgesic activity of Baccharis trimera: Identification of active \nconstituents. Planta Medica, v. 62, n. 3, p. 232-335, 1996. \n \n\nGEN\u00c9, R.; MARIN, E.; ADZET, T.  Anti-inflammatory effect of aqueous extracts of \nthree species of the genus Baccharis. Planta Medica, v. 58, n. 6, p. 565-566, 1992. \n \n \nGIANELLO, J. C.; GIORDANO, O. S. Examen quimico en seis especies del genero \nBaccharis. Revista Latinoamericana de Quimica, v. 15,  n. 2, p. 84-86, 1984. \n \n\nGIANELLO, J. C.; CIFUENTE, D. A.; GIORDANO, O. S.; TONN, C. E. Bioactive \nflavones and terpenes from Baccharis calliprinos and B. rhetinodes (ASTERACEAE). \nActa Farmaceutica Bonaerense, v. 18, n. 2, p.  99-102, 1999. \n \n \nGIULIANO, D. A. Clasificaci\u00f3n intragen\u00e9rica de las especies Argentinas de \nBaccharis (Asteraceae, Astereae). Darwiniana, v. 39, n. (1 \u2013 2), p. 131 \u2013 154, 2001. \n \n\nGUO, Y.; LI, Y.; XU, J.; WATANABE, R.; OSHIMA, Y.; YAMAKUNI, T.; OHIZUMI, Y. \nBioactive ent-clerodane diterpenoids from the aerial parts of Baccharis \ngaudichaudiana. Journal of Natural Products, v. 69, n. 2, p. 274-276, 2006. \n \n \n\n\n\n 1 0 7\n\nGUO,Y.; LI, Y.; XU, J.; LI, N.; YAMAKUNI, T.; OHIZUMI, Y. Chemical \nPharmaceutical Bulletin, v. 55, n. 10, p. 1532-1534, 2007. \n \n\nGUPTA, M. A. (Ed.) 270 Plantas Medicinales Iberoamericanas. Bogot\u00e1: Cyted-\nSecab-Unesco, 1995. \n \n \nHABERMEHL, G. G. Isolation and structure of new toxins from plants. Pure and \nApplied Chemistry, v. 61, n. 3, p. 377-380, 1989. \n \n \nHABERMEHL, G. G.; BUSAM, L.; HEYDEL, P. MEBS, D.; TOKARNIA, C. H.; \nDOBEREINER, J.; SPRAUL, M. Macrocyclic trichothecenes: cause of livestock \npoisoning by the Brazilian plant Baccharis coridifolia. Toxicon, v. 23, n. 5, p. 731-\n745, 1985. \n \n\nHALLIWELL B.; GULTERIDGE, J. M. C. Free Radicals in Biology and Medicine. \nOxford: Clerodon Press, 1999. \n \n \nHE, K.; MONTENEGRO, G.; HOFFMANN, J. J.  Diterpenoids from Baccharis linearis. \nPhytochemistry, v. 41, n. 4, p. 1123-1127, 1996. \n \n\nHERAS, B.; SLOWING, K.; BENEDI, J.; CARRETERO, E.; TOLEDO, C.; BERMEJO, \nP.; IGLESIAS, I; ABAD, M. J.; GOMEZ \u2013 SERRANILLOS, P.; LISO, P. A.; VILLAR, \nA.; CHIRIBOGA, X. Antiinflamatory and antioxidant activity of plants used in \ntraditional medicine in Ecuador. Journal of Ethnopharmacology, v. 61, n. 2, p.   \n161-166, 1998.  \n \n\nHERZ, W.; PILOTTI, A.; S\u00d6DERHOLM, A.; SHUHAMA, J. K.; VICHNEWSKI, W.  \nNew ent-clerodane-type diterpenoids from Baccharis trimera. Journal of Organic \nChemistry, v. 42, n. 24, p. 3913-3916, 1977. \n \n\nHIKAWCZUK, V. E. J.; ROSSOMANDO, P. C.; GIORDANO, O. S.; SAAD, J. R. neo \n\u2013 Clerodane diterpenoids from Baccharis flabellata. Phytochemistry, v. 61, p. 389 \u2013 \n394, 2002. \n \n\nJAKUPOVIC, J.; SCHUSTER, A.; WASSHAUSEN, D. C. Acetylenes and labdanes \nfrom Baccharis pedunculata. Phytochemistry, v. 30, n. 8, p. 2785-2787, 1991. \n \n\nJARVIS, B. B.; PENA, N. B.; C\u00d6MEZOGLU, S. N.; RAO, M. M. Non-trichothecenes \nfrom Baccharis megapotamica. Phytochemistry, v. 25,  n. 2, p. 533-535, 1986. \n \n\n\n\n 1 0 8\n\nJARVIS, B. B.; C\u00d6MEZOGLU, S. N.; AMONN, H. L.; BREEDLOVE, C. K.; MILLER, \nR. W.; STREELMAN, D. R.; SNEDEN, A. T.; DAILEY Jr, R. G.; KUPCHAN, M. New \nmacrocyclic trichothecenes from Baccharis megapotamica. Journal of Natural \nProducts, v. 50, n. 5, p. 815-828, 1987a. \n \n\nJARVIS, B. B.; WELLS, K. M.; LEE, Y. W. BEAN, G. A.; KOMMEDAHL, T.; \nBARROS, C. S.; BARROS, S. S. Macrocyclic trichothecene mycotoxin in Brazilian \nspecies of Baccharis. Phytopathology, v. 77, n.6, p. 980-984, 1987b. \n \n\nJARVIS, B. B; MIDIWO, J. O.; BEAN, G. A. ABOUL \u2013 NASR, M. B.; BARROS, C.S. \nThe mystery of trichothecenes antibiotics in Baccharis species. Journal of Natural \nProducts, v. 51, n. 4, p. 736-744, 1988. \n \n\nJARVIS, B. B.; MOKHTARI-REJALI, N.; SCHENKEL, E. P.; BARROS, C.S.; \nMATZENBACHER, N. I. Trichothecenes mycotoxins from Brazilian Baccharis \nspecies. Phytochemistry, v. 30, n. 3, p. 789-797, 1991. \n \n \nJARVIS, B.; WANG, S.; COX, C. RAO, M. M.; PHILIP, V.; VARASCHIN, M. S.; \nBARROS, C. S. Brazilian Baccharis toxins: Liverstock poisoning and the isolation of \nmacrocyclic trichothecene glucosides. Natural Toxins, v. 4, n. 2, p. 58-71, 1996. \n \n\nKUPCHAN, S. M.; BAUERSCHMIDT, E. Cytotoxic Flavonols from Baccharis \nsarothroides. Phytochemistry, v. 10, n. 3, p. 664-666, 1971. \n \n\nKUPCHAN, S. M.; STREELMAN, D. R.; JARVIS, B. B.; DAYLEI, R. G. Jr.; SNEDEN, \nA. T. Isolation of potent new antileukemic trichothecenes from Baccharis \nmegapotamica. Journal of Organic Chemistry, v. 42, n. 26, p. 4221-4225, 1977. \n \n\nLABBE, C.; CASTILLO, M.; HERNABDEZ, M. Diterpenoids from Baccharis lej\u00eda. \nPhytochemistry, v. 30, n. 5, p. 1607-1611, 1991. \n \n\nLI, C.J.; AHMED, A. A.; ARIAS, A. C. MABRY, T. J. Clerodane diterpenoids, long \nchain esters of coumaric acid and other compounds from Baccharis myrsinites. \nPhytochemistry, v. 45, n. 3, p.  571-574, 1997. \n \n\nLOAYZA, I.; ABUJDER, D.; ARANDA, R.; JAKUPOVIC, J.; COLLIN, G.; \nDESLAURIERS, H.; IDA, F. Essential oils of Baccharis salicifolia, Baccharis latifolia \nand Baccharis dracunculifolia. Phytochemistry, v. 38, n. 2, p. 381-389, 1995. \n \n\n\n\n 1 0 9\n\nLOPES, G. K.; SCHULMAN, H. M.; HERMES-LIMA, M. Polyphenol tannic acid \ninhibits hydroxyl radical formation from Fenton reaction by complexing ferrous ions. \nBiochemistry Biophysical Acta, v. 1472, n. 1-2, p. 142 \u2013152, 1999. \n \nMELLO, J. C. P. Desenvolvimento gal\u00eanico de macerados de Baccharis trimera \n(less.) DC.-Compositae-(carqueja). 1989. 136 p. Disserta\u00e7\u00e3o (Mestrado) \u2013 \nPrograma de P\u00f3s Gradua\u00e7\u00e3o em Ci\u00eancias Farmac\u00eauticas, Universidade Federal do \nRio Grande do Sul, Porto Alegre, 1989.    \n \n\nMIROCHA, C. J.; ABBAS, H. K.; KOMMEDAHL, T.; JARVIS, B. B. Mycotoxin \nproduction by Fusarium oxysporum and Fusarium sporotrichioides isolated from \nBaccharis spp. from Brazil. Applied e Environmental Microbiology, v. 55, n. 1, p. \n254-255, 1989.  \n \n \nMIROCHA, C. J.; ABBAS, H. K.; TREEFUL, L.; BEAN, G. T-2 toxin and diacetoxys \ncirpenol metabolism by Baccharis spp. Applied and Environmental Microbiology, \nv. 54, n. 9, p. 2277-2280, 1988. \n \n \nMIYAKADO, M.; KATO, T.; OHNO, N.; MABRY, T. J. Pinocembrin and (+)-?-\neudesmol from Hymenoclea monogyra and Baccharis glutinosa. Phytochemistry, v. \n15, n. 5, p. 846, 1976. \n \n\nMONGELLI, E.; DESMARCHELIER, C.; TALOU, J. R.; COUSSIO, J.; CICCIA, G. In \nvitro antioxidant and cytotoxic activity of extracts of Baccharis coridifolia DC. Journal \nof Ethnopharmacology, v. 58, n. 3, p. 157-163, 1997. \n \n\nMONGELLI, E.; PAMPURO S.; COUSSIO, J.; SALOMON, H.; CICCIA, G.  Cytotoxic \nand DNA interaction activities of extracts from medicinal plants used in Argentina. \nJournal of Ethnopharmacology, v. 71, n.1-2, p. 145-151, 2000. \n \n \nMOLT, O.; TRKA, A. Zusammensetzung des brasilianischen vassoura-\u00f3ls aus \nBaccharis dracunculifolia. Parf\u00fcmerie und Kosmetik, v. 64, n. 9, p. 488-491, 1983. \n \n\nMONTANHA, J. A.; MOELLERKE, P.; BORDIGNON, S. A. L.; SCHENKEL, E. P.; \nROEHE, P. M. Antiviral activity of Brazilian plant extracts. Acta Farmac\u00e9utica \nBonaerense, v. 23, n. 2, p. 183-186, 2004. \n \n \nMUSCHIETTI, L.; MARTINO, V.; FERRARO, G.; COUSSIO, J.; SEGURA, L.; \nCARTA\u00d1\u00c1, C.; CA\u00d1IGUERAL, S.; ADZET, T. The antiinflammatory effect of some \nspecies from South America. Phytotherapy Research, v. 10, n. 1, p. 84-86, 1996.   \n \n\n\n\n 1 1 0\n\nNAGATANI, Y.; WARASHINA, T.; NORO, T. Studies on the constituents from the \naerial part of Baccharis dracunculifolia DC. Chemical Pharmaceutical Bulletim, v. \n49, n. 11, p. 1388 \u2013 1394, 2001. \n \n\nPALACIOS, P.; GUTKIND, G.; RONDINA, R. V. D. COUSSIO, J. D. Antimicrobial \nactivity of Baccharis crispa and Baccharis notosergila (II). Planta Medica, v. 49, n. 2, \np. 128, 1983. \n \n\nPAREJO, I.; VILADOMAT, F.; BASTIDA, J.; ROSA-ROMERO, A. SAAVEDRA, G.; \nMURCIA, M. A.; JIMEN\u00c9Z, A. M.; CODINA, C. Investigation of Bolivian plant extracts \nfor their radical scavenging activity and antioxidant activity. Life Sciences, v. 73, p. \n1667-1681, 2003. \n \n\nPAVAN, A. Baccharis trimera Less. (Carqueja Amarga) Uma Planta da Medicina \nPopular Brasileira. Anais da Faculdade de Farm\u00e1cia e Odontologia da \nUniversidade de S\u00e3o Paulo, v. 10, p. 205-214, 1952. \n \n \nPALOMINO, S. S.; ABAD, M. J.; BEDOYA, L. M.; GARC\u00cdA, J.; GONZALES, E.; \nCHIRIBOGA, X.; BERMEJO, P.; ALCAMI, J. Screening of South American plants \nagainst human immunodeficiency virus: Preliminary fractionation of aqueous extract \nfrom Baccharis trinervis. Biological &amp; Pharmaceutical Bulletin, V. 25, n. 9, p. 1147-\n1150, 2002. \n \n \nP\u00c9REZ, F.; MARIN, E.; ADZET, T. The antiinflammatory effect of several \nCompositae from South America extracts in rats. Phytotherapy Research, v. 9, n. 2, \np. 145-146, 1995. \n \n \nRAHALISON, L.; BENATHAN, M.; MONOD, M.; FRENK, E.; GUPTA, M. P.; SOLIS, \nP. N.; FUZZATI, N. Antifungal principles of Baccharis pedunculata. Planta Medica, v. \n61, pp. 360\u2013362, 1995. \n \n \nRENDON, W.; VILA, J. L. Phytochemical study of Baccharis trimera. Revista \nBoliviana de Quimica, v. 12, n. 1, p. 13-15, 1995. \n \n\nRIVERA, A. P.; FAINI, C. L. F.; CASTILLO, M. 15?-hydroxy-?-amirin and Patagonic \nacid from Baccharis magellanica and Baccharis patagonica. Journal of Natural \nProducts, v. 51, n. 1, p. 155-157, 1988. \n \n\nRIZZO, I.; VARSAVKY, E.; HAIDUKOWSKI, M.; FRADE, H. Macrocyclic \ntrichothecenes in Baccharis coridifolia plants and endophytes and Baccharis \nartemisioides plants. Toxicon, v. 35, n. 5, p.  753-757, 1997.  \n\n\n\n 1 1 1\n\nROSSO, L.; MAIER, M. S.; BERTONI, M. D. Trichothecenes production by the \nhypocrealean epibiont of Baccharis coridifolia. Plant Biology, v. 2, p. 684-686, 2000. \n \n\nSAAD, J. R.; DAVICINO, J. G.; GIORDANO, O. S. A Diterpene and Flavonoids of \nBaccharis flabellata. Phytochemistry, v. 27, n. 6, p.  1884-1887, 1988. \n \n\nSALAMA, A. M.; POLO N, A.; CONTRERAS, C. R. MALDONADO, L. Analisis \nfitoquimico y farmacologico preliminar de las hojas de Baccharis decussata. Revista \nColombiana de Ciencias Quimico-Farmaceuticas, v. 16, p. 45-50, 1987. \n \n\nSAKIHAMA, Y.; COHEN, M. F.; GRACE, S. C.; YAMASAKI, H. Plant phenolic \nantioxidant and prooxidant activities: phenolics-induced oxidative damage mediated \nby metals in plants. Toxicology, v. 177, n. 1, p. 67 \u2013 80, 2002. \n \n \nSANTOS FILHO, D.; SARTI, S. J.; VICHNEWSKI, W. BULH\u00d5ES, M. S.; LEIT\u00c3O \nFILHO, H. F. Atividade moluscicida em Bionphalaria glabrata de uma lactona \nditerp\u00eanica e de uma flavona isoladas de Baccharis trimera (Less.) A. P. de Candole. \nRevista da Faculdade de Farm\u00e1cia e Odontologia de Ribeir\u00e3o Preto, v. 17, n. 1, \np. 43-47, 1980. \n \n\nSHARP, H.; BARTHOLOMEW, B.; BRIGHT, C. LATIF, Z.; SARKER, S. D.; NASH, R. \nJ. 6-oxygenated flavones from Baccharis trinervis (Asteraceae). Biochemical \nSystematics and Ecology, v. 29, n. 1, p. 105-107, 2001. \n \n\nSCHENKEL, E. P.; SOBOTTKA, A. M.; LANKHORST, P. P.; SCHRIPSEMA, J. An \nunusual diterpene and other constituents from Baccharis ochracea. Phytochemistry, \nv. 44, n. 4, p. 755-757, 1997. \n \n\nSIM\u00d5ES-PIRES, C. A.; QUEIROZ, E. F.; HENRIQUES, A. T; HOSTETTMANN, K. \nIsolation and on line identification of antioxidant compounds from three Baccharis \nspecies by HPLC-UV-MS/MS with post-column derivatisation. Phytochemical \nAnalysis, v. 16, p. 307-314, 2005. \n \n\nSILVA, M.; MUNDACA, J. M.; SAMMES, P. G. Flavonoid and triterpene constituents \nof Baccharis rhomboidalis. Phytochemistry, v. 10, n. 8, p.  1942-1943, 1971. \n \n\nSOBOTTKA, A. M. Estudo qu\u00edmico de Baccharis ochracea spreng. e Iodina \nrhombifolia Hook. et Arn. e efeito de seus extratos aquosos sobre a \nreprodu\u00e7\u00e3o de ratas. 1992. 102 p. Disserta\u00e7\u00e3o (Mestrado) - Curso de P\u00f3s-\nGradua\u00e7\u00e3o em Ci\u00eancias Farmac\u00eauticas, Universidade Federal do Rio Grande do \nSul, Porto Alegre, 1992. \n\n\n\n 1 1 2\n\n \n \nSOICKE, H.; LENG-PESCHLOW, E. Characterization of flavonoids from Baccharis \ntrimera and their antihepatotoxic properties. Planta Medica, v. 53, n. 1, p. 37-39, \n1987. \n \n\nSTAPEL, G.; MEN?EN, H. G.; SNATZKE, G. Isolierung und strukturaufkl\u00e4rung von \nzwei diterpenen aus Baccharis articulata. Planta Medica, v. 39, n. 4, p. 366-374, \n1980. \n \n\nTOKARNIA,C. H.; DOBEREINER, J. Intoxica\u00e7\u00e3o experimental em ovinos por \u201cMio-\nmio\u201d, Baccharis coridifolia. Pesquisa Agropecu\u00e1ria Brasileira S\u00e9rie Veterin\u00e1ria, v. \n11, p. 19-26, 1976. \n \n \nTONN, C. E.; GIANELLO, J. C.; GUIDUGLI, F. H. Some essential oil components of \nBaccharis crispa and Baccharis articulata. Anales de la Asociacion Quimica \nArgentina, v. 75, n. 1, p. 5-6, 1987. \n \n\nVARASCHIN, M. S.; BARROS, C. S. L.; JARVIS, B. B. Experimental poisoning by \nBaccharis coridifolia (Compositae) in cattle. Pesquisa Veterin\u00e1ria Brasileira, v. 18, \nn. 2, p. 69-75, 1998. \n \n\nVERASTEGUI, M. A.; SANCHEZ, C. A.; HEREDIA, N. L.; GARCIA-ALVARADO, J. \nA. Antimicrobial activity of extracts of three major plants from the Chihuahuan Desert. \nJournal of Ethnopharmacology, v. 52, pp. 175\u2013177, 1996. \n \n \nVERDI, L. G.; BRIGHENTE, I. M. C.; PIZZOLATTI, M. G. G\u00eanero Baccharis \n(Asteraceae): Aspectos qu\u00edmicos, econ\u00f4micos e biol\u00f3gicos. Qu\u00edmica Nova, v. 28, n. \n1, p. 85-94, 2005. \n \n \nW\u00c4CHTER, G. A.; MONTENEGRO, G.; TIMMERMANN, B. N. Diterpenoids from \nBaccharis pingraea. Journal of Natural Products, v. 62, n. 2, p. 307-308, 1998. \n \n \nWAGNER, H.; IYENGAR, M. A. Flavonol-3-glucosides in Baccharis angustifolia and \nBerlandiera pumila. Phytochemistry, v. 11, n. 1, p. 444, 1972. \n \n\nWAGNER, H.; SEITZ, R., LOTTER, H.; HERZ, W. New furanoid ent-clerodanes from \nBaccharis tricuneata. Journal of Organic Chemistry, v. 43, n. 17, p. 3339-3345, \n1978. \n \n\n\n\n 1 1 3\n\nWARNING, U.; BOHLMANN, F.; SANCHEZ, H.; DEL RIO, S. E.; DOMINGUEZ, X. A. \nNew constituents of Baccharis salicifolia. Revista Latinoamericana de Quimica, v. \n17, n. 3-4, p. 199-200, 1986.  \n \n\nZAMORANO, R.; AGUIRRE, M. E.; MU\u00d1OZ DE LA PENA,  A. et al. Flavonoids from \nBaccharis concava Pers. Boletin de la Sociedad Chilena de Quimica, v. 32, n. 2, \np. 101-103, 1987.  \n \nZARDINI, E. M. Etnobot\u00e1nica de Compuestas Argentinas com especial referencia a \nsu uso farmacol\u00f3gico (primera parte). Acta Farmaceutica Bonaerense, v. 3, n. 1, p. \n77-99, 1984. \n \n\nZDERO, C.; BOHLMANN, F.; KING, R. M. ROBINSON, H. Diterpene glycosides and \nother constituents from Argentinian Baccharis species. Phytochemistry, v. 25, n. 12, \np. 2841-2855, 1986. \n \n\nZDERO, C.; BOHLMANN, F.; SOLOMON, J. C.; ROBINSON, H. ROBINSON, H. Ent-\nclerodanes and other constituents from Bolivian Baccharis Species. \nPhytochemistry, v. 28, n. 2, p. 531-542, 1989. \n \n\nZDERO, C.; BOHLMANN, F.; NIEMEYER, H. M. An unusual dimeric sesquiterpene \nand other constituents from chilean Baccharis species. Phytochemistry, v. 30, n. 5, \np. 1597-1601, 1991. \n \n\nZUNINO, M. P.; NEWTON, M. N.; MAESTRI, D. M.; ZYGADLO, J. A. Essential oils of \nthree Baccharis species. Planta Medica, v. 64, n. 1, p. 86-87, 1998. \n \n\nZUNINO, M. P.; LOPEZ, M. L.; FAILLACI, S. M. LOPEZ, A. G.; ESPINAR, L. A.;  \nZYGADLO, J. A. Essential oil of Baccharis cordobensis Heering. Flavour and \nFragrance Journal, v. 15, n. 3, p. 151-152, 2001. \n \n \nh t t p : / / w w w . i b . u n i c a m p . b r / p l a n t - a q - S P / i m g / p l a n t a s / B a c c h a r i s . h t m l  (acesso em \n14/12/2007). \n \n\n \n\n\n\n 1 1 4\n\nBiografia \n \n\nDados Pessoais \n \n\nNome: Simone Quintana de Oliveira \n\nData de nascimento: 07/04/73 \n\nNaturalidade: Porto Alegre/RS \n\nNacionalidade: Brasileira \n\nFilia\u00e7\u00e3o: Moacir Viegas de Oliveira e Eva Eloina Quintana de Oliveira \n\nProfiss\u00e3o: Farmac\u00eautica \n\n \n\nDados Acad\u00eamicos \n\n \n\n1992/02: Ingresso na Faculdade de Farm\u00e1cia da Universidade Federal do Rio \n\nGrande do Sul. \n\n \n\n1997/02: Obten\u00e7\u00e3o do Grau de Farmac\u00eautico - Faculdade de Farm\u00e1cia da \n\nUniversidade Federal do Rio Grande do Sul. \n\n \n\n1995-1998: Bolsista de Inicia\u00e7\u00e3o Cient\u00edfica (PROPESQ \u2013 UFRGS) no Programa de \n\nP\u00f3s-Gradua\u00e7\u00e3o em Ci\u00eancias Farmac\u00eauticas da Faculdade de Farm\u00e1cia (UFRGS) \n\nsob a orienta\u00e7\u00e3o do Prof. Dr. Volker Spitzer. \n\n \n\n1998-2000: Bolsista de Inicia\u00e7\u00e3o Cient\u00edfica (CNPq) no Programa de P\u00f3s-Gradua\u00e7\u00e3o \n\nem Ci\u00eancias Farmac\u00eauticas da Faculdade de Farm\u00e1cia (UFRGS) sob a orienta\u00e7\u00e3o \n\ndo Prof. Dr. Eloir Paulo Schenkel. \n\n \n\nmar\u00e7o/2000-abril/2002: Bolsista de Mestrado (CAPES) no Programa de P\u00f3s-\n\nGradua\u00e7\u00e3o em Ci\u00eancias Farmac\u00eauticas da Faculdade de Farm\u00e1cia (UFRGS) sob a \n\norienta\u00e7\u00e3o da Profa. Dra. Grace Gosmann. \n\n \n\n\n\n 1 1 5\n\nAgosto/2003: Ingresso no Doutorado no Programa de P\u00f3s-Gradua\u00e7\u00e3o em Ci\u00eancias \n\nFarmac\u00eauticas da Faculdade de Farm\u00e1cia (UFRGS) sob a orienta\u00e7\u00e3o da Profa. Dra. \n\nGrace Gosmann. \n\n \n\nBolsista de Doutorado (CNPq) no Programa de P\u00f3s-Gradua\u00e7\u00e3o em Ci\u00eancias \n\nFarmac\u00eauticas da Faculdade de Farm\u00e1cia (UFRGS) a partir de setembro de 2005. \n\n \n\nPublica\u00e7\u00f5es \n\nDe OLIVEIRA, S. Q., DAL PIZZOL, F., GOSMANN G.; GUILLAUME, D.; MOREIRA, \n\nJ. C. F.; SCHENKEL, E. P.  Antioxidant activity of Baccahris articulata. Isolation of its \n\nactive constituent. Free Radical Research, v. 37, n. 5, p. 555-559, 2003. \n\nDe OLIVEIRA, S. Q., DAL PIZZOL, F., MOREIRA, J. C. F.; SCHENKEL, E. P.; \n\nGOSMANN, G. Antioxidant activity of Baccahris spicata, Baccharis trimera and \n\nBaccharis usterii. Acta Farmac\u00e9utica Bonaerense, v. 23, n. 3, p. 365-368, 2004. \n\nDe OLIVEIRA, S.Q., TRENTIN, V.H., KAPPEL, V.D., BARELLI, C., GOSMANN, G., \n\nREGINATTO, F. Screening of Antibacterial Activity of South Brazilian Baccharis \n\nSpecies. Pharmaceutical Biology, v. 43, n. 5, p. 434\u2013438, 2005. \n\nDe OLIVEIRA, S.Q., BARBON, G., GOSMANN, G. BORDIGNON, S. Differentiation \n\nof South Brazilian Baccharis Species by TLC. Journal of Liquid Chromatography \n&amp; Related Technologies, v. 29, p. 2603\u20132609, 2006."}]}}}